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Cryphonectria parasitica is the causal agent of chestnut blight, which devastated
the American Chestnut tree population in the early 20th century. The discovery of
hypoviruses that reduce the severity of the chestnut blight infection offers the potential
for biological control. However, the spread of the hypoviruses is hampered by a diverse
genetically controlled nonself-recognition system, vegetative incompatibility
(vic). CPVIB-1 was identified as a transcription regulator playing an important role in the
programmed cell death response to this stimulus. In this study, we have found that
CPVIB-1 is ubiquitin-decorated which might lead to its degradation in the proteasome
pathway. RNA-Seq and ChIP-Seq were used to further explore the downstream targets of
CPVIB-1 that mediate the various metabolic changes that lead to the altered phenotype of
the Δcpvib-1 mutant. Due to inaccuracies in the prior annotation, we performed a genome
re-annotation to improve the accuracy using a MAKER2-two-pass pipeline. To validate
the improvement a second pipeline, PEPA, was developed to compare quality metrics
between the old and new annotations. Approximately 1/3 of the original annotations from
2009 were found to be inaccurate. Experimental confirmation by testing 27 predicted

genes using a diagnostic PCR protocol to differentiate between prior and new transcript
structures showed that over 80 % of tested genome locations supported for the new
annotation. Using rapamycin treatment to mimic stimulation of the vic response and
applying the RNA-seq and ChIP-seq data to this new information, we found that CPVIB1 is related to TOR signaling pathways, promoting autophagy and the proteasome
pathway, but repressing carbon metabolism, protein and lipid biosynthesis. In depth
analysis of CPVIB-1-bound DNA targets showed that this protein is a member of the
GAGA regulator family, a group of multifaceted transcription factors with diverse roles
in gene activation and repression, maintenance of mitosis, and cell development.
Following treatment with rapamycin the recognition sequence bound by CPBVIB-1 was
altered leading to the regulation of different suite of genes with diverse metabolic
functions. Ultimately, we have developed a revised model of TOR signaling pathway
where TORC1 and TORC2 signaling pathways are connected by the action of CPVIB1.
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INTRODUCTION
Cryphonectria parasitica causes chestnut blight.
Fungus C. parasitica
In 1906, William A. Murrill first reported a new fatal epidemic disease, chestnut
blight, of native American chestnut (Castanea dentata), which he observed in New York
City, New Jersey, Maryland, the District of Columbia as well as Virginia [1; 2]. The pure
culture of the fungus causing the chestnut blight was obtained and isolated from the
infected chestnut twigs collected in the New York Botanical Garden [1]. The disease
starts from the fungus entering through a wound or dead limb of the tree and growing
under the cortex in the layers of the inner bark and cambium. The symptom of the
infection in chestnut tree bark is a brown and soft canker with numerous yellowish-brown
fruiting pustules called pycnidia containing massive amounts of spores[1]. Both the
asexual conidia and the sexual ascospores are able to be dispersed into fresh wounds of
trees rapidly by wind and rain as well as transmitted by beetles and birds (Figure 1.1) [2;
3]. In time, depending on the size of the infected area, the fungus starts to form a canker
around the infected spot, eventually girdling the stem or branch, leading to death [2].
Unfortunately, the mycelium of the fungus growing on the tree was found so active and
well protected that no treatment was proved to be effective [1].
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In the Murrill’s report, the fungus was named Diaporthales parasitica, a sac fungi
species based on the observation of the mycelium and spore morphology in the life cycle.
In 1978, based on the DNA sequence comparison and phylogenetic analysis, the chestnut
blight fungus was identified as one species of phylum ascomycetes, class
Sordariomycetes, order Diaporthales, and family Cryphonectriaceae and revised with a
worldly accepted new name Cryphonectria parasitica (Murr.) [4].
C. parasitica devastated the American chestnut Castanea dentata
American chestnut trees (Castanea dentata) were once dominant, the major
hardwood trees in the forests of the eastern regions of the USA [5]. In the southern part of
its range, American chestnut trees generally grew to 37 meters tall and 1.5 meters in
diameter. Due to the wood being extremely hard and resistant to decay, the American
chestnut was widely utilized for construction, furniture, railroad ties, musical instruments,
and many other items [5]. The nuts used to be an important source of food for wildlife,
domestic livestock, and humans. Furthermore, the tannins extracted from the bark and
wood used to provide for the basis of a large tanning industry [4-6]. Since C. parasitica
was introduced into North American and spread rapidly, it devastated the American
chestnut throughout its natural range by killing about 3.6 million hectares of American
chestnut trees, an estimated loss of four billion stems, within 50 years (Figure 1.2) [5; 78]. This filamentous fungus colonized in the wounded cambium of tree stems regardless
of the size, except the root systems that are protected in the soil. Root-collar sprouts
formed from the uninfected root systems allow the tree to start the asexual reproduction
in the natural forests, but frequently become infected with blight fungus again [8], thus
providing a continuous inoculum to the surrounding forest. Unfortunately, the rare
2

existence of the sexual reproduction in nature leads to the functional extinction of the
American chestnut trees in the current forests [8].
Hypoviruses, a potential way to save American chestnut trees
C. parasitica was also reported in Europe in 1938, near Genova, Italy where the
fungus spread rapidly and caused the serious cankers on European chestnut trees as well
[9]. However, the damage caused by the fungus was found to have less severity in Europe
than in North America, leading to the discovery of the double strands RNA virus,
Hypovirus [9]. In 1951, some healed cankers with the fungal mycelium only growing on
the outer layers of the bark was discovered resulting in the chestnut trees survival from
the infection and this phenomenon was called hypovirulence [10]. Later, the hypovirulent
fungal strain was found to contain the high molecular weight double-stranded RNA
(dsRNA) leading to the white hypovirulence phenotype (Figure 1.3) [11]. Molecular
characterizations have shown hypovirus lacks capsid structures [12]. The best
characterized type of hypoviruses, the CHV-1 family, have dsRNA approximately 12.7
kb in length that contains two open reading frames (ORFs), ORF A encoding a papainlike protease that generates two polypeptides p29 and p40, and ORF B encoding a similar
protease p48 at amino-terminus (N-terminal) and containing regions of RNA-dependent
RNA polymerase (RdRp) and helicase (Hel) binding motifs, but with as yet undetermined
mature protein products [13-15]. It was found that the dsRNA was successfully
transmitted to the virulent strains by converting them to hypovirulence through hyphal
anastomosis [16]. Since then, this chestnut blight fungus and its associated hypovirus
have been widely studied to provide a potential biocontrol strategy to restore the chestnut
trees from the blight in North America [9; 17].
3

Vegetative Incompatibility, limiting the transmission of hypoviruses among C.
parasitica strains
In the United States, since 1975, the hypoviruses have been released into the
natural forests for the biological control of chestnut blight [18]. However, almost all these
efforts have resulted in the failure of transmitting the hypoviruses among the various
strains of C. parasitica [18]. The main factor that has received most attention is the
vegetative incompatibility system that restricts the hypovirus transmission between
individuals. Vegetative incompatibility is a self/nonself-recognition system that results in
the program cell death when cells of two incompatible individuals anastomose [19]. As a
defense mechanism of fungi, vegetative incompatibility is genetically regulated to trigger
programmed cell death to prevent the mixing of cytoplasm of one individual with another
during hyphal fusion when the horizontal transmission of hypoviruses can occur [20].
Vegetative incompatibility is a common phenomenon in the filamentous
ascomycete fungi. In model species Neurospora crassa and Podospora anserina, a few
genes that control this process were characterized at the molecular level [21].
Heterokaryon incompatibility (het) genes of the two species were characterized to encode
the proteins containing the conserved HET domain, which induces the recognition signal
and activates the programmed cell death process [22]. In C. parasitica, vegetative
incompatibility is controlled by at least six unlinked vegetative incompatibility loci (vic
loci), with two alleles at each locus [23]. Individuals are compatible if they share the
same alleles at all vic loci, but are incompatible if they differ at one or more locus. The
six unlinked vic loci (vic1, vic2, vic3, vic4, vic6, vic7) have been characterized through
linkage mapping and comparative genomics [24]. Most of them contains the common
HET domain and NACHT/WD40 domain, which were found to associate with the
4

activation of programmed cell death in vegetative incompatibility [20; 25]. At vic4, two
alleles encoding a 359 amino acids protein kinase c-like and a 1,628 amino acids
NACHT/P-loop and WD40 repeats domains, respectively, were identified (vic4-1 and
vic4-2) [24]. The two individuals differing at the vic4 (with vic4-1 and vic4-2 genotype
respectively) were found to form the barrage triggered by the above genes during
anastomosis, but it was found not to impede the transmission of the hypovirus like the
other loci, and the mechanism of this phenomenon is still unclear [26].
CPVIB-1, a transcription factor that is essential for the vegetative incompatibility
trigged by vic4
Transcription factors are a group of proteins that bind to specific DNA sequences
to mediate the expression levels of target gene in response to a signal [27]. There is a
class of p53-like transcription factors that is known as NDT80/PhoG-like DNA-binding
family, the Ndt80 protein from Saccharomyces cerevisiae is one of the first members
found to bind to the middle sporulation element (MSE) to trigger the expression of 150
genes during meiosis [28-29]. The number of NDT80-like genes in fungi are varied as
well as their roles, which include regulation of meiosis, sexual development, virulence
and the response to nutrient stress and programmed cell death [30-31].
In N. crassa, a mutant in an ORF named VIB-1 (vegetative incompatibility
blocked) was found to suppress the phenotypic aspects of vegetative incompatibility
trigged by the het-c locus [32]. VIB-1 was identified as a putative 670 amino acids
transcriptional factor due to its NDT80/PhoG-like coding domain, an ortholog of Ndt80
gene of S. cerevisiae [33]. Later, VIB-1 was characterized to localize and aggregate in the
nuclei supporting its DNA binding characteristics [33]. qPCR analysis revealed that VIB5

1 is essential for the expression of several genes involved in programmed cell death
triggered by vegetative incompatibility, such as pin-c, het-6, and tol [32-33]. Further
study suggested that CPVIB-1 functions as a regulator of hyphal compartmentation, death
rates and conidiation in vegetative incompatibility as well as a repressor of glucose
metabolism [34].
In the chestnut blight fungus C. parasitica, an ortholog of VIB-1 of N. crassa, the
putative CPVIB-1 was identified by Rong Mu (unpublished study). CPVIB-1 was found
to produce a protein of 649 amino acids in length, share 48% identity with VIB-1 of N.
crassa, and contain a NDT80/PhoG-like domain (unpublished study). In order to
characterize the role of the CPVIB-1 such as vegetative incompatibility, virulence,
hyphal growth, and the programmed cell death process, a cpvib-1 deletion strain was
generated. The cpvib-1 deletion strain was observed with phenotype shifting in various
aspects, including virulence, hyphal growth, sporulation, and vegetative incompatibility
regulation.
The Dcpvib-1 mutant strain shows reduced hyphal extension and profuse conidiation,
indicating CPVIB-1 is required for fungal cell growth and to regulate the signals
controlling sporulation (Figure 1.5). The deletion of cpvib-1 largely decreasing the canker
formation on the chestnut stems indicates that CPVIB-1 plays a direct or indirect role in
virulence (Figure 1.6 (A)). Statistical analysis shows the canker size of the ∆cpvib-1
strain is significantly smaller compared to both EP155 wild type (WT) strain and its
hypovirus-infected strain (Figure 1.6 (B)). Also, the deletion of cpvib-1 alters the barrage
formation pattern between EU1 and EP155 strain, which differ from each other in the
vic4 loci (Figure 1.7). The barrage formation was observed between EU1 and EP155
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(Figure 1.7 (A)) but disappeared when cpvib-1 was disrupted from both sides (Figure 1.7
(B)) implying that CPVIB-1 is required for the barrage formation in vegetative
incompatibility triggered by vic4 (unpublished study, R. Mu).
In conclusion, consistent with the roles of VIB-1 in N. crassa, CPVIB-1 in C.
parasitica is crucial for vegetative incompatibility triggered by at least one allelic
mismatch, hyphal growth, sporulation, and pathogenesis.
The goal of this project
The primary objective of this study is to identify the direct and indirect targets of
CPVIB-1 in C. parasitica to further build the complete pathway for the vegetative
incompatibility system. As a transcription factor with a NDT80/PhoG like domain,
CPVIB-1is hypothesized to bind specifc DNA sites in the genome to activate or repress
the transcription of its targeted genes, which then affect their downstream factors. We
propose two strategies to achieve the goal. The first strategy is the large scale
transcriptome sequencing (RNA-Seq) of the EP155 wild type and its isogenic Dcpvib-1
strain. Transcriptome comparison analysis is the critical step to provide the informative
insights into the downstream effectors of CPVIB-1 with the well accepted bioinformatics
pipeline and reliable genome reference. The second, more challenging, stategy is to
identify the exact binding locations of CPVIB-1 by using ChIP-Seq (Chromatin
Immunoprecipitation and Sequencing). This will use a tagged CPVIB-1 protein
containing the FLAG peptide, cross-link it with its bound DNA, fragment the DNA, then
immunoprecipitate the protein-DNA complex with specific antibodies to recover the
DNA fragments bound to the CPVIB-1 protein, prior to sequencing the bound sites using
a high throughput platform. A critical and initially overlooked factor that affects both the
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transcriptome comparison analysis and ChIP-Seq analysis was the availability of an
accurate and reliable genome reference and annotation, which brings up the second
objective of this study.
The second objective of this study became a re-annotation of the C. parasitica
genome with improved accuracy and enriched structual and functional information.
Using outdated bioinformatics tools, the shortage of transcripts evidence (ESTs from
Sanger sequences), and the discovery of mistakenly annotated genes (Willyerd, et al.
unpublished data), the prior genome annotation (2009-version) from JGI (Joint Genome
Institute) was hypothesized to be in a poor condition with misannotated gene models
structurally and functionally. The general existence of the inaccurately predicted gene
models could impact studies to identify specific functional genes as well as studies of
revealing the regulation mechanisms using genome scale strategies. We therefore set out
to re-annotate the genome of C. parasitica with the advanced MAKER2-two-pass
pipeline to generate gene models to train the predictors and provide the quality metrics
system, the RNA-Seq data to provide sufficient transcripts evidence, and the newly
UniProt/SwissProt protein database to provide more experimentally reviewed protein
evidence. With this re-annotated version (2017-version), the first objective of this study
was carried out relying on this improved annotation to provide more accurate and
informative results. However, with both the prior annotation and the re-annotated version
available, it was necessary to carry out a comparison between them to report their
differences in structural and functional predictions and their accuracy as well, which
became the third objective of this study.
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The third objective of this study was to develop a pipeline to evaluate the prior
annotation of C. parasitica and compare it to the re-annotated version with the purpose of
evaluating each of the gene predictions, and finally sort them into four categories
corresponding to their accuracy and consistency between the annotations.
In summary, this study began with investigations of the vegetative incompatibility
pathway of C. parasitica using newly available high throughput transcriptome and ChIPSeq technologies. Fulfillment of those goals also necessitated re-annotating and
validating gene model predictions in order to be confident that the results of our studies
would be as accurate as possible. As a beneficial by-product of this work, we have
developed a novel pipeline for genome annotation comparisons that is broadly applicable
to other experimental systems, and also greatly improved the accuracy of genome
resources available to the community of researchers working with C. parasitica.
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Figure 1.1

Infection cycle of C. parasitica in American chestnut trees based on
information read in reference [3].

The mycelium in the infected canker region is able to produce conidia with asexual
reproduction process as well as ascospores with sexual reproduction process by mating
with spores from other strains. Both conidia and ascospores are able to enter fresh
wounds in another American chestnut tree by the dispersion of vectors, such as wind,
rain, and insects and germinate to orange mycelium leading to the formation of the
canker in this infected regions.
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Figure 1.2

The natural range of American chestnut trees [8].

The gray shaded area represents the natural range of American chestnut populations; the
dash lines represent the progress of the disease during the first half of the 20th century.

11

(A)
Figure 1.3

(B)

The phenotype comparison of the two representative C. parasitica strains.

(A) represents the phenotype of EP155 wild type strain without hypovirus infection, (B)
represents the phenotype of EP155 wild type strain with hypovirus infection.
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Figure 1.4

Vegetative incompatibility (vic) assay displaying the compatible and
incompatible phenotypes [24].

The bottom image represents the incompatible phenotype with a red arrow pointing to the
barrage lines (a line of dead cells) that forms when two individuals that differ at one or
more vic locus merge and trigger the programmed cell death.
The left and right two images represents the compatible phenotype.
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Figure 1.5

CPVIB-1 regulates sporulation and aerial hyphal growth [35].

(A) Morphological phenotype representatives of the cpvib-1 deletion, complementary and
overexpression mutants (∆cpvib-1, OECPVIB-1-∆cpvib-1, OECPVIB-1-EP155) as
compared to the EP155 wild type strain when grown on petri plates. Sporulation and
aerial hyphal growth patterns were shown under each strain. ∆cpvib-1 strain produces
profuse spores and reduced aerial hyphal growth compared to EP155 strain. (B)
Quantitative analysis of sporulation using individual median test to determine pairwise
differences with three biological replicates. Levels not connected by the same letter are
significantly different [35].
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Figure 1.6

CPVIB-1 is important for fungal pathogenicity[35].

(A) Representative virulence assays on dormant chestnut stems carried out for 28 days.
Canker sizes were labeled with red lines for each strain. (B) Graphical representation of
the virulence assay using individual median test to determine pairwise differences with
three biological replicates. Levels not connected by the same letter are significantly
different. Y-axis: Canker size (mg) after 28 days [35].
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Figure 1.7

CPVIB-1 is involved in vegetative incompatibility [35].

(A) EP155 (WT) demonstrating incompatibility with EU1 but compatibility to EU5. (B)
Deletion of cpvib-1 from both EP155 and EU1 and EU5 changes the compatibility
between EP155 and EU1 but keeps the compatibility unchanged between EP155 and EU5
[35].
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RE-ANNOTATION OF THE GENOME OF CRYPHONECTRIA PARASITICA
Abstract
Next generation sequencing (NGS) technologies create great opportunities for
various genomics, transcriptomics and proteomics projects of exotic non-model
organisms. A well-annotated genome reference is critical for these projects like exploring
target genes’ functions or characterizing gene expression profiles. However, the errors in
the annotation are often present in existing databases such as NCBI and JGI because of
the lack of supporting evidence. Now, for exotic organisms, having the assembled
genomes, detailed transcript evidence from RNA-Seq and more recent curated proteins
database available, provides opportunities to perform a better quality new genome
annotation or an improved re-annotation. Therefore, a practical MAKER2-two-pass
pipeline was designed to perform a re-annotation of the genome of C. parasitica. This
resulted in 11,171 predicted gene models, with 92% of them having coding domains
matching various databases, and 78.36% of them having at least one conserved domain
and important coding sites with an InterPro ID. The re-annotation provided new
structural and functional features including, mRNA, UTRs and quality metrics system
and ortholog proteins names, conserved domain IDs, and GO terms (Gene Ontology
terms), separately. Together, these results suggested that the re-annotation provides an
improved annotation version in both accuracy and information details.
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Introduction
Next generation sequencing (NGS) techniques have dramatically dropped the
costs of genome sequencing projects leading to unprecedented opportunities for many
non-model organisms’ genome projects [36]. At the time of writing, 5,386 eukaryotes
genome sequences are recorded in NCBI genomes database with “scaffold or contigs”
and “Chromosomes” status, indicating those are at the amenable stage for gene and
genome annotation.
Most recent gene predictors for annotation were built based on the Hidden
Markov Model (HMM), which defines probability distributions statistically for sections
of genomic sequences in eukaryotes, like introns, exons, untranslated regions (UTRs),
etc. [37]. The accuracy of gene prediction with the above tools mainly depends on the
amount of evidence to pinpoint boundaries between each two states, such as intron-exon
boundaries or UTR-exon boundaries[38].
Yet, in many ways, the genome annotation for non-model organisms has
encountered a lot of challenges. One of the factors responsible for this is the absence of
sufficiently large and reliable experimental evidence for the gene finder algorithms.
Second is the lack of pre-existing gene models like the first generation of genome
projects with relatively large resources [39].
By investigating gene expression profiles using RNA-Seq data aligned to a
reference genome [40], the advance of NGS technologies and the corresponding
bioinformatics tools have allowed more and more non-model organisms to have
unprecedented opportunities for their unique metabolic pathways to be
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explored. However, there are many challenges in obtaining the reliable results from such
projects especially given the lack of a high-quality genome annotation.
The genome project of the C. parasitica was carried out in 2009 using
predominantly Sanger sequencing technology, and along with its first version of gene
predictions, was released by the Joint Genome Institute (JGI). Although this was a
significant advance at the time, the bioinformatics tools used, and the lack of quality
metrics, have made this information outdated. Contributing to this problem were the use
of low coverage expressed sequence tags (ESTs), a then current (but now outdated)
proteins database, and the fact that there were only 15 gene models of C. parasitica
reviewed in Swiss-Prot database with experimental evidence. Considering these factors, it
is no surprise that there are mistakenly annotated gene models structurally and
functionally in the first annotation version of C. parasitica.
While it is not feasible for any genome annotation, to be 100 % accurate,
inaccurately predicted gene models have the potential to impact the studies of functional
genes and domains of interest that relate to all aspects of the organism’s biology. Before
the work performed for this study, there were at least four genes on different scaffolds of
the C. parasitica Ep155 assembled genome that were identified as not matching the
predictions from the first annotation (2009-version). Three of them were transcribed in
different regions and one was found with different reading frame (Willyerd, Pokharel,
Ren and Dawe, unpublished observations).
Furthermore, our initial transcriptome profiling project using knock-out strains for
different genes of interest failed to provide efficient and informative output. Moreover,
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these errors found in the C. parasitica Ep155 strain are common for a genome project of
its age with insufficient evidence, annotation tools and strategy [41-42].
Fortunately, the NGS high-throughput RNA-Seq technique offers an enormous
amount of assembled transcript data to help predict new genes and transcripts [41-42].
Out of all forms of evidence, high quality RNA-Seq assembled transcriptome sequences
have the greatest potential to improve the accuracy of gene annotations, as these data
provide copious evidence for better delimitation of exons, splice sites and alternatively
spliced exons [39]. Compared to first-generation sequencing, NGS could generate more
than 500 gigabases in a single run creating a great opportunity to improve annotation
quality and reveal each transcript with high coverage, high sensitivity and high dynamic
range [43].
In this study, we proposed to re-annotate the genome of C. parasitica taking
advantage of more transcript evidence from the NGS transcriptome sequencing (RNASeq) and the newly updated protein evidence from the UniProt/SwissProt database
consisting of all manually annotated and reviewed proteins. The Illumina HiSeq2500
platform was used to sequence three samples of the transcriptome from the C. parasitica
Ep155 strain in the 100bp pair end mode. Each sample library yielded between 45 and 51
million 100 bp reads for a total of about 21 Giga bases of sequence data. With the
abundant RNA-Seq data, the genome reference based transcriptome assembly was in
order to provide assembled transcript evidence to the re-annotation process using the
widely accepted Tophat and Cufflinks Tuxedo suite pipeline [44].
The second advantage of this study was to use the advanced MAKER2-two-pass
optimum annotation pipeline, which is a configurable genome annotation and curation
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pipeline incorporating three gene predictors, GeneMark-ES, SNAP and Augustus[38; 4548].
An important feature of this pipeline is GeneMark-ES-3.0, a self-training gene
predictor employing an unsupervised training procedure to produce a reliable ab initio
gene model training sets for subsequent gene finder methods, SNAP and Augustus [47].
Then, the HMM based gene finder Augustus was used to find an optimal parse of a given
genomic sequence. The advantage of using SNAP is to allow for both change of the
underlying HMM and flexible inputs from the above steps, resulting in iteratively
improved training sets with transcriptome and protein evidence [45; 49-50]. MAKER2 is
an annotation management tool that combines all three of the above gene predictors along
with built-in tools, including RepeatMasker, BLAST+, and Exonerate. It provides an
easy-to-use way to either perform a de novo genome annotation with a new genome, or
update a pre-existing annotation with quality-control metrics, by aligning protein and
RNA evidence in a splice-aware manner to accurately identify splice sites [45].
The resulting C. parasitica genome re-annotation provides more accurate and
informative predicted gene models than the prior annotation (2009-version). New
structural and functional features as well as quality metrics system for each predicted gene
model were generated in this study based on more evidence and better tools. Overall, this
new annotation, named 2017-version, provided an improved annotation file and facilitates
the future gene identification and characterization in C. parasitica.
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Materials and Methods
Fungal transcriptome preparation and RNA-sequencing
Mycelia of C. parasitica’s wild type strain EP155 were cultured in potato
dextrose broth (PDB; Difco, Sparks, MD) on the benchtop under ambient conditions. The
cultures were homogenized and diluted with fresh media (1:1 volume) and allowed to
grow for an additional 16-18 hours to achieve log phase fungal cells for RNA extraction.
Following harvesting by filtration through Miracloth, the cultures were then immediately
ground to a fine powder by using a sterilized mortar and pestle with liquid nitrogen [51].
Total RNA was then isolated from about 30 mg powered mycelia using RNeasy® mini
kit (Qiagen) according to the manufacturers protocol. Next, the quality of the total RNA
was determined by agarose gel and analysis on an Agilent 2100 Bioanalyzer®
(www.chem.agilent.com). Briefly, 1 µg total RNA with a RNA integrity number (RIN) of
8 or higher was enriched for mRNA using Illumina TruSeq RNA sample preparation Kit
v2, Set B (Illumina, #RS-122-2001) according to manufacturer’s instruction. Next, the
Bioanalyzer was used to detect size distribution of the transcriptome after fragmentation
and adapter ligation, and a Qubit® Fluorometer (InvitrogenTM, Waltham, MA) was used
to quantify the yield post-PCR amplification. Finally, the pooled cDNA libraries with 10
µM concentration from each sample were sequenced on Illumina HiSeq2500 platform in
a 2 x 100bp paired-end (PE) configuration with High Output mode (V4 chemistry) at
Genewiz (South Plainfield, NJ).
Reference based transcriptome assembly
A python pipeline script was written to perform one-step transcriptome assembly
with the raw RNA-Seq FASTQ files obtained from three biological replicate samples
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above by using the open source software programs of the Tuxedo suite and other
auxiliary programs (Figure 2.1) [52]. First, a widely applied quality assessment software
FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) was used to exam
the quality of the reads, which indicated no need for any trimming process. All
sequencing files were then aligned to C. parasitica reference genome from JGI
MycoCosm genome portal (http://genome.jgi.doe.gov/Crypa2/Crypa2.download.html)
with Bowtie2 (http://bowtie-bio.sourceforge.net/bowtie2/index.shtml) and TopHat
(https://ccb.jhu.edu/software/tophat/index.shtml) to discover transcripts splice sites, using
default parameters [44]. Subsequently, Cufflinks was utilized to assemble the transcripts
from all successfully aligned reads of each sample, followed with running Cuffmerge to
merge their assemblies together into an integrated reference transcriptome annotation file
[ 42; 44; 52]. The python script file Transcritpome.assemble.pipeline.py is available from
the GitHub website (https://github.com/didiren/transcriptome_assembly) and can be
applied to run one-step transcriptome assembly in any system with Bowtie2, TopHat,
Cufflinks and Python available [42; 52]. A README.md file has been included to
demonstrate the usage of this pipeline starting with the raw RNA-Seq FASTQ files. The
output generated was a file called Assembled_transcriptome.fasta that was then used for
genome annotation in the next section.
MAKER2-two-pass genome annotation pipeline
The MAKER2-two-pass genome annotation strategy used in this study required
three input files for this pipeline: the assembled C. parasitica genome file; the newly
generated assembled transcriptome file; and, the well-characterized protein dataset
uniprot_sprot.fasta downloaded from Swiss-Prot database [53-55]. These components
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provided the intrinsic RNA evidence and the extrinsic protein evidence to improve the
gene model prediction (Figure 2.2).
RepeatMasker was used to identify the repeats regions in conjunction with the
compacted repeat libraries RepBase in MAKER2 package by taking all libraries as
resource (Figure 2.2) [39]. Subsequently, GeneMark-ES-3.0, a self-training gene finder
that can identify protein-coding genes, was run to creates the ab initio HMM gene models
from the genome file only [56]. Next, the gene model predicted above was applied to the
MAKER2-first pass annotation process to train its installed gene-predictors, SNAP and
AUGUSTUS, as well as experimental evidence of exon-intron boundaries from
transcriptome assembly and the protein dataset to improve the accuracy of gene
prediction [23; 38; 46; 57; 58]. Because of the iterative fashion of MAKER2, the gene
prediction process can achieve higher accuracies by running the MAKER2 a second time
using the gene models built from the first pass as training data [45; 48; 59]. At the end of
the second run, MAKER2 consolidated the output to a final annotation in GFF3 format
(called 2017-version) by picking the post-processed gene models that were most
consistent with the experimental evidence such as RNA and proteins alignments [39; 45;
59]. Along with the annotation file, the gene, transcript, CDS and protein sequences for
the predicted final gene model were extracted in FASTA format. Although the structural
predictions of the gene model are complete at this point, it is essential to assign putative
gene functions to newly annotated genes. In order to build these annotations, the
reviewed proteins dataset from UniProt/Swiss-Prot was used as reference to append the
matching protein’s name to each predicted gene model in the GFF3 file using BLASTp.
Additionally, InterPro conserved domain ID and GO ID (https://www.ebi.ac.uk/interpro/)
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were appended to the predicted gene models using InterProScan [60-62]. The detail for
the above operations are illustrated in https://github.com/didiren/PEPA.
Results
Description of C. parasitica genome
The first step towards the successful annotation of any genome is a good genome
assembly [39]. The Ep155 strain of C. parasitica used in this study is the laboratorystandard well-characterized, virulent strain (ATCC 38755) [63]. The latest genome
assembly was completed with 26 main genome scaffolds in a size of 43.9 Mb by
constructing the whole genome shotgun reads in 2010. Assembly parameters are reported
by JGI as follows: Scaffold N50 is 5,118,729 bp, the estimated gap percent is 0.2%, and
the coverage of genome is 99.6 %
(http://genome.jgi.doe.gov/Crypa2/Crypa2.download.html).
Quality assessment of the RNA-Seq reads
The transcriptomes of three biological replicates of Ep155 strain generated 147.7
million reads for three libraries with the average mean quality scores of 35.57 to 35.71
and >=Q30 scores of 94.07 % to 94.53 % (Table 2.1). Generally, sequence runs with >50
% of the nucleotides having quality scores >Q30 are considered acceptable [64].
Therefore, 35.65 as the mean quality score of the three libraries combined, and >94%
bases per read with a quality score >Q30, indicated the high quality of the sequences
generated for the C. parasitica transcriptome.
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Quality assessment of the transcriptome assembly
94.2 % to 95.1 % of the reads from the three samples were mapped to the
reference genome, with 93 % of the reads being concordant from paired files of one
sample (Table 2.2). This compares favorably with expected sequencing accuracy, given
that 70 – 90 % of RNA-Seq reads from humans samples are expected to map onto the
humans genome [65]. In order to improve annotation with the new transcripts evidence,
the transcriptome assembly was performed without using the prior annotation as
reference to reveal novel transcripts [65]. There were 12,926 to 13,037 novel transcripts
in each transcriptome as defined by Cufflinks in General Transfer Format (GTF) format,
and Cuffmerge united three of them to 14,707 novel transcripts for C. parasitica genome
(Table 2.2).
New structural and functional features in the re-annotated version
Compared to the prior annotation file from JGI additional gene structures, such as
mRNA, exon, coding sequences (CDS), 3’UTR and 5’UTR, were listed for each
predicted gene. Also, quality metrics, including MAKER mRNA Quality Index (QI) tags
and the Annotation Edit Distance (AED) scores, were added to each predicted gene
model in light of new transcript and protein evidence. AED is a measure of the agreement
between each predicted gene model and its supporting evidence, with a number between
0 and 1. An AED score of 0 denotes a perfect prediction with clear supporting evidence,
while a value of 1 indicates a complete absence of evidence supporting the annotated
gene model [59]. In addition, the predicted protein’s name from UniProt/SwissProt
dataset as well as the conserved domain information, such as InterPro ID, Pfam ID and
GO ID, were also appended (Table 2.3).
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Optimum predicted gene models from the MAKER2-two-pass pipeline
There were 8,278 gene models predicted in MAKER2-first pass preliminary
annotation step and 11,171 genes models after the completion of MAKER2-second pass
final annotation while using the full strategy (Table 2.4) (Figure 2.2). In contrast, only
7,419 and 7,272 predicted gene models were discovered without applying the ab initio
gene predictor GeneMark-ES (Table 2.4) (Figure 2.2).
A previous study reported that a well annotated proteome would mean that 55 to
65 % of the predicted proteins should contain a recognizable domain [45; 48]. For these
11,171 predicted gene models, 10,285 (92 %) of them have hits from at least one domain
database (such as CDD, Gene3D, Hamap, PATHER, Pfam, SMART), and of those 8,059
(78.36 %) have clear conserved domains and important coding sites with the InterPro IDs
and GO IDs. This provides additional supporting evidence as to the effectiveness and
accuracy of this new annotation.
Discussion
The accuracy and completeness of a genome annotation directly impacts the
validity of individual gene or genetics-based functional studies [66]. During a study to
identify potential virulence effectors and downstream factors of related transcriptional
regulators in C. parasitica, the prior annotation (2009-version) resulted in miss-steps due
to the mistakenly predicted gene models. It is especially critical for plant pathology, for
which extensive research efforts have been invested into identifying and characterizing
putative virulence-associated effectors to contribute to the control of disease and the
protection of the plants against pathogens [67].
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As mentioned above, the first step towards a successful genome annotation is to
conduct an assessment of its genome assembly to describe its completeness and
continuity with a N50 score, which is the most widely used statistics for describing the
genome assembly quality [39]. Therefore, the N50 scaffold length of the C. parasitica
genome equals to 5,118,729 bp indicates a high-quality genome assembly. Two other
informative statistical parameters reflecting the quality of genome assembly are the
percentage of gaps and the coverage of genome [39]. In this case, these values are 0.2 %
and 99.6 %, respectively. Thus, the C. parasitica genome assembly obtained from Sanger
sequencing was demonstrated to be a remarkably high-quality product.
When re-annotating this genome, the transcriptome assembly was generated from
approximately 146 million 100bp mRNA reads, which have a mean quality score of
above 35 (25 is considered decent score in NGS). Moreover, more than 94% of reads
were aligned to the genome assembly leading to more than 300-fold increased coverage
of the transcriptome in C. parasitica. The Tuxedo suite pipeline generated a large set of
transcripts models, many of them overlapping one another. The final transcriptome
assembly comprised 14,707 transcripts. This represented about 3,000 more novel
transcripts and about 650bp longer average transcript length compared to the prior
annotation (2009-verion).
In addition to new transcript evidence, the protein evidence was used in this study
is from UniProtKB/SwissProt database, which has been highly recommended as an
excellent core source of curated proteins [53]. This is the recommended database to use
when working with an organism that has a limited number of reviewed proteins (such as
C. parasitica) [39].
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In the prior annotation, the bioinformatics tools were only capable of finding the
most-likely CDS of a gene but did not report UTRs or alternative spliced variants. The
MAKER2-two-pass pipeline for the genome annotation provides a much more complex
output than simple gene prediction. It not only reports the CDS, exon and gene structural
features based on the heterogeneous evidence, but also synthesizes gene models and
produces an output that describes detailed features such as 5’UTRs, 3’UTRs, exon and
mRNA, which can be visualized in genome browsers and annotation databases. Secondly,
MAKER2 is the first bioinformatics tool to provide a quality metrics system. MAKER2
mRNA Quality index (QI) tags and the Annotation Edit Distance (AED) scores are
included in the annotation process. Thus, the quality assessment provided a means to
highlight any problematic predicted gene models for further manual curation and also
gave a measure for the comparison of two annotation versions. The third feature in the reannotation version is the functional addition to each predicted gene model of a conserved
domain ID, GO ID and protein name from the UniProtKB/SwissProt database. With the
addition of the three new features to the annotation it provided both more accurate
predicted gene models and increased confidence in the information presented.
The overall quality assessment of an annotation has been suggested to consider
three factors: the number of predicted gene models; the protein domain content; and, the
AED scores. In this study, as a non-model organism, C. parasitica does not have a preexisting gene model to train the gene predictors. The MAKER2-two-pass pipeline took
the advantage of the specific self-training gene predictor, GeneMark-ES to provide a
training gene model and iteratively improve the prediction quality resulting in 11,171
predicted gene models in the 43.9 million bp genome. As a reference, gene numbers from
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the model fungus, N. crassa, has about 10,000 protein coding genes in approximately 40
million bp size genome (http://fungi.ensembl.org/Neurospora_crassa/Info/Index).
Therefore, the total gene number in the re-annotation is similar compared to other related
organisms. Secondly, 92 % of the predicted gene models (2017-version) have at least one
coding domain, more than the 55 – 65 % usually considered to represent a high-quality
annotation [59]. The third factor, AED scores, will be described in detail in Chapter 3.
In conclusion, the genome of C. parasitica was sequenced, annotated, and
released in 2009 using the technology and tools available at that time. However, with
deep transcriptome sequencing and updated protein evidence, re-annotation is now more
accurate and informative. This improved genome annotation provides a valuable resource
for researchers who are interested in both comparative and functional studies of C.
parasitica. The integrated annotation analysis by applying the MAKER2-two-pass
pipeline has facilitated the improvement of the genome annotation and this approach can
be applied to other biological systems.
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Figures and Tables
Table 2.1

RNA-Seq read quality from three biological replicates of the C. parasitica
Ep155 strain.
Sample

Reads Yield
(Million)
EP155s1 51.94
EP155s2 45.44
EP155s3 50.34

*% of >= Q30
Bases
94.37
94.53
94.07

Mean Quality
Score
35.57
35.68
35.71

*% of >= Q30 Bases means the percentage of all baes in a read containing no more than
one error in each 1000 bases [68; 75].
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Table 2.2

a

The quality of read alignments and transcriptome assembly.

Sample

Read Yield
(Million)

Read number
mapped to
genome

a

Concordant pair
alignment rate

b

Discordant
alignments rate

Transcript
Counts
(Cufflinks)

EP155s1

51.94

94.2%

0.3%

13,037

EP155s2

45.44

94.7%

0.3%

12,926

EP155s3

50.34

49.88 M
(96.1%)
43.86 M
(96.5%)
48.92 M
(97.2%)

95.1%

0.5%

13,010

Total
TranscriptCounts
(Cuffmerge)

14,707

Concordant pair alignment rate, referring to the percentage of reads from both pairedend sequencing file matched to the same locus in the genome.
b
Discordant alignment rate, referring to the percentage of reads from both paired-end
sequencing file, did not match to the same locus in the genome.
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Table 2.3

New structural and functional features in the re-annotated version
compared to the prior annotation.
Prior version
gene
exon
CDS

Re-annotated version
Structural
gene
features
mRNA
exon
CDS
three_prime_UTR
five_prime UTR
Functional
None *
Ortholog proteins name from UniProt/SwissProt
features
InterPro domain ID
GO ID
Extra domain databases ID
* indicates there are no functional features attached in the prior GTF annotation file, but
the JGI website has protein names, domain ID and GO ID for each predicted gene model
if you examine each individual gene model.
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Table 2.4

Comparison of the predicted gene model when applying the different
strategy of MAKER2-two-pass pipeline.

With GeneMark-ES (cRed)

Predicted gene models number
Use the first passa
Use two-passa, b
8,278
11,171

Without GeneMark-ES
7,491
7,272
c
( Red)
a
referred to the steps highlighted in blue in MAEKR2 two-pass pipeline. b referred to the
process highlighted in green in MAEKR2 two-pass pipeline. c referred to the process
highlighted in red in MAEKR2 two-pass pipeline.
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Figure 2.1

Transcriptome assembly Tuxedo suite pipeline strategy.

All RNA-Seq fastq files were fed into this Tuxedo suite pipeline with the beginning step
of quality examination by FastQC. Trimming process was optional based on the quality
of the reads from the former step. Then, the alignment was performed against the
reference genome using TopHat, the transcripts were assembled individually with
Cufflinks and merged into one integrated GTF file with Cuffmerge.
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Figure 2.2

MAKER2-two-pass genome annotation strategy.

(A) The strategy started from the prerequisite RepeatMasker included in MAKER2, then
in the MAKER2-first pass, an external gene predictor GeneMark-ES highlighted in red
were used to provide a training HMM file along with the RNA and proteins evidence for
the second pass gene predictors, showing a significant improvement in the number of
predicted genes. (B) In the MAKER2-second pass, the gene models generated above
were applied to train the other gene predictors, SNAP and Augustus along with
MAKER2 internal programs to improve the gene models.
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PEPA: A PIPELINE TO COMPREHENSIVELY EVALUATE A PRIOR GENOME
ANNOTATION AGAINST A NEWER VERSION
Abstract
For the non-model organisms, a well-annotated genome reference is critical for
either exploring single target gene function or characterizing whole genome expression
profiles. Recently, some integrated genome annotation pipelines were developed to
combine the evidence of abundant transcripts and the improved protein evidence to
increase the performance of genome annotation. However, in terms of all target genes
predicted and annotated from a prior and potentially outdated genome annotation, it is
essential to evaluate the accuracy and discrepancy compared to the newer version. In the
case of C. parasitica a simple pipeline, PEPA, was developed to comprehensively
estimate the accuracy of each prior predicted gene model (2009-version) with updated
transcript and protein evidence using the MAKER2 legacy annotation program, and
thereby enrich the gene models with a quality metrics system and internal domain
information (InterPro ID). Subsequently, a comparison of the prediction quality of all
gene models from the prior annotation (2009-version) and the re-annotation (2017version) from above was carried out. A python script was developed to sort each
individual gene model from the prior genome annotation (2009-version) into four
categories (Match, Similar, Different, Noexist based on their comparison to the newer
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version (2017-version)). Twenty-seven of the predicted gene models comprising
representatives from the Similar, Different and Noexist categories were then
experimentally validated using a diagnostic PCR design to amplify the distinct regions to
differentiate between the possible mRNA products predicted by the different annotation
results. Of 11,609 predicted gene models from the 2009-version, only eight (0.06 %)
were completely supported with transcript and SwissProt protein evidence.
When the two annotations were compared using the PEPA pipeline, 32.73% of
predicted gene models were sorted into the Match category, 33.19% into the Similar
category, 30.84% into the Different category and 1.1% into the Noexist category.
Subsequently, 22 out of 27 chosen predicted gene models (from 2009-version) were then
experimentally proven by PCR to support the re-annotation. Altogether, the results
showed the general existence of errors in the 2009 annotation and the applicability of the
PEPA evaluation pipeline in identifying the potential mistakenly predicted gene models
to any genome annotation project.
Introduction
NGS encourages researchers to obtain the genome sequence of the exotic, nonmodel, organisms rapidly and with relatively low cost. Consequently, the accumulation of
the genome annotations is rapidly increasing but they are mainly accomplished with
automated annotation systems rather than something with more manual input as can be
accomplished for model organisms supported by large research communities [69-70].
Many institutes, such as Joint Genome Institute [71] and University of Maryland’s IGS
(Institute for Genome Sciences) annotation engine
(http://www.igs.umaryland.edu/research/bioinformatics/analysis/), offer annotation
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systems for various genome projects of bacteria and fungi. However, a reality of using
automated annotation systems is the existence of errors in the output annotation, which
can mislead future work. Also, when annotated once, these projects may not be updated
to take advantage of the most recent tools and databases available to improve the
annotation.
For the same set of genome data different annotation systems may generate
different results based on their various methods [72]. However, it is difficult to decide
which one is more suitable and accurate without comparing them, since a universal
standard is not available. Therefore, quality control is the significant issue for all genome
annotation projects.
The definition of genome annotation generally refers to the structural and
functional annotation [39]. The approach for testing the quality of the structural
annotation is to establish the quality metrics that measure the consistency of each
annotation with its overlapping evidence, such as protein and transcriptomic data [39].
One example of a quality metrics system that was developed by Sequence Ontology
Projects is the Annotation Edit Distance (AED). This was applied in an integrated
annotation pipeline, MAKER2, which is able to automatically calculate AED for each
predicted gene model [39; 73].
Considering the impact of potentially incorrect gene model predictions on further
studies of charactering individual target genes and also genome scale expression profiles,
re-evaluating genome annotation projects that were prepared without any quality metric
system is of considerable importance.
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Here, PEPA uses MAKER2 to not only carry out a re-annotation utilizing new
mRNA-Seq data and updated protein data to improve annotation quality, but also to add
quality metrics like AED to a legacy-annotation [48].
Then, PEPA will evaluate the prior genome annotation, regardless of the format,
against a newer version to illustrate the structural and functional differences of each gene
model and its accuracy and sort each predicted gene model into four categories (Match,
Similar, Different, Noexist) based on discrepancy between the structural (start/end
coordinates) and functional (coding domain InterPro ID) information compared to the
same predicted gene model from the newer version.
To test the efficacy of this approach, we used the most recently released genome
annotation of C. parasitica from 2009, publicly available from the USDA Joint Genome
Institute (JGI; http://genome.jgi.doe.gov/Crypa2/Crypa2.download.html). Both the
quality metrics AED system and conserved coding domain InterPro ID were appended to
this legacy data. Following this process for C. parasitica, we found that only
approximately 1/3 of the original predicted genes were considered the same in both
annotations. Furthermore, when tested individually by diagnostic PCR, 81.5 % of a
selection of different annotations supported the newer version.
This evaluation pipeline of a prior genome annotation has major implications for
future work by providing reliable insights of each predicted gene model with the new
quality metrics and identifying which specific gene predictions may be problematic.
Especially in non-model organisms, using more efficient and accurate results with
reliable evidence to improve the structural and functional accuracy of a predicted gene
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model is extremely important for future characterization by specific studies and also for
large scale transcriptomics data analysis.
Materials and Methods
Transcriptome evidence and protein evidence
The same transcriptome and protein evidence were used here as described in the
Materials and Methods of Chapter II.
MAKER2 legacy protocol
Like the MAKER2-two-pass pipeline described in the Materials and Methods of Chapter
II, MAKER2 legacy annotation protocol provided the means for employing the transcript
and protein evidence to train its installed gene finders to evaluate the accuracy of the
prior genome annotation. The details for this operation are illustrated in the
README.md file available in https://github.com/didiren/PEPA.
InterProScan protocol
The same tool and protocol was used here as described in the Materials and
Methods of Chapter II. The commands for this operation are illustrated in
https://github.com/didiren/PEPA.
Visualizing the quality distribution comparison of legacy annotation and reannotation version
An R script was developed to visualize the qualities of the predicted gene models
at the genome-level by displaying the cumulative distribution of AED scores [59]. This R
script file AEDdistribution.R is available in https://github.com/didiren/PEPA.
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Sorting genes predictions from the prior annotation by their discrepancies against
the re-annotation
A custom python script was developed to sort each predicted gene model from the
prior version to four categories, Match, Similar, Different, and Noexist, based on the
discrepancies of coding regions (start/end coordinates) and coding domains (InterPro ID)
against the newer version (Figure 3.1). The script ultimately generated a text file for each
category with the gene model ID, the coordinates, the AED scores and the protein
ortholog names from both annotation versions attached. If the predicted gene models
from the prior annotation shared the exact same coordinates for their CDS with the newer
version, they were sorted to the Match category (Figure 3.1). If their CDS coordinates
were different but their transcript coordinates overlapped with the newer version gene
models and they shared the same conserved InterPro domain ID, they were sorted to the
Similar category (Figure 3.1). Thus, the Different category included those predicted gene
models from the prior annotation that shared different conserved InterPro domain ID in
addition to overlapped transcript coordinates with the newer version (Figure 3.1). The last
category, Noexist, contained the predicted genes from the prior annotation that were not
predicted to be present in the newer version as well as any that were not supported by any
RNA evidence (Figure 3.1). This python scripts file named PEPA.py is available in my
GitHub website (https://github.com/didiren/PEPA.git). The README.md file
demonstrates the usage of this script starting with two annotation files as well as the
output from the MAKER2 legacy and InterProScan protocol described above.
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Validation of 27 predicted genes from the prior annotation showing discrepancies
with the re-annotated prediction
There were 27 genes in total, seven from the Similar category, six from the
Noexist category and 14 from the Different category chosen to experimentally validate
the quality of the newer annotation. For each, the specific primers were designed based
on the distinct region of their predicted transcript from the two annotation versions.
Polymerase chain reaction (PCR) was used to amplify those regions from both cDNA and
genomic DNA. All the products were viewed on a 1% (w/v) agarose gel to examine the
accuracy of each prediction. Selected genes and their primers are listed in Appendix A
chapter.
Results
The quality comparison of the predicted gene models from the prior and newer
annotation version
As one of the two important factors to evaluate a genome annotation, the quality
metrics AED scores cumulative distribution curves were displayed for each annotation
set (Figure 3.2). Although 9,127 out of 11,609 (78.6%) predicted genes from the 2009
annotation set have an AED of less than 0.5, only 3,262 (28.10%) have AED scores less
than 0.3 and eight predicted genes have a AED score of zero (Table 3.1). This implies
that there are significant disagreements between the predicted exons or splice sites and
the newly assembled transcriptome and protein evidence (Table 3.1).
In a second estimate of improved quality, we used the old data (EST evidence
from JGI) with the newer annotation tools (the MAKER2-two-pass pipeline). In this case,
the quality of the annotation set was improved with 402 (3.5%) out of 11,371 predicted
genes with the AED score of zero, 6,180 (54.3%) with the AED score less than 0.5, and
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5,003 (44.00%) with AED scores less than 0.3, which indicated a much lower prediction
accuracy (Figure 3.2). Therefore, although there were incremental improvements, the
older EST data was not fully effective at providing an accurate annotation even with
newer bioinformatics tools (Table 3.1).
In contrast, the newer re-annotation set was generated with the assembled
transcriptome and current protein evidence with the same MAKER2-two-pass pipeline.
This returned a much-improved annotation build with 2,747 (24.6%) out of 11,171
predicted genes having the perfect AED score of zero, 7,741 (69.30%) having the AED
score less than 0.3, and 9,392 (84.1%) having the AED score less than 0.5 (Figure 3.2;
Table 3.1).
Sorting the predicted genes in categories
Using all 11,609 predicted genes from the prior annotation, 3,800 (32.73%) of
were sorted into the Match category, meaning they share the same CDS coordinates and
domain ID with the predicted genes from the newer (Figure 3.3). 3,854 (33.19%) of them
were sorted into the Similar category and 3,581 (30.84%) of them were sorted into the
Different category (Figure 3.3). 126 (1.1%) sorted into the Noexist category meaning
they lacked any supporting evidence (Figure 3.3). Any remaining predicted genes from
2009 were not in any category because despite the existence of a transcript alignment
there was no gene model prediction in the newer annotation (Figure 3.3). This may be
because, for the C. parasitica genome, the protein evidence dataset in
UniProtKB/SwissProt is derived from experimentally reviewed data of model organisms,
so these may represent a set of genes that are specific to C. parasitica, or at least to its
relatives more closely related than the nearest model organisms.
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Quality comparison of the predicted gene models in the four categories of the
compared annotations
Figure 3.4 shows a comparison of the AED scores in the predicted gene models
from each category. The majority of predicted gene models in the Match, Similar and
Different categories of the newer version have AED scores equaling to 0. In contrast, for
the prior annotation there were two peaks for all three categories which contained the
majority of predicted gene models, one is between the 0.4 and 0.5, the other one is 1.0
(Figure 3.4).
Out of 3,800 genes in the Match category, there were 2,491 genes from the prior
annotation with a conserved domain InterPro ID, but the newer annotation had 599 more
genes (3,090) with at least one conserved domain (Table 3.2). The possible reason for a
different protein product from the same CDS sequence is the reading frame shift or the
inaccuracy of translation in the JGI workflow with a given annotation file. No differences
were found in the Similar category because the strategy required that they must share the
same domain information (Table 3.2) only. There were 663 more predicted genes in the
newer annotation coding for at least one conserved domain in Different category than the
1,058 predicted genes of the prior annotation (Table 3.2).
Validation of the new predicted gene models by PCR
From the amplified transcript bands in agarose gel pictures of Appendix A chapter,
for the Similar category, six out of seven chosen predicted genes were proven to support
the prediction of the newer version. For the Different category, 11 of 14 predicted genes
supported the newer version, while five of six predicted genes in the Noexist did not
produce detectable transcripts experimentally, which is consistent with the prediction of
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the newer version (Table 3.3). In total, for the 27 predicted gene models of the prior
annotation tested by PCR that were predicted to produce different transcript products in the
new annotation, 81.48% supported the newer predictions (Table 3.3).
Discussion
This study has provided a tool (PEPA) that can help to evaluate the prior
annotation of a genome by analyzing and comparing the accuracy of each predicted gene,
as well as the structural and functional features of each predicted gene, against the newer
version, with no limitation of the format and the source of the prior annotation of a
genome.
To test the efficacy of this tool, the prior annotation of C. parasitica was used as a
test. From the accuracy analysis and comparison, we have observed that the old
annotation, although based on the best available tools and information at the time,
contained many ambiguities and incorrect predictions. Even using the older evidence
with newer tools did not compensate for the lack of coverage provided by EST data only.
However, when used in conjunction with RNA-Seq data prepared by the MAKER2-twopass pipeline used in Chapter II, the product was much more accurate gene models.
The PEPA tool presented here also provides the utility of sorting and comparing
the output of the annotations. This is especially important in order to be able to pursue
specific genes for functional studies. Given that 65.92 % of the prior predictions were
sorted in Match or Similar categories, this suggested that approximately 2/3 of the
predicted gene models have trustworthy annotation predictions in the older version.
However, that also implies that approximately 1/3 of the prior predictions were incorrect,
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with potential significant impact on further studies of either individual genes or large
scale analyses.
In addition to analyzing computational metrics such as AED scores to evaluate the
efficacy of the new annotation predictions, we also validated 27 specific genes
experimentally using PCR primers designed to differentiate between the old and new
predictions. The observation that 21 (81.48%) of them provided unambiguous support for
the new annotation is further strong evidence of the improvement in accuracy. However,
it also points to the important fact that with current available technology no annotation
can be considered to complete or 100 % accurate.
Before this study, there were multiple tools designed to compare two annotations,
such as BEACON and gffcompare, or semi-automated genome annotation comparison
[74-75]. BEACON was limited and only suitable for GenBank format annotation file
[74], while gffcompare was designed to compare two annotations in genome scale
statistically that does not provide the individual gene-level of resolution as produced by
PEPA. The semi-automated genome annotation comparison scheme was designed to
perform the functional comparison only between two annotations [75]. PEPA was
designed to comprehensively compare two annotations of one genome in both accuracy
and structure/function. A limitation of PEPA is the requirement to run multiple tools,
such as MAKER2, as well as and R and python scripts.
Although tested here on the C. parasitica genome, PEPA is broadly applicable to
other experimental systems where new data is available that was not present when an
original genome annotation were prepared. This makes it possible to help the users to
have better confidence in the predicted genes they are interested in and provide data to
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design diagnostic PCR primers to validate their own specific areas of interest, and to
provide better support for future large-scale sequencing analyses.
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Figures and Tables
Table 3.1

The distribution of the predicted gene models’ AED scores in both genome
annotations.
Total

Predicted gene number with

Predicted
gene number
2009-version
2017-version
Control-version

11,609
11,171
11,371

AED=0.0
8 (0.06%)
2,747 (24.60%)
402 (3.55%)
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AED≤0.3
3,262 (28.10%)
7,741 (69.30%)
5,003 (44.00%)

AED≤0.5
9,392 (80.90%)
9,128 (81.71%)
6,180 (54.35%)

Table 3.2

2009version
2017version

The distributions of the predicted gene models with conserved domain in
each category from both annotation version.
Total
Predicted
gene
number
11,609

Gene
number
With
domain
8,309

Match
With
Without
Domain Domain

Similar
Match
Without
Domain Domain

Different
Mismatch
Domain

Without
Domain

2,491

1,309

3,288

566

1,058

2,523

11,171

8,059

3,090

710

3,288

566

1,721

1,860
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2009
2017

2009
2017

2009
2017

2009
2017

2009
2017

2009
2017

2009
2017

1

2

3

4

5

6

7

Similar

Annotation

Predicted
gene

58876
Ep155_U_T00000186_1

263897
Ep155_U_T00008600_1

355955
Ep155_U_T00004864_1

231803
Ep155_U_T00004505_1

255909
Ep155_U_T00004868_1

356517
Ep155_U_T00006216_1

258862
Ep155_U_T00006215_1

Gene ID

0.4
0.01

0.36
0

0.22
0

0.45
0.11

1
0.1

1
1

0.48
0.25

AED

scaffold_1
scaffold_1

scaffold_7
scaffold_7

scaffold_4
scaffold_4

scaffold_3
scaffold_3

scaffold_4
scaffold_4

scaffold_5
scaffold_5

scaffold_5
scaffold_5

Scaffold

678670
678481

1689695
1688290

1069744
1069009

4888579
4885525

1076299
1076177

924032
924078

920289
918882

Start

679423
679500

1691232
1692388

1070666
1070853

4889682
4890764

1077428
1077593

924674
924454

920820
921612

End

753
1019

1537
4098

922
1844

1103
5239

1129
1416

642
376

531
2730

Predicted
gene size
(bp)

/
380

/
153

/
817

/
2100

998
1051

330
292

400
2261

Predicted
transcript
PCR size
(bp)

/
yes

/
yes

/
yes

/
yes

yes
no

no
yes

yes
yes

Positive in
PCR

Validation results of the 27 chosen predicted genes from the prior annotation and newer annotation.

Category

Table 3.3

2017

2017

2017

2017

2009

2017

2017

PCR
supportive
annotation

52

8

Different

18

17

16

15

14

13

12

11

10

9

Predicted
gene

Category

Table 3.3 (continued)

Ep155_U_T00000872_1
357444
Ep155_U_T00008473_1
222652
Ep155_U_T00007540_1
346810
Ep155_U_T00006866_1
260426
Ep155_U_T00006108_1

2009
2017
2009
2017
2009
2017
2009
2017

261603

2009

2017

Ep155_U_T00007829_1

2017

245160

357202

2009

2009

Ep155_U_T00007119_1

2017

Ep155_U_T00005807_1

102253

2009

2017

Ep155_U_T00007748_1

2017

346358

231853

2009

2009

Ep155_U_T00006769_1

2017

Ep155_U_T00007774_1

98319

2009

2017

Gene ID

Annotation

0.04

0.31

0

0.03

0

0.45

0

0.43

0.22

0.38

0.02

0.36

0

0.41

0.05

0.38

0.36

0.84

0.25

0.45

0.06

0.41

AED

scaffold_5

scaffold_5

scaffold_5

scaffold_5

scaffold_6

scaffold_6

scaffold_7

scaffold_7

scaffold_1

scaffold_1

scaffold_4

scaffold_4

scaffold_6

scaffold_6

scaffold_6

scaffold_6

scaffold_5

scaffold_5

scaffold_6

scaffold_6

scaffold_5

scaffold_5

Scaffold

570975

570069

3366769

3366779

1369252

1371443

1258718

1259884

3172638

3176047

4657590

4656868

2522966

2523249

2895033

2896210

4274791

4277195

2408261

2410893

2993355

3000738

Start

573657

572567

3374058

3373770

1373733

1372342

1261375

1260550

3176405

3177203

4661908

4660251

2525960

2525371

2897647

2897553

4277389

4277888

2412803

2412035

3001226

3002855

End

2682

2498

7289

6991

4481

899

2657

666

3767

1156

4318

3383

2994

2122

2614

1343

2598

693

4542

1142

7871

2117

Predicted
gene size
(bp)

1080

1919

873

3027

145

208

1022

/

258

/

574

550

280

570

320

/

2303

2105

/

1052

1609

1068

Predicted
transcript
PCR size
(bp)

yes

no

yes

yes

yes

no

yes

/

yes

/

yes

no

yes

yes

yes

/

yes

yes

/

yes

yes

yes

Positive in
PCR

2017

2009

2017

2017

2017

2017

2009

2017

2017

2009

2017

PCR supportive
annotation
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Ep155_U_T00007212_1
322230
Ep155_U_T00005405_1
231988
Ep155_U_T00001901_1

2017
2009
2017
2009
2017

2009

2009

26

27

24

68001

71384

334967

2009

2009

75444

2009

23

25

241925

2009

22
65946

94097

2009

1

1

1

1

1

1

0.05

0.37

0.01

0.35

0.01

0.03

scaffold_4

scaffold_2

scaffold_10

scaffold_11

scaffold_1

scaffold_1

scaffold_1

scaffold_1

scaffold_4

scaffold_4

scaffold_6

scaffold_6

1226218

1034513

685961

865322

2700456

168020

7074829

7077089

3220823

3221369

279282

279282

1227846

1035594

687176

866791

2702059

168910

7078602

7078251

3222517

3222209

280496

280501

1628

1081

1215

1469

1603

890

3773

1162

1694

840

1214

1219

525

777

430

1195

750

352

2511

/

972

/

157

110

no

no

no

no

yes

no

yes

/

yes

/

yes

no

2017

2017

2017

2017

2009

2017

2017

2017

2017

For some genes, if both annotations have yes in ‘Positive in PCR’ column this indicated one of their amplifying regions was
completely within of the second one. In that case ‘PCR supportive version’ listed the longer region version, which is the correct
prediction. For the genes, ‘/’ represented no PCR process were necessary.

Noexist

21

20

19

Table 3.3 (Continued)

Figure 3.1

The newly developed custom Python sorting schematic diagram
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Predicted genes from the prior annotation (2009-vesion) were sorted into four categories,
Match, Similar, Different, and Noexist based on their structural and functional
discrepancies with the newer set (2017-version).
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0.8
0.6
0.4
0.2

Cumulative fraction of annotation

1.0

Cumulative distribution of AED Value

2009−version(ESTs+old_tools)
2017−version(RNA−seq+MAKER2)

0.0

Control(ESTs+MAKER2)
0.0

0.2

0.4

0.6

0.8

1.0

AED value

Figure 3.2

Cumulative distribution of AED values in both annotation versions.

Shown on the x-axis is the AED score from 0 to 1, and y-axis is the cumulative
distribution of AED for each annotation version. (1) The red line presents the gene
models from 2009-version annotation completed by JGI tools with only ESTs as RNA
evidence. (2) The black line shows the gene models from 2017-version annotation
generated with MAKER2-two-pass pipeline with RNA-Seq produced transcriptome as
RNA evidence. (3) The green line is a gene models generated as pipeline control using
MAKER2 tools and only ESTs.
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Predicted gene models distribution from 2009-version
Noexit
1%

Others
2%

Match
Match
33%

Different
31%

Similar
Different
Noexit
Others

Similar
33%

Figure 3.3

The distribution of predicted gene models from the prior annotation (2009version) in the four categories.

(Orange pie) represents the portion of the total predicted gene models from the prior
annotation that were sorted into the Match category. (Yellow pie) represents the portion
of the total predicted gene models from the prior annotation that were sorted into the
Similar category. (Green pie) represents the portion of the total predicted gene models
from the prior annotation that were sorted into the Different category. (Maroon pie)
represents the portion of the total predicted gene models from the prior annotation that
were sorted into the Noexist category. (Brown pie) represents the portion of the total
predicted gene models from the prior annotation that were sorted into the Others
category.
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Figure 3.4

The AED score density curves of the predicted gene models from the
Match, Similar and Different categories of both annotation sets.

(1) Red line presents the AED scores density from DIFFERENT category genes of 2009version. (2) Red dash-line presents the AED scores density from SIMILAR category
genes of 2009-version. (3) Red dot-line presents the AED scores density from MATCH
category genes of 2009-version. (4) Black line presents the AED scores density from
DIFFERENT category genes of 2017-version. (5) Black dash-line presents the AED
scores density from SIMILAR category genes of 2017-version. (6) Black dot-line
presents the AED scores density from MATCH category genes of 2017-version.
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EXPLORE THE DOWNSTREAM TARGETS OF CPVIB-1 USING
TRANSCRIPTOME PROFILING OF THE CPVIB-1 MUTANT AND ITS WILD TYPE
STRAIN
Abstract
C. parasitica is the causal agent of chestnut blight, which devastated the American
Chestnut population in the early 20th century. The discovery of hypoviruses that reduce the
severity of the chestnut blight infection offers the potential for biological control. However,
the spread of the hypoviruses is hampered by a diverse nonself-recognition system,
vegetative incompatibility (vic), among strains. VIB-1 in N. crassa has been reported as a
transcriptional regulator that is required for the expression of downstream effectors of N.
crassa’s nonself-recognition system, heterokaryon incompatibility (HI). CPVIB-1, as an
ortholog of the VIB-1, was identified as a transcription regulator playing an important role
in programmed cell death in response to allelic variation at the vic4 locus. In order to
explore the downstream targets that interact with CPVIB-1 to mediate the various
phenotypic changes observed in the Δcpvib-1 mutant strain, including enhanced
pigmentation and conidiation, less pathogenicity and reduced vic triggered program cell
death, RNA-Seq was used to profile the variation of expression patterns between Δcpvib1 mutant and wild-type strain. The high-quality RNA-Seq reads, were aligned against the
C. parasitica genome using both the prior and newer genome annotation. After generating
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a list of read counts per transcript to indicate the significantly changed transcripts a
visualized expression pattern contrast between mutant and wild-type strain was used to
examine biological processes altered by the absence of cpvib-1. In the absence of cpvib-1,
there were 1,064 transcripts were altered significantly, with 245 (23%) up-regulated and
819 (77%) down-regulated. CPVIB-1 was found to be a key universal transcription
activator required for preventing oxidative stress, for glucose signaling pathway, for DNA,
protein and lipids synthesis, and for the pathogenesis.
Introduction
The pathogen that causes the chestnut blight, C. parasitica, was first discovered in
New York City in 1904 [18]. After the introduction from the imported chestnut nursery
stock, C. parasitica spread very rapidly, resulting in a devastating epidemic in American
chestnut population. [5]. While C. parasitica almost caused complete destruction of C.
dentata in USA, another chestnut species, Castanea sativa, suffered too in Europe.
However, 10 years after the disease was first reported in Europe, the transmissible
hypovirulence strains were discovered and identified to contain the transmissible RNA
virus attributing to the striking reduction in fungal virulence [16]. Later the transmissible
RNA virus was identified as a member of the hypovirus family and successfully applied
as a biological way of controlling the spread of C. parasitica in Europe [76].
Unfortunately, the same strategy was not effective in North America [18]. The
reason for the failure was later proposed to be vegetative incompatibility, which induces
the sealing of the fused compartments that subsequently undergo programmed cell death
between incompatible strains [77] and limit cytoplasmic exchange. Vegetative
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incompatibility in C. parasitica is a nonself-recognition system, which is genetically
controlled by at least six vegetative incompatibility (vic) loci [23; 63; 66; 77].
The mechanism of the genetic regulation of the vegetative incompatibility has
been studied extensively in one of the ascomycete species, N. crassa to reveal a broad
regulatory process [32]. As one of the studied targets, VIB-1 was discovered to be
required for the programmed cell death and the hyphal compartmentation triggered by its
heterokaryon incompatibility (het-c) locus [32; 63; 66; 78]. As a transcriptional activator
with a DNA binding domain NDT80/PhoG-like, VIB-1 was found to be a regulator of
conidiation, non-repressible acid phosphatase, other heterokaryon incompatibility locus
(het-e, het-6, het-8) [63; 66; 78], downstream effectors associated with heterokaryon
incompatibility, and the carbon and nitrogen metabolism [32-33; 79].
As for the chestnut blight pathogen C. parasitica, CPVIB-1, a putative ortholog of
VIB-1 was identified coding a protein of 688 amino acids in length, sharing 40% identity
with VIB-1 from N. crassa and containing the same NDT80/PhoG-like DNA binding
domain. It was reasonable to hypothesize that CPVIB-1 might represent a potential
candidate for modulation by hypoviruses by subverting the vegetative incompatibility. In
order to test this hypothesis, a cpvib-1 deletion strain (Δcpvib-1) was established to test
its role in vegetative incompatibility system. The disruption of cpvib-1 in wild type
EP155 strain exhibited reduced virulence, reduced aerial hyphal growth and profuse
conidiation. Furthermore, CPVIB-1 was demonstrated to be required for programmed cell
death and barrage formation between two incompatible strains with different alleles in
vic4 locus in the vegetative incompatibility assay. Thus, it is clear that CPVIB-1 plays a
role in modulating the signaling pathways for at least one (vic4) allele interaction in C.
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parasitica as well as the virulence, hyphal growth, pigmentation, and the conidiation
process.
With the knowledge of VIB-1 mediating multiple downstream targets associated
with heterokaryon incompatibility and the carbon and nitrogen metabolism in N. crassa,
we proposed the hypothesis that CPVIB-1 is a mediator of the vegetative incompatibility,
the virulence, and the fungal vegetative growth processes requiring the interactions with
the downstream effectors.
In this chapter, the first strategy we proposed to achieve the goal of testing the
above hypothesis was to carry out a comparative analysis of the large-scale transcriptome
profile between the Δcpvib-1 strain and its isogenic wild type EP155 strain. RNA-Seq is a
well-established high-throughput approach to obtain transcriptome profiling using the
NGS deep-sequencing technologies, which provides a far more precise measurement of
levels of transcripts and their isoforms than other methods [80].
In this study, three biological replicates of the above two strains were cultured in
the same conditions and their transcriptome library was prepared and sequenced in the
same lane using the RNA-Seq strategy described in chapters II and III. A widely applied
transcriptome differential expression bioinformatics analysis pipeline was used to access
the quality of the RNA-Seq reads, and align them to the reference genome, assemble the
reads into transcripts, and count the read number mapped to each transcript [42; 81].
These data were used to infer functional and mechanistic pathway changes from the
Δcpvib-1 strain.
Consistent with the proposed role of VIB-1 made in N. crassa, CPVIB-1 was
found to be a universal transcription activator that regulates more than 1,000 genes in C.
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parasitica. Moreover, compared to only the general metabolism pathways were
highlighted to be significantly regulated using 2009-version annotation, there were 17
metabolism pathways were significantly up-regulated including six carbon metabolisms
and 3 metabolism pathways down-regulated including RNA processing metabolism
pathways in the Δcpvib-1 strain.
Materials and Methods
Fungal transcriptome preparation and RNA-sequencing
The wild type strain of EP155 was obtained from Dr. Donald L. Nuss (Center for
Biosystems research, UMBI) and its isogenic cpvib-1 mutant strain was obtained from
Dr. Rong Mu (New Mexico State University).
The preparation of transcriptome and RNA-sequencing for the wild type EP155
strain of C. parasitica were demonstrated in Chapter II. At the same time and with the
exactly same procedure, the transcriptome of the cpvib-1 mutant strain was prepared and
sequenced in the same Illumina lane.
Differential expression analysis of the EP155 strain and its isogenic Dcpvib-1 strain
Similar to the one-step transcriptome assembly python scripts demonstrated in
Chapter II, a python script pipeline was developed here to perform the first segment
(steps in blue frames) of the differential expression analysis workflow of the given two
sets of RNA-Seq data, each from 3 biological replicates samples (Figure 4.1). The first
step of the pipeline is to inspect the reads quality of each RNA-Seq raw sequencing file
with FastQC [82]. Based on the quality output from the last step, Trimmomatic was the
optional tool for trimming the adapters and poor quality reads if required [83]. Then, all
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remaining paired-end reads were aligned to the C. parasitica reference genome from JGI,
the same one used in the Chapter II and III, with Bowtie2 and TopHat [42; 44; 52; 84-85;
]. Subsequently, all mapped reads were sorted with Samtools and counted per transcript
with HTseq-count using both the 2009-version annotation and 2017-version annotation as
references. [86-87].
The python scripts file differential_expression.pipeline.py can be downloaded
from the GitHub website (https://github.com/didiren/RNA-seq-differential_expression)
and run for one-step transcriptome assembly in any system with Bowtie2, TopHat,
Samtools, HTseq-count and Python available. The details of how to run the pipeline are
in the README.md file at the same web address.
Differential expression analysis with DESeq2
The reads count text files output from HTseq-count were fed into DESeq2, an R
package providing the means to test differential expressed genes from the Dcpvib-1 strain
compared to the EP155 strain by using the negative binomial generalized linear models
[88]. In this study, it is the first step of the second segment (steps in orange frames) in the
differential expression analysis workflow (Figure 4.1), included in a R script to
summarize the reads count from all six samples to a condition dependent count matrices,
analyze the count matrices for differentially expressed genes, visualize the results and
cluster samples and genes using transformed counts. This R script is available in the
GitHub website (https://github.com/didiren/RNA-seq-differential_expression) mentioned
above.
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KEGG pathways enrichment analysis with GAGE and Pathview R packages
As the second step of the second segment (steps in orange frames; Figure 4.1), a
few tools were utilized together to discover the significantly regulated metabolism
pathways in the Dcpvib-1 strain compared to the EP155 strain. At first, the BLASTp
program from NCBI was used to match all genes from C. parasitica to their ortholog
genes in N. crassa. Then the ortholog KEGG ID of N. crassa was extracted and replaced
the original C. parasitica gene ID in the output reads count text files generated from
HTseq-count. Second, to enrich sets of related genes sharing the same metabolic
pathways from the gene expression data, the Generally Applicable Gene-set Enrichment
(GAGE) was applied to this study [89]. All reads count text files with the N. crassa
KEGG ID now were fed to the GAGE package to highlight the significant regulated
metabolic pathways in the Dcpvib-1 strain compared to the wild type strain based on the
integrated p-value from all related genes in the same pathways. The R/Bioconductor
package, Pathview, was used to visualize the individual metabolic pathways from KEGG
by automatically downloading the pathways graph data, parsing the data file, mapping the
output data from GAGE to the data file and integrating the results to a new Graphviz
graph along with the native KEGG view graph [90-91]. A python script and R script to
run ID conversion and GAGE as well as Pathview are listed in the GitHub website
(https://github.com/didiren/RNA-seq-differential_expression) mentioned above.
GO enrichment analysis with REVIGO
As the last segment (steps in green) of the differential expression analysis
workflow (Figure 4.1), a web server, Reduce and visualize gene ontology (REVIGO) was
used to summarize long, unintelligible lists of GO terms by finding a representative
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subset of the terms using a simple clustering algorithm that relies on semantic similarity
measures [92]. Essentially, the significantly differential expressed genes from DESeq2
that were statistically interpreted with the p-values lower than 0.05 and the log2 fold
change larger than +2/-2 were subsequently linked to the GO ID of each gene by a small
python script. Next, REVIGO was used to cluster and visualize the non-redundant GO
term set to facilitate the interpretation of the output of differential expression of large set
of genes from DESeq2 [92].
Results
Quality assessment of RNA-Seq reads and alignments in Dcpvib-1 strain
The transcriptome of three Dcpvib-1 strain biological replicates were sequenced
with the isogenic wild type EP155 strain in the same lane using the Illumina paired end
sequencing technology. There were 24 to 47 Million reads for these three libraries with
the average mean quality scores of 35.57 to 35.75 and >=Q30 scores of 93.82% to
94.74% (Table 4.1). With the quality examination by FastQC, there were no adapters or
poor quality reads with a mean quality score lower than 25 detected in all three Dcpvib-1
strain libraries, and the same for EP155 samples. In the light of the discovery that
trimming process of RNA-Seq reads could alter the expression pattern estimation of
samples, the Trimmomatic step was skipped in this study to avoid the unnecessary bias
leading to the inconsistent results [93]. After the alignment with Bowtie2 and TopHat,
there were 95.45% to 97.02% reads from the three samples of the Dcpvib-1 strain mapped
to the reference genome along with approximately 93% reads being concordant from
paired files of one sample (Table 4.2). The above results indicated that the quality of the
65

libraries for both the Dcpvib-1 strain and the EP155 strain was consistent among the
biological replicates.
Differentially expressed genes in the Dcpvib-1 strain
The matrix with six columns and 11,171 rows (after mapping to 2017-version
annotation reference) were normalized by modeling with negative binomial distribution
with both the mean, dispersion values and the individual normalization size factors of
each gene. Then, both the fold change and its dispersion (estimated standard error)
between the treatment (Dcpvib-1) and control (EP155) were included in the reduced
process to report the significantly differentially expressed genes. In this case, the log2
fold change plot was a useful overview of the differential expression analysis of the
Dcpvib-1 strain compared to EP155 strain results from DESeq2 (Figure 4.2). This plot
demonstrated that some genes with small normalized count (in the left part of Figure 4.2)
were also called significant with a small p-value, leading to the requirement of the
DESeq2’s shrinkage estimation strategy by considering the dispersion factors within the
group variability. The red trend line showed the dispersions’ dependence on the mean
that was set to shrink each gene’s estimates (black dots) towards to the trend to obtain the
final estimates (blue dots) as well as the dispersion outliers (blue circles) were cut from
the total gene sets because of the high gene-wise dispersion estimates (Figure 4.3). The
dispersion value was estimated to be 0.01 in this study represented the gene’s expression
tends to differ 10% between samples of the same group [88].
It was important to perform the sample difference and clustering analysis between
the two strains in this study to validate that the designed RNA-Seq experiments fit to our
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expectation. In order to fulfill the goal, at first, the regularized-logarithm transformation
(rlog) strategy of DESeq2 was used to get rid of the bias of a few low reads count
contributing to the major absolute differences between samples. In this study, there were
two ways to present the differences of six samples after the rlog transformation. The first
mean is to calculate the Euclidean distance between each two samples in counting of all
genes in the genome and visualize in the heatmap (Figure 4.4) and the second one is to
cluster the top significantly down-regulated genes in the two strains based on their
expression level and visualize them in a heatmap (Figure 4.5). The results from both
means were consistent in clustering the three biological replicates of each strain together
and different from the three biological replicates of the other strain.
To further validate the quality improvement of the 2017-version annotation, the
same differential analysis workflow was performed but using the 2009-version annotation
as the reference for the HTseq-count step. There were 819 genes significantly downregulated with a log2 fold change less than -2 and 245 genes significantly upregulated
with a log2 fold change larger than +2 while using the 2017-version annotation as
reference (Table 4.3). On the contrary, 958 and 251 genes were found significantly downregulated and upregulated in the same level while using the 2017-version annotation as
reference (Table 4.3).
Significantly regulated KEGG metabolism pathways in Dcpvib-1 strain
As one of the GSA tools, GAGE was designed to reveal the relevant regulatory
mechanisms from the transcriptome scale based differential expression analyses. In this
study, the transcriptomes of Dcpvib-1 strain was the treated group and the EP155 strain
was the untreated one with the expression level of each gene normalized by DESeq2
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mentioned above. After the ID conversion using BLASTp and IDcoversion.py, 7,079 out
of 11,171 genes returned the N. crassa KEGG ID compatible with the GAGE and
Pathview tools. The normalized expression level of each gene with a recognizable KEGG
ID matrix was fed to the GAGE with the N. crassa metabolism pathways KEGG dataset
as reference.
In the end, there were 91 metabolic pathways summarized to be different with
statistical data in the Dcpvib-1 strain compared to the EP155 stain. Twenty-nine of them
were down-regulated and 62 up-regulated, respectively. Furthermore, GAGE provides a
z-test to compare the net effect of differential expressed gene while using the as.group
option rather than the paired_sample option leading to a relatively larger but more
reliable p value [89]. There were two metabolic pathways highlighted as significantly
down-regulated (p.value <0.1, highlighted in green) and 19 significantly up-regulated
(p.value <0.1, highlighted in red) in the Dcpvib-1 strain from the GAGE analysis (Table
4.4).
In the down-regulated pathway group, the top four were the RNA transport,
Ribosome, Aminoacyl-tRNA biosynthesis, and the mRNA surveillance pathways are all
down-regulated with the relatively lower statistics means (stat.mean: mean of the geneset transcription level changes) from -0.27 to -0.77 in the Dcpvib-1 strain compared to the
EP155 strain (Table 4.4). The next four were the Proteasome, Arginine and proline
metabolism, Ubiquitin mediated proteolysis and the Alanine, aspartate and glutamate
metabolism pathways with the statistics means from -0.18 to -0.2 in the Dcpvib-1 strain
while compared to the EP155 strain (Table 4.4).
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In the up-regulated pathway group, four of the top five were the Biosynthesis of
antibiotics, Biosynthesis of secondary metabolites, Carbon metabolism, and the
Biosynthesis of amino acids pathways (Table 4.4). All of the listed pathways are the
broad metabolism pathways composed of many individual pathways and highlighted here
because the clustering of those individual pathways. Except for the above three, the most
up-regulated pathway in the Dcpvib-1 strain is the Glycolysis / Gluconeogenesis pathway
(Table 4.4). Furthermore, in all the 15 individual significantly up-regulated pathways,
eight of them were the individual carbon metabolic pathways (Table 4.4).
In contrast, while using the 2009-verison annotation as reference in HT-seq-count
and the same following procedures described above, in the ID conversion step, 7,007 out
of 11,609 genes returned the N. crassa KEGG ID compatible with the GAGE. There
were three metabolism pathways highlighted as significantly down-regulated (p.value
<0.1, highlighted in green) and five significantly up-regulated (p.value <0.1, highlighted
in red) in the Dcpvib-1 strain (Table 4.5). In the five significantly up-regulated pathways
highlighted in red, there was only one individual carbon metabolism pathway (Table 4.5).
The Pathview package was used to visualize the pathways of interest in this study.
First, in the up-regulated pathways group in the Dcpvib-1 strain, the ncr00010 Glycolysis
/ Gluconeogenesis pathway was presented with all critical enzymes in one string
regulated consistently (Figure 4.6). The ncr00500 Starch and sucrose metabolism, the
ncr00052 Galactose metabolism, and the ncr00680 Methane metabolism that are all
linked to the glycolysis in the bigger view were presented with most critical enzymes
consistently flowing to the D-glucose (Figure 4.7, Figure 4.8, Figure 4.9). One special
pathway was presented here was the Oxidative phosphorylation metabolism (Figure
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4.10). Besides, the ncr03013 RNA Transport pathway and ncr04120 Ubiquitin mediated
proteolysis pathway was presented as the examples for the down-regulated pathways
group in the Dcpvib-1 strain (Figure 4.11, Figure 4.12).
Significantly expressed genes’ GO enrichment in Dcpvib-1 strain
REVIGO was used to cluster the GO terms based on the functional similarity by
feeding with a matrix of the GO term and its associated log2 fold change. The table
showed the most frequent GO terms in the significantly regulated genes in the Dcpvib-1
strain (Table 4.6). The results showed a small number of top-ranking GO terms with a
dispensability value as 0 were the GO:0003700 transcription factor activity, GO:0003884
D-amino-acid oxidase activity, GO:0005375 copper ion transmembrane transporter
activity and the GO:0045735 nutrient reservoir activity and all having the log2 fold
change value less than -2, except the GO:0005096 GTPase activator activity with a log2
fold change value as 3.23 (Table 4.6). Moreover, there were some more GO terms related
to carbon and lipid metabolism and DNA polymerase activities that were listed in the
table as well drew the attention because of the phenotype shift in the Dcpvib-1 strain and
former studies of VIB-1 in N. crassa (Table 4.6).
In addition to a table format, REVIGO provides three additional visualization
strategies. First, the scatterplot was draw based on the semantic similarities of the GO
terms (x axis) and the log2 fold change values (y axis). The scatterplot here showed the
up-regulated clusters (Red color bubbles) were the Oligopeptide transport, Carbohydrate
metabolism, Proteolysis, Carboxylic acid metabolism, etc. (Figure 4.13). Meanwhile, the
down-regulated clusters (Blue-green bubbles) were the Pathogenesis, D-amino acid
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metabolism, lipid catabolism, RNA processing, iron transmembrane transport, and others
(Figure 4.13).
The second presentation method is the graph-based clusters interaction view,
which using a node to represent a cluster from the scatterplot and use the edges to
represent at least 3% of the strongest GO term pairwise similarities. The interactive graph
showed the level of the transcription regulating was related to RNA process and the
nucleoside metabolism, which related to the carbon, lipid and protein metabolism (Figure
4.14). On the other side, another interactive net was listed here of different molecule
transport processes, which were highlighted and linked with each other (Figure 4.15).
The last presentation method is the treemap showing the two-level hierarchy of
GO terms by joining the clusters from the scatterplot and interactive graph to several
high-level groups. In the treemap graph, each rectangle represents a single cluster, which
were joined into the superclusters in different colors. It was obvious that the D-amino
acid metabolism was the most major supercluster regulated in the Dcpvib-1 strain (Figure
4.20). The response to stress, pathogenesis, molecular transport, and carbon metabolism
were highlighted as the relatively smaller superclusters, which were consistent with the
phenotype observed in the absence of cpvib-1 (Figure 4.16).
Discussion
RNA-Seq is now widely used to reveal the transcriptome profile in organisms and
can be essential for interpreting the functional elements of the genome and revealing the
molecular constituents of the metabolic pathways. The depth of data assisted the reannotation of the genome by providing accuracy and improved gene model predictions.
71

Here, it was utilized to provide insights into the regulation mechanisms of the
transcriptional activator CPVIB-1 in the plant pathogen C. parasitica.
As mentioned in Chapter II concerning the quality of the RNA-Seq reads and
their alignment percentages to the genome, both the transcriptome of the Dcpvib-1 and
EP155 strains shared similar high-quality results as described in Results of this Chapter.
Furthermore, with the advanced rlog strategy to remove the bias of the low count reads
from the biological replicates of two strains, the sample transcriptome profiles’ similarity
was displayed in the Euclidean distance heatmap and expression level heatmap,
indicating their consistency within the same strain and differences among the two strains.
The above results provided evidence to confirm the accuracy of the RNA-Seq platform
and credibility of the library preparation of the samples.
CPVIB-1 was found to be a universal transcriptional activator itself by the
differential expression analysis using DESeq2 after the normalization and statistics
analysis. There were 1,064 genes (approximately 10% of the genome) found significantly
regulated with a p-value < 0.05 and log2 fold change’s absolute value > 2 in the Dcpvib-1
strain (Table 4.3). Moreover, the GO term clusters summarized from the significantly
regulated genes in the Dcpvib-1 strain (Table 4.6) showed great diversity. One of the
highlighted GO term is GO:0003700 transcription factor activity with a mean log2 fold
change value as -2.3627 indicating the transcript level of various transcription factors
were down-regulated in the absence of the cpvib-1 gene in C. parasitica (Table 4.6). This
result was found to be consistent with the phenotype shift of the Dcpvib-1 strain resulting
in the slower hyphal growth rate, profuse conidiation and increased pigmentation caused
by broad cell cytoplasm processes.
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CPVIB-1 was discovered to mediate the carbohydrate catabolite metabolism and
other nutrient catabolite metabolism by affecting the hydrolytic-activity-related genes.
Two sets of results were found to support this. First, there were five various but directly
related specific KEGG carbon pathways found significantly up-regulated in the Dcpvib-1
strain (Table 4.4). The starch and sucrose metabolism taking both the polysaccharides
and sucrose as the sugar resource to produce the D-glucose (Figure 4.7). Also, as the
product of the methane metabolism as well as the fructose and mannose metabolism, the
fructose 6-P is convertible with D-glucose (Figure 4.9). Moreover, both the pentose
phosphate pathway and galactose metabolism are also leading to the product of Dglucose, which is also reversible (Figure 4.8). Almost all enzymes that are comprising the
glycolysis/gluconeogenesis pathway were regulated in the Dcpvib-1 strain and they were
consistently regulated in the same metabolic flow direction to consume the glucose to the
citrate cycle for ATP synthesis (Figure 4.6).
During the conversion of KEGG ID’s from C. parasitica to N. crassa, we found
that only 7096 genes were mapped to the KEGG pathways, presumably due to N. crassa
possessing different pathways. Given N. crassa is not a pathogen, pathways of specific
interest to the understanding of such behavior could be missed and thus they would not
be highlighted. Additionally, therefore, we use REVIGO term enrichment analysis to
provide additional global information. In the Dcpvib-1 strain transcriptome, the results
from the clustered GO terms in scatterplot indicated the up-regulation of carbohydrate,
carboxylic acid and amine catabolism metabolism as well as the down-regulation of lipid
and D-amino acid metabolism with the log2 fold change values larger than +4 (Figure
4.13). Meanwhile, the super-group treemap graph of the clustered GO terms in the
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Dcpvib-1 strain transcriptome, the major super-group that were significantly regulated
were the nutrient metabolism, molecular transport (Figure 4.16). In N. crassa, VIB-1 was
found to repress the glucose signaling and encourage the carbon catabolite repression
process, thus enabling a proper cellular response for plant biomass deconstruction [34].
Therefore, it was not surprising that the Dcpvib-1 strain resulted in encouraging the
utilization of carbon catabolite and glucose signaling process without the presence of the
CPVIB-1.
CPVIB-1 was also found to be a mediator to the pathogenesis of C. parasitica.
Although the KEGG pathway analysis did not highlight pathways in the Dcpvib-1 strain
related to the pathogenesis, the GO term enrichment analysis highlighted a cluster of
genes related to the pathogenesis with a mean log2 fold change value as -6 (Figure 4.13).
Additionally, the super-group treemap graph of the clustered GO terms in the Dcpvib-1
strain transcriptome highlighted the pathogenesis super-group (in pink color) as one of
the major significantly regulated super-groups (Figure 4.16). In conclusion, the downregulation of pathogenesis related genes in the Dcpvib-1 strain was consistent with the
virulence attenuation phenotype we found in the virulence assay of the Dcpvib-1 strain.
CPVIB-1 was discovered to be essential for proper RNA processing and
biosynthesis. Both the KEGG pathway analysis and GO term enrichment analysis were
consistent in presenting the significant down-regulation these pathways in the Dcpvib-1
strain. Similar results were reported in N. crassa that VIB-1 mutant strain displayed
significantly reduced hyphal growth rate and reduced cellulose consumption level.
The absence of CPVIB-1 triggered the higher transcription level of genes
responding to oxidative stress, the oxidation reduction process, and oxygen binding. In
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the transcriptome of the Dcpvib-1 strain, the oxidative phosphorylation pathway,
oxidation reduction process and oxygen binding GO term cluster were both found
significantly up-regulated. Without CPVIB-1 the balance of producing and eliminating
reactive oxygen species (ROS) was disturbed leading to the oxidative stress which can
lead to the severe damage of DNA, protein and lipids [94]. In response to the stress in the
absence of CPVIB-1, the genes related to response to the oxidative stress were
transcribed in higher level.
With all the above results, it is now clear that the absence of the key universal
transcription activator CPVIB-1 caused the imbalance of stress response systems, altered
DNA, protein and lipids synthesis, disturbed various transcription factor activities and
also RNA processing. The attenuated pathogenesis feature might be caused by the
glucose signaling pathway shift in the Dcpvib-1 strain preventing the fungus from
utilizing the plant cell wall components, like cellulose. These results indicate that
CPVIB-1 is a much more global regulator than was first suspected, and is critical for the
proper function of many cellular activities that may be unrelated to its role in vegetative
incompatibility.
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Figures and Tables
Table 4.1
Sample

RNA-Seq read quality of three biological replicates from the C. parasitica
Dcpvib-1strain.
Reads Yield (Million) *% of >= Q30 Bases Mean Quality Score

Dcpvib-1s1 47.00
Dcpvib-1s2 24.27
Dcpvib-1s3 33.99

94.74
94.12
93.82

35.75
35.63
35.57

*% of >= Q30 Bases means the percentage of all bases in a read containing no more than
one error in each 1,000 bases [68; 75].
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Table 4.2

The quality of read alignments from Dcpvib-1 strain.

a
b
Reads
Reads number
Concordant
Discordant
Yield
mapped to
pair alignment
alignments rate
(Million) genome
rate
47.00
44.86 M (95.45%) 92.5%
0.4%
Dcpvib-1s1
24.27
23.53
M
(96.95%)
93.5%
0.6%
Dcpvib-1s2
33.99
32.98 M (97.02%) 93.4%
0.7%
Dcpvib-1s3
a
Concordant pair alignment rate, referring to the percentage of reads from both pairedend sequencing file matched to the same locus in the genome.
b
Discordant alignment rate, referring to the percentage of reads from both paired-end
sequencing file did not match to the same locus in the genome.

Sample
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Table 4.3

The number of significantly regulated genes in the Dcpvib-1 strain
compared to EP155 strain.

Gene number

2017-version

2009-version

Up-regulated
245
251
Down-regulated
819
958
Nonzero reads counts
10,755
11,209
These are significantly regulated gene number with a p adjusted value less than 0.05 and
a log2 fold change larger than 2 or less than -2.
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stat.mean
-0.77
-0.73
-0.31
-0.27
-0.20
-0.18
-0.18
-0.18
-0.15
-0.14
-0.13
-0.13
-0.13
-0.12
-0.11
-0.09
-0.09
-0.08
-0.07
-0.07
-0.07
-0.07
-0.05

ncr03013 RNA transport

ncr03010 Ribosome

ncr00970 Aminoacyl-tRNA biosynthesis

ncr03015 mRNA surveillance pathway

ncr03050 Proteasome

ncr00330 Arginine and proline metabolism

ncr04120 Ubiquitin mediated proteolysis

ncr00250 Alanine, aspartate and glutamate metabolism

ncr04113 Meiosis - yeast

ncr00340 Histidine metabolism

ncr04111 Cell cycle - yeast

ncr03022 Basal transcription factors

ncr00410 beta-Alanine metabolism

ncr00240 Pyrimidine metabolism

ncr00760 Nicotinate and nicotinamide metabolism

ncr00220 Arginine biosynthesis

ncr03020 RNA polymerase

ncr00380 Tryptophan metabolism

ncr04136 Autophagy - other

ncr00310 Lysine degradation

ncr00280 Valine, leucine and isoleucine degradation

ncr04011 MAPK signaling pathway - yeast

ncr04138 Autophagy - yeast

0.47

0.46

0.45

0.45

0.45

0.45

0.44

0.44

0.43

0.42

0.41

0.41

0.41

0.41

0.40

0.38

0.38

0.38

0.37

0.32

0.30

0.10

0.09

p.val

ncr00562 Inositol phosphate metabolism

ncr00100 Steroid biosynthesis

ncr01212 Fatty acid metabolism

ncr01040 Biosynthesis of unsaturated fatty acids

ncr00620 Pyruvate metabolism

ncr03018 RNA degradation

ncr00230 Purine metabolism

ncr00071 Fatty acid degradation

ncr00350 Tyrosine metabolism

ncr00040 Pentose and glucuronate interconversions

ncr00190 Oxidative phosphorylation

ncr00260 Glycine, serine and threonine metabolism

ncr00520 Amino sugar and nucleotide sugar metabolism

ncr00051 Fructose and mannose metabolism

ncr00030 Pentose phosphate pathway

ncr00680 Methane metabolism

ncr00052 Galactose metabolism

ncr00500 Starch and sucrose metabolism

ncr01230 Biosynthesis of amino acids

ncr01200 Carbon metabolism

ncr00010 Glycolysis / Gluconeogenesis

ncr01110 Biosynthesis of secondary metabolites

ncr01130 Biosynthesis of antibiotics

Up-regulated
pathway name

0.48

0.50

0.55

0.63

0.63

0.75

0.78

0.83

0.85

0.93

0.92

0.98

0.98

1.53

1.70

1.79

1.80

2.06

2.21

2.37

2.78

2.64

2.80

stat.mean

0.20

0.20

0.17

0.14

0.14

0.10

0.09

0.08

0.07

0.06

0.06

0.05

0.05

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

p.val

The metabolic pathways regulated in Dcpvib-1strain compared to EP155 strain with 2017-version annotation as
reference.

Down-regulated
pathway name

Table 4.4
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stat.mean
-1.89
-1.11
-0.80
-0.65
-0.60
-0.32
-0.16

p.val
0.00
0.03
0.09
0.14
0.15
0.29
0.39

Up-regulated
pathway name
ncr01100 Metabolic pathways
ncr00010 Glycolysis / Gluconeogenesis
ncr01210 2-Oxocarboxylic acid metabolism
ncr03040 Spliceosome
ncr01110 Biosynthesis of secondary metabolites
ncr01130 Biosynthesis of antibiotics
ncr03013 RNA transport

stat.mean
1.29
0.97
0.89
0.85
0.84
0.77
0.73

p.val
0.01
0.05
0.07
0.07
0.07
0.09
0.11

The metabolism pathways regulated in the Dcpvib-1strain compared to EP155 strain with 2009-version annotation as
reference.

Down-regulated
pathway name
ncr03010 Ribosome
ncr03030 DNA replication
ncr03430 Mismatch repair
ncr03420 Nucleotide excision repair
ncr00240 Pyrimidine metabolism
ncr04146 Peroxisome
ncr04145 Phagosome

Table 4.5

81

D-amino-acid oxidase activity
GTPase activator activity
copper ion transmembrane transporter activity
binding
FMN binding
nutrient reservoir activity
S-(hydroxymethyl)glutathione synthase activity
RNA-3'-phosphate cyclase activity
hydroxymethyl-, formyl- and related transferase activity
mannose-6-phosphate isomerase activity
triglyceride lipase activity
ligase activity
hydrolase activity
translation initiation factor activity
DNA-directed DNA polymerase activity

GO:0003884
GO:0005096
GO:0005375
GO:0005488
GO:0010181
GO:0045735
GO:0051907
GO:0003963
GO:0016742
GO:0004476
GO:0004806
GO:0016874
GO:0016787
GO:0003743
GO:0003887

0.02%
0.18%
0.03%
55.66%
0.70%
0.04%
0.00%
0.01%
0.23%
0.03%
0.04%
3.54%
22.29%
0.41%
0.46%

frequencyc
4.22%

-10.9393
3.2366
-5.0129
3.0819
-7.5603
-4.8423
-4.9121
-4.1529
-8.6942
3.1358
-8.109
-3.1298
2.1006
2.9937
-2.5228

valuea
-2.3627

0.909
0.985
0.948
0.993
0.893
0.985
0.926
0.936
0.884
0.949
0.836
0.942
0.935
0.947
0.863

0
0
0
0
0
0
0.015
0.016
0.02
0.02
0.021
0.03
0.093
0.1
0.24

uniquenessb dispensability
0.974
0

b

Value column is representing the mean log2 fold change values for each GO term.
Uniqueness column is representing the similarity measurement of the GO term in the cluster.
More unique term tends to be less dispensable.
c
Frequency is the percentage of humans proteins in UniProt were annotated with a GO term in the GOA database, i.e., a higher
frequency denotes a more general GO term, a lower frequency denotes a more specific GO term [92].

a

description
transcription factor activity, sequence-specific DNA binding

The top rank GO term summarized in the REVIGO from the significantly regulated genes in the Dcpvib-1 strain.

term_ID
GO:0003700

Table 4.6

Figure 4.1

The differential expression analysis workflow.

Blue frames were included in the python on-step pipeline. Orange frames were included
in the R script. Green frame was a web-server performance.
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Figure 4.2

Log2 fold change plot of the Dcpvib-1 strain over the mean of normalized
counts.

The plot represents each gene with a dot. The x axis is the average expression over all
samples, the y axis is the log2 fold change between treatment and control. Genes with an
adjusted p value below a threshold (here 0.1, the default) are shown in red. The red
labeled triangles at the bottom represents the genes with a log2 fold change less than -10
and an adjusted p value below 0.1. This plot demonstrates that only genes with a large
average normalized count contain sufficient information to yield a significant call.
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Figure 4.3

Dispersion plot of the Dcpvib-1 strain over the mean of normalized counts.

One black dot represents a gene’s original dispersion and the mean of normalized counts.
One blue dot represents the gene shrunken version of the dispersion and the mean of
normalized counts. The red line is the trend of the mean of the dispersions of all genes.
The blue circle represents the gene with a large dispersion that is not included in the
shrunken process.
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Figure 4.4

VIB1treated_5

VIB1treated_6

VIB1treated_4

untreated_1

untreated_2

untreated_3

untreated_3

Heatmap of Euclidean sample distances of six samples in two strains after
rlog transformation.

Three biological replicates for EP155 strain were labeled with untreated_1, untreated_2,
untreated_3.
Three biological replicates for Dcpvib-1strain were labeled with VIB1treated_1,
VIB1treated_2, VIB1treated_3.
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Ep155_U_T00003111_1
Ep155_U_T00007404_1
Ep155_U_T00007402_1
Ep155_U_T00009005_1

Heatmap of the top 25 significantly down-regulated genes clustering in six
samples.

Three biological replicates for EP155 strain were labeled with untreated_1, untreated_2,
untreated_3.
Three biological replicates for Dcpvib-1strain were labeled with VIB1treated_1,
VIB1treated_2, VIB1treated_3.
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Figure 4.6

KEGG view of ncr00010 Glycolysis / Gluconeogenesis pathway.

Each red labeled frame stands for an enzyme with a positive fold change in the Dcpvib-1
strain.
Each green labeled frame stands for an enzyme with a negative fold change in the
Dcpvib-1 strain.
Each gray labeled frame stands for an enzyme with no fold change in the Dcpvib-1 strain.
Each white labeled frame stands for an enzyme not existing in N. crassa.
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Figure 4.7

KEGG view of ncr00500 Starch and sucrose metabolism pathway.

Each red labeled frame stands for an enzyme with a positive fold change in the Dcpvib-1
strain.
Each green labeled frame stands for an enzyme with a negative fold change in the
Dcpvib-1 strain.
Each gray labeled frame stands for an enzyme with no fold change in the Dcpvib-1 strain.
Each white labeled frame strands for an enzyme not existing in N. crassa.
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Figure 4.8

KEGG view of ncr00052 Galactose metabolism pathway.

Each red labeled frame stands for an enzyme with a positive fold change in the Dcpvib-1
strain.
Each green labeled frame stands for an enzyme with a negative fold change in the
Dcpvib-1 strain.
Each gray labeled frame stands for an enzyme with no fold change in the Dcpvib-1 strain.
Each white labeled frame strands for an enzyme not existing in N. crassa.
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Figure 4.9

KEGG view of ncr00680 Methane metabolism pathway.

Each red labeled frame stands for an enzyme with a positive fold change in the Dcpvib-1
strain.
Each green labeled frame stands for an enzyme with a negative fold change in the
Dcpvib-1 strain.
Each gray labeled frame stands for an enzyme with no fold change in the Dcpvib-1 strain.
Each white labeled frame stands for an enzyme not existing in N. crassa.
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Figure 4.10

KEGG view of ncr00190 Oxidative metabolism pathway.

Each red labeled frame stands for an enzyme with a positive fold change in the Dcpvib-1
strain.
Each green labeled frame stands for an enzyme with a negative fold change in the
Dcpvib-1 strain.
Each gray labeled frame stands for an enzyme with no fold change in the Dcpvib-1 strain.
Each white labeled frame stands for an enzyme not existing in N. crassa.
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Figure 4.11

KEGG view of ncr03013 RNA Transport metabolism pathway.

Each red labeled frame stands for an enzyme with a positive fold change in the Dcpvib-1
strain. Each green labeled frame stands for an enzyme with a negative fold change in the
Dcpvib-1 strain. Each gray labeled frame stands for an enzyme with no fold change in the
Dcpvib-1 strain. Each white labeled frame stands for an enzyme not existing in N. crassa.
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Figure 4.12

KEGG view of ncr04120 Ubiquitin mediated proteolysis pathway.

Each red labeled frame stands for an enzyme with a positive fold change in the Dcpvib-1
strain. Each green labeled frame stands for an enzyme with a negative fold change in the
Dcpvib-1 strain. Each gray labeled frame stands for an enzyme with no fold change in
the Dcpvib-1 strain. Each white labeled frame stands for an enzyme not existing in N.
crassa.
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Figure 4.13

The “Scatterplot & Table” view of REVIGO showing the GO clusters of
the significantly regulated genes in the Dcpvib-1 strain.

The y axis represents the log2 fold change value of each GO term. The x axis represents
the semantic scale of the GO terms. The bubble color indicates the log2 fold change value
from the positive (red, up-regulated) to negative (blue, green, and yellow downregulated). The size of the bubble indicates the frequency of the GO term in the dataset.
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Figure 4.14

The “Interactive graph” view of REVIGO presenting the carbon, nitrogen
metabolism clusters and their interactive RNA processing clusters in nodes
and their interactive relationship by edges from the significantly regulated
genes in the Dcpvib-1 strain.

The bubble size refers to the number of genes in the biological processes. The log2 fold
change values were shown using color shading with negative values in red and positive
values in green.
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Figure 4.15

The “Interactive graph” view of REVIGO presenting the clusters of
different transport process in nodes and their interactive relationship by
edges from the significantly regulated genes in the Dcpvib-1 strain.

The bubble size refers to the number of genes in the biological processes. The log2 fold
change values were shown using color shading with negative values in red and positive
values in green.
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The “Treemap graph” view of REVIGO representing the supercluster
groups in different colors.

One rectangle is representing a cluster from the scatterplot and interactive graph. Each
color represents a supercluster group. The size of the rectangle is adjusted based on the
log2 fold change values and the frequency of the GO term in the dataset.
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IDENTIFYING THE DIRECT TAGETS OF CPVIB-1 USING CHROMATIN
IMMUNOPERCIPITATION SEQUENCING
Abstract
Genetic regulation of vegetative incompatibility (vic) has been hypothesized to be
a means of limiting the spread of hypoviruses. Compatible strains will form a stable
heterokaryon, while incompatible strains will seal fused compartments that subsequently
undergo programmed cell death. The transcriptional factor CPVIB-1 was found essential
for the processes leading to vegetative incompatibility in C. parasitica, a model system
for hypovirus-host interactions. In order to explore the direct targets of CPVIB-1, a
detectable FLAG-tagged CPVIB-1 construct was transformed into the Dcpvib-1 strain. A
ChIP-Seq strategy was applied to reveal the precise recognition sequence and target
genes potentially regulated by the CPVIB-1 protein. We found the GAGA-repeat motif
was recognized and bound specifically by the CPVIB-1 protein. We found 264 genes that
CPVIB-1 targeted with function in remarkably diverse biological processes, including
cell fusion, transcription, translation, autophagy, telomere maintenance, response to
oxidative stress, lipid and protein biosynthesis, and carbon metabolism. From a former
study, the TOR signaling pathway was demonstrated to be inactivated by both rapamycin
and nutrient starvation, thus mimicking the vic response. Combined, our data revealed by
the viable cell rate assay, hyphal growth rate assay, western blot assay, and ChIP-Seq,
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indicate the connection of rapamycin, nutrient starvation, CPVIB-1 and the TOR
signaling pathway in C. parasitica. This represents the first report that CPVIB-1 is
induced by rapamycin treatment and carbon starvation treatment, that CPVIB-1 is
essential for rapamycin to trigger autophagy, that CPVIB-1 is essential for both
rapamycin and nutrient starvation to inhibit the hyphal growth, and that CPVIB-1 targets
the TOR2 subunit directly. In conclusion, CPVIB-1 is a GAGA factor (GAF) interacting
with a large collection of factors and genes that function in many different aspects of
gene activity, chromosome structure and cell development and can be stimulated by
rapamycin and nutrient starvation to inhibit the TOR signaling pathway.
Introduction
In the chestnut blight pathogen fungus C. parasitica, the genetic regulation of
vegetative incompatibility (vic), a form of nonself allorecognition, restricts transmission
of the virulence-attenuating hypoviruses [20]. Paired strains of C. parasitica that have
allelic differences at vic loci display vegetative incompatibility responses, as recognized
by programmed cell death leading to barrage formation [24; 95].
In N. crassa, VIB-1 has been highlighted as a transcriptional activator that is
required for the expression of downstream effectors responsible for programmed cell
death and the hyphal compartmentation triggered by the heterokaryon incompatibility
(het-c) locus [32; 63; 66; 78]. In the plant pathogen C. parasitica, we have identified
CPVIB-1, a putative ortholog of VIB-1, containing the same NDT80/PhoG-like DNA
binding domain. In exploring the role of a putative CPVIB-1 from the model system for
mycovirus-host interactions and causative agent of chestnut blight, the deletion of cpvib-1
from the wild-type strain EP155 was performed resulting in enhanced pigmentation,
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conidiation and defective vegetative incompatibility triggered by vic4, which indicated
the role of CPVIB-1 is similar with the VIB-1 of N. crassa [32]. CPVIB-1 was also found
to play a role in pathogenesis as well, suggesting a potential broad range of targets that
this protein may influence. In this system, we predict that CPVIB-1 is part of a signaling
response, which is triggered by at least some of the allelic differences that define the
vegetative incompatibility system. Using a polymorphism-based comparative genomics
approach, six vic loci in the genome were recently identified [22-24], including vic-4,
although it is not currently known whether CPVIB-1 is responsible for signaling
generated by other allelic differences.
The presence of a conserved DNA binding domain indicated CPVIB-1 may also
act as a transcription factor and act to control the rate of transcription of genes by binding
to specific DNA sequences in their promoter regions [96-97]. In order to further identify
the downstream target genes of this potential CPVIB-1 activity, we began with
comparison of large-scale transcriptome profiling of the Δcpvib-1 mutant strain and its
isogenic wild type EP155 strain using RNA-Seq [80]. With the absence of CPVIB-1,
there were 1,064 transcripts altered significantly, with 245 (23%) up-regulated and 819
(77%) down-regulated. This indicates CPVIB-1 is a key transcription regulator
responsible for various biological processes, including response to oxidative stress,
repressing the glucose signaling pathway, and control of the DNA, protein and lipid
synthesis, all of which could contribute to affect the observed reduced virulence of the
knock-out strain.
A more direct strategy to reveal the direct targets of CPVIB-1, chromatin
immunoprecipitation sequencing (ChIP-Seq) [98] was applied to determine the precise
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binding locations of the CPVIB-1. In 2007, Robertson G et al. first developed the ChIPSeq method and used it to identify the DNA sequences bound by transcription factors
STAT1 in interferon g (IFNg)-stimulated and unstimulated in human cells [99]. Since
then, the ChIP-Seq method has become the most popular strategy due to its ability to
identify the target DNA sequences of the protein of interest rapidly, with high efficiency
and relatively low cost [100]. Here in this study, ChIP-Seq method was used to discover
the DNA binding location of the transcription factor CPVIB-1 and identify the genes it
targets in both rapamycin treated and untreated samples.
Rapamycin is known to be a compound with remarkable anti-fungal and
immunosuppressive properties by acting with peptidyl-prolyl isomerase FPR1 to
influence the Target Of Rapamycin (TOR) complex in yeast [101-102]. The TOR
signaling pathway was subsequently discovered to be a conserved central controller of
cell growth from yeast to humans in response to nutrient availability, stress, and growth
factors [103-104]. Later in 2003, Dementhon et al. successfully linked the programmed
cell death process trigged by vegetative incompatibility to the autophagy induced TOR
signaling pathway in one of the model fungal species, P. anserina [105]. In the light of
rapamycin treatment mimicking the vegetative incompatibility response, we used
rapamycin in our ChIP-Seq experiment to identify the targets of CPVIB-1 that pertained
specifically to the vegetative incompatibility pathway. Unexpectedly, this has revealed a
relationship between CPVIB-1 and the TOR signaling pathway as well.
ChIP-Seq requires the ability to detect and recover the DNA portion of interest.
Therefore, we used a FLAG-tagged CPVIB1 protein expressed in the Δcpvib-1 mutant
strain was constructed to express the detectable FLAG tagged CPVIB-1 protein. FLAG™
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tag is a short peptide sequence (DYKDDDDK) that is easily and specifically recognized
by the commercially available anti-FLAG antibody. This system has been widely used in
western blot, immunohistochemistry, and immunoprecipitation with high specificity and
protein expression, modification, purification without affecting the biological function of
the tagged protein due to the small size [106-108]. With this tool validated we could then
proceed with crosslinking of FLAG-CPVIB-1 protein, recovering the fixed protein-DNA
complexes using the anti-FLAG antibody and then recovering the bound DNA for library
preparation and analysis by high-throughput sequencing [100; 109].
With the 16 to 26 million reads generated from the FLAG-tagged CPVIB-1
samples and its rapamycin treatment samples this strategy found 275 and 357 peaks in the
rapamycin untreated and treated samples, respectively. 264 (untreated) and 292 (treated)
of these were found to be in the region of annotated genes using our newly prepared
genome annotation (see Chapter III). We have identified GAGA-repeats that were found
to be the specific binding sites of CPVIB-1 in both treated and untreated samples.
Association with this GAGA motif places CPVIB-1 functionally in the GAGA factors
(GAFs) family. This family of proteins has an extraordinarily diverse set of functions
including the activation and repression of gene expression, nucleosome organization and
remodeling, higher order chromosome architecture and mitosis [96; 110-112]. In
accordance with these broad roles, CPVIB-1 was found to target genes with functions in
cell fusion, transcription, translation, autophagy, telomere maintenance, response to
oxidative stress, and lipid and protein biosynthesis. Furthermore, we found that the
targets of CPVIB-1 protein following rapamycin treatment include the TOR complex-2
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subunit and several transcriptional factors playing roles in phosphorylation, protein
repair, and cell redox homeostasis.
From work in yeast, we know that both rapamycin and nutrient limitation inhibit
the TOR signaling pathway, which controls the various cellular processes [103; 113].
With our results, we can now associate CPVIB-1 to the TOR signaling pathway and
provide evidence for the connection between the TOR inhibitors, nutrient limitation and
response to rapamycin with the CPVIB-1 protein.
Materials and Methods
Fungal spheroplast preparation
The following fungal spheroplast preparation protocol was adopted from the
paper of Churchill [114]. The Dcpvib-1 mutant strain was previously prepared by Dr.
Rong Mu and cultured in 50 ml potato dextrose broth (PDB; Difco, Sparks, MD) at room
temperature on the bench for four days. After the homogenization of the fungal culture
and addition of another 50 ml fresh PDB broth, the hyphal cells were expected to achieve
log phase growth rate. The suspended mycelium particles were collected by filtering
through sterile Miracloth® (Calbiochem) and then washed with 0.6 M MgSO4
thoroughly. Harvested mycelium were then tapped dry with paper towels and transferred
to a flask containing 50 ml Digestion Buffer (Table 5.1) to break down the fungal cell
wall by incubating overnight on a platform shaker at 100 rpm at room temperature.
The next day, 10 ml of the spheroplast suspension was aliquoted into 50 ml
polypropylene tubes and 12.5 ml cold sterile Tapping Buffer (Table 5.1) was gently
overlaid onto the spheroplast suspension to form a clear interface between two layers.
The tube was then centrifuged in Beckman JS13 rotor (Bucket) at 4,700 rpm at 4 ℃ for
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35 minutes. The spheroplast tube was placed on ice gently and the cloudy interface
containing spheroplast was collected to a new 50 ml polypropylene tube. In the same
tube, 2 volumes of 1 M sorbitol solution was slowly added to the harvested spheroplast
suspension with gentle mixing. The diluted spheroplast were pellet down by
centrifugation in Beckman JS13 rotor at 7,000 rpm at 4 ℃ for 6 minutes.
Supernatant was removed and the spheroplast pellet was suspended in 5 ml of
STC (Table 5.1) and centrifuged in Beckman JS13 rotor at 7,000 rpm at 4 ℃ for 10
minutes. Supernatant was removed and the pellet was suspended with 100 – 200 µl of the
solution with 4 parts STC (Table 5.1), 1 part PTC (Table 5.1), and 0.05 parts DMSO. The
re-suspended spheroplast of the Dcpvib-1 mutant strain were stored at -80 ℃.
Epitope FLAG-tagging of cpvib-1 gene
The cpvib-1 gene is 2546 nucleotides in length and encoding a protein product
with 688 amino acids in length and 72 kilodaltons (KDa) in weight. The FLAG epitope
tag (DYKDDDDK) was tagged to the N- terminus of the cpvib-1 gene using the protocol
described by McClean [115]. Briefly, the addition of FLAG-tag was achieved by PCR
using the primer set CPVIB1-nFLAG (sense sequence: 5’AGCGGCCGCATGGATTACAAGGATGACGACGATAAGATGGCAGAGTTGAAG
GAGCCGGCG -3’ and anti-sense sequence: 5’AAAGCTTTTACGATGTGTTCCACGAGTAGTGGCC -3’). Purified PCR products
from a 1% agarose gel were cloned into the StrataClone PSC-A-amp/kan PCR cloning
vector (Agilent, USA) with instruction manual for sequencing. Confirmed FLAG-tagged
cpvib-1 sequences were removed and purified from pSC-A cloning vector using the
restriction sites (NotI and HindIII) designed and highlighted in the primers. The purified
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FLAG-tagged cpvib-1 DNA products were subsequently cloned into a C. parasitica
expression vector, pCPXNBn1, containing a benomyl selection cassette.
Transformation of the FLAG-tagged cpvib-1 gene into the Dcpvib-1 strain
The above construction of the expression vector and the FLAG-tagged cpvib-1 gene
was transformed into fungal spheroplast prepared in the first step of Methods and Mateirals
in this Chapter [114]. At first, 200 µl of the Dcpvib-1 strain fungal spheroplast were quickly
thawed at 37 ℃ then placed on ice. Subsequently, 5-10 µg of FLAG-tagged CPVIB-1
expression construction DNA was added to a pre-cooled 15 ml FalconTM tube and gently
mixed with 100 µl thawed spheroplast. A control was set up using autoclaved distilled
water as DNA input with the same amount of spheroplast. The mixture was incubated on
ice for 30 minutes and gently added 1ml PTC (Table 5.1) with a following incubation at
room temperature for 25 minutes. In the end, 1ml of STC (Table 5.1) was then added and
mixed gently and aliquoted to petri dishes in small droplets.
Subsequently, 12.5 ml of 45-48 ℃ Regeneration Medium (Table 5.1) was pipetted
onto the droplets and swirled to mix with the transformed spheroplast thoroughly and
allowed to solidify at room temperature. After 16-18 hours of incubation at room
temperature, another 12.5 ml of 45-48 ℃ Regeneration Medium (Table 5.1) containing
desired selective agent Benomyl (Aldrich chemistry, USA) with the final concentration as
500ng/µl was added to overlay the first Regeneration Medium layer. The plates were then
kept on the bench for 5-9 days at room temperature to germinate hyphae on the top layer.
Individual transformants that survived Benomyl selection were picked out to inoculate the
potato dextrose agar (PDA; Difco, Sparks, MD) plates and went through sporulation
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process for 7-9 days. In the end, the diluted spores were spread on the Benomyl selection
PDA (final concentration as 400 ng/µl) plates for the second selection process, therefore
the positive transformants were obtained from the thriving colonies from the single spores.
Expression validation of the FLAG-tagged CPVIB-1 vector construction and
phenotype testing
Phenotype recovery assay
Fungal strains (EP155 wild type strain is isogenic to Dcpvib-1 and the positive
FLAG-tagged CPVIB-1 strains) were cultured on PDA plates for 7 days to encourage
hyphae growth at room temperature in the same environment. In brief, the same size
plugs with mycelium from PDA plates were inoculated on the same set of PDA plates.
Vegetative incompatibility assay
The vegetative incompatibility assay was designed by Lynn Geletka to test the
ability of hyphae of different strains to fuse and exchange cytoplasm [116]. The strategy
of pairing the above three strains (EP155 wild type strain, its isogenic Dcpvib-1 strain and
the positive FLAG-tagged CPVIB-1 strain) and their compatible (EU5) and incompatible
strains (EU5) of C. parasitica was described in Chapter I. All of the above five strains were
firstly revived on PDA plates for 5 days in order to obtain the fresh condition mycelium.
Small plugs (4 mm2) with mycelium were cut from all of the above five strains and paired
with 3 mm separation between the two strains on BGA Medium (Table 5.1). One petri dish
contains approximately 45 ml of BGA medium. The plates were then incubated in the dark
for 4 days at room temperature and exposed to the light for another 2 or 3 days on the
bench. Barrage formation was recorded as a manifestation of vegetative incompatibility.
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Virulence assay
The three strains (EP155 wild type strain, its isogenic Dcpvib-1 strain and the
positive FLAG-tagged CPVIB-1 strain) were started on PDA plates for 5 days again to
obtain the fresh same condition mycelium. First, bark indentations (6 mm in diameter) were
drilled into the American chestnut stems (C. dentata) approximately 20 cm apart from each
other. Second, the mycelium plugs (6 mm in diameter) of three strains drilled from the PDA
plates were inoculated into the indentations. Third, parafilm was wrapped around the
wound with the inoculation of the fungus to prevent desiccation. At the end, the stems
inoculated with three replicates of each of the three strains were kept in a clean container
at room temperature for 21 days. After that, the ovate infection areas with the mycelium
growth were traced on a piece of semi-transparent paper, cut out and weighed to measure
the extent of the infection area. The statistics analysis of variance (ANOVA) was used to
evaluate the measurements using avo package in R. Another R package ggboxplot were
used to assist the analysis and display the results.
Western blot assay
The mycelial plugs from the fungal strains to be tested were inoculated on PDA
plates for 5 days to obtain fresh mycelium. Plugs from these were then cultured in PDB
broth on the bench, stationary and at room temperature, for four days. After
homogenization and re-growth to achieve log phase fungal cells for total protein
extraction, they were harvested by filtration through Miracloth, and then immediately
ground into a fine powder by using a sterilized mortar and pestle [51]. If rapamycin was
included, it was added at a concentration of 10 ng/ml immediately after homogenization.
The total protein was then extracted using the Protein Extraction Buffer (Table 5.1) in a
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ratio of 1:2 (2 ml the Protein Extraction Buffer per 1 g mycelium powder) with 50 µl
protease inhibitor cocktail for yeast (Sigma, USA) per 1 g mycelium powder. The above
mixture was vigorously vortexed for 15 seconds and incubated on ice for 30 mins with
the above vortex and incubation one additional time. The mixture was then centrifuged at
maximum speed (14,000 xg) for 15 minutes at 4°C.
The extracted total protein samples were mixed with a 1x final concentration of
LDS sample buffer (Invitrogen) with the addition of b-mercaptoethanol (4 %) per
manufacturer’s instructions, boiled for 4 minutes and loaded on a precast 10%
polyacrylamide gels (Bio-Rad Laboratories, Inc., USA) in TGS running buffer. The
proteins separated in polyacrylamide gel were then transferred to an Immobilon-P
membrane (Millipore, USA) using a Trans-Blot SD semi-dry electrophoretic transfer cell
(Bio-Rad Laboratories, Inc., USA) using Transfer Buffer at 18 volts for 45 minutes. The
membrane was briefly washed with distilled water and allowed to dry. After wetting in
100% methanol, the membrane was placed in a 5 % nonfat dry milk block (Bio-Rad
Laboratories, Inc., USA) prepared in the TBST for 1 hour at room temperature or
overnight at 4 °C. The membrane was briefly washed in the TBST and incubated in a
1:1000 dilution of a-FLAG monoclonal (Sigma, USA), 1:1000 dilution of a-FLAG
monoclonal (Sigma, USA), 1:5000 dilution of anti-beta actin (Abcam, USA) primary
antibody or 1:1000 dilution of anti-ubiquitin antibody (Cell Signaling Technology, USA)
for 2 hours at room temperature. The membrane was washed three times in the TBST for
5 minutes prior to incubation in a 1:2000 dilution of HRP-Goat Anti-mouse (Bio-Rad
Laboratories, Inc., USA) secondary antibody for 1 hour at room temperature. FLAGtagged proteins were detected using Clarity Western ECL Substrate (Bio-Rad
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Laboratories, Inc., USA) and imaged on a Chemi-doc Imager (Bio-Rad Laboratories,
Inc., USA).
For the purpose of the detecting only ubiquitinated proteins, the membrane was
then stripped with a 0.5 M NaOH solution for 15 minutes at room temperature with a
gentle shaking process and rinsed three times using TBST buffer. Subsequently, the
membrane was re-blocked with 5% nonfat milk and the exact same procedure above
followed with the substitution of the Anti-Ub antibody (Cell Signaling Technology, Inc.,
USA).
Growth rate assay of nutrient starvation and rapamycin treatment on the EP155
and Dcpvib-1 strain
The mycelium plugs from the EP155 wild type strain and its isogenic Dcpvib-1
strain were inoculated on PDA plates for 5 days to obtain the same condition mycelium.
The same size fresh mycelium plugs (4 mm in diameter) from above were then cultured
in minimal defined media EMM (Edinburgh Minimal Media, Sunrise Science, USA),
Full Medium (Add 20 g glucose and 5 g NH4Cl per liter) plates, EMM-Low glucose (Add
5 g glucose and 5 g NH4Cl per liter) plates, or EMM-No Nitrogen (Add 20g glucose and
0g NH4Cl per liter) plates, all on the bench at room temperature for 7 days and all with or
without 10 ng/mlrapamycin (Cayman chemical, USA). The diameters of the mycelium
growth area were measured using a micrometer each day to calculate the growth rate in
millimeter per day unit. The ggplot2 package of R was used to visualize the growth rate
of each samples with histogram figure.
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The viable cell measurement (MTT) assay of rapamycin treated mycelium
The effects of the rapamycin on cell viability of C. parasitica was detected by
using the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay
following the protocol from Patel [117]. Both the EP155 wild type strain and its isogenic

Dcpvib-1 strain were cultured in PDB broth for 4 days and harvested from the lower layer
containing loose filamentous hyphae. Next, 50 ml of PB Buffer was used to rinse and
remove residual media. Small pieces mycelium was weighed and inoculated into PB
Buffer with and without 10 ng/mlRapamycin for 16 hours at room temperature. All
mycelium cells were collected, rinsed with 10ml PB Buffer for 4 times and merged in the
MTT Solution for the viable cells reacting with MTT to produce a purple colored
formazan at 30 °C with shaking for 90 minutes. After centrifuged for 10 minutes for cell
collection, the MTT Solution was removed completely and 800 µl MTT solvent was
added to dissolve the purple formazan. A Gen5 Microplate Reader was used to measure
the absorbance (A570) of each sample (9 samples for each stain in each treatment) [117].
All results were statistically analyzed using one-way ANOVA test using the avo package
of R.
ChIP-sequencing
The mycelial plugs from the Dcpvib-1 strain and its isogenic positive FLAGtagged CPVIB-1 strain were inoculated on the PDA plates for 5 days to obtain the same
condition mycelium. Three biological replicates of the Dcpvib-1 strain and six biological
replicates of the positive FLAG-tagged CPVIB-1 strain mycelium plugs were cultured in
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PDB broth for 4 days and homogenized. 10 ng/ml Rapamycin for treatment was added to
three of the six FLAG-tagged CPVIB-1 strain cultures.
Next day, all of the above mycelium were harvested and fixed using 1 %
Formaldehyde Solution (PierceTM 16 % Formaldehyde, Methanol-free suspended in 1X
PBS, Thermo Fisher Scientific, USA) for 10 minutes on a platform shaker at 100 rpm at
room temperature. Subsequently, 2.5 M glycine was used to quench the formaldehyde to
a final concentration as 0.1 M for 5 minutes on the same platform shaker. After that, all
mycelium was harvested on Miracloth, and then immediately washed by 1X PBS for
three times.
The total protein extraction was performed using the similar protocol mentioned
above but replacing the vigorous vortex step with gentle rotation for 1 hour at 4°C to
minimize dissociation of the protein-DNA complex. For each 1 ml total protein solution,
3 µl of 1M CaCl2 and 5 µl of micrococcal nuclease (MNase, NEB, USA) was added, and
incubated for 20 minutes in a 37°C water bath with mixing every 2 minutes by inversion
to digest the chromatin into small fragments. To stop the reaction and prevent over
digestion, 6 µl of 0.5M EGTA (pH 8.0) was added. Next, the samples were filtered by
0.22 µm filter to remove any remaining cell debris and particulates that may interfere
with protein immunoprecipitation and 140 µl of 1M NaCl was added to minimize
nonspecific protein binding.
For each 1 ml nuclease digested protein-chromatin solution, 40 µl of the ANTIFLAG M2 Magnetic Beads (Sigma, USA) was used to capture and precipitate the FLAGtagged CPVIB-1 proteins and its bound chromatin fragments according to the
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manufacturer’s instruction manual. These were then eluted using a 0.1 M Glycine HCl,
pH 3.0 elution protocol.
To the protein-chromatin solution, 5 µl of RNase A, DNase and protease-free 10
mg/ml (Thermo Fisher Scientific, USA) was added to a final working concentration
100ug/ml and incubated at 37°C water bath for 30 minutes. Subsequently, the solution
was boiled for 10 mins and then incubated at 48°C water bath for overnight with 8µl
Proteinase K (NEB, USA) to reverse the crosslinking by digesting the protein and release
the DNA fragments.
ChIP DNA Clean& Concentrator Kits from Zymo Research was used to purify
the DNA fragments from the above solution. 5 volumes of ChIP DNA binding buffer
from the kits were used based on the DNA solution volume from the last step. 20 µl of
1X TE Buffer was used to elute the DNA from all columns of each biological replicate.
The concentrations of the purified DNA fragments were examined using Qbit
Fluorometer (Invitrogen, USA) and dsDNA HS Assay Kit (Invitrogen, USA).
NEBNext® Ultra™ II DNA Library Prep Kit for Illumina® (NEB, USA) was
used to prepare the ChIP DNA library using at least 1.5 ng input amounts (Table
5.2). Three steps were modified. First, in the Adapter Ligation step, instead of using
25-Fold (1:25) dilution in Tris/NaCl, pH 8.0, 50-Fold (1:50) dilution was used for all
samples after the optimization in my experiment to prevent the adapter self-ligation
from composing the major portion of the library. Second, in the PCR Enrichment of
Adapter-ligated DNA step, both the Index Primer/i7 Primer and Universal PCR
Primer/i5 Primer were reduced to half of the dose (2.5 µl instead of 5 µl) and the
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NEBNext Ultra II Q5 Master Mix cut to 20 µl to avoid primer-dimer formation.
Third, the number of PCR cycles for each sample was pre-optimization and set at 18.
The Illumina HiSeq2500 platform was used to sequence six samples of the
ChIP-Seq DNA library from three replicates of the FLAG-tagged-CPVIB-1 and from
three replicates of FLAG-tagged-CPVIB-1-Rapamycin using Illumina V4 chemistry
and paired end 150 cycle reads. The sequencing was performed by Genewiz, Inc.,
(South Plainfield, NJ).
Bioinformatics analysis
The first step of the ChIP bioinformatics analysis was to use FastQC to perform
the quality assessment of each sequencing file. Second, Trimmomatic and the
adapter/primers database from the NEBNext Ultra™ II DNA Library Prep Kit was
performed because the results from FastQC indicated that the existence of the low
qualities of the nucleotides and the possible presence of NEB adapters and primers [83]
with the SLIDINGWINDOW and MINLEN parameters setting as 4:25 and 36,
separately. Third, Bowtie2 was used to align all reads using default parameters to the C.
parasitica reference genome to generate a sequence alignment/map (SAM) format file
composed of alignment information including the short reads ID, scaffold name,
coordinate information, mismatch information, and the raw nucleotides of the read,
among others [84]. Fourth, grep function command (grep –v “XS:i:” alignment_file.sam
> alignment_file_unique.sam) was used to extract the reads that were only aligned to the
genome uniquely. Fifth, Model-based Analysis of ChIP-Seq version 2 (MACS2) was
used to remove the redundant reads from PCR step of ChIP DNA library preparation,
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adjust read position based on fragment size distribution, calculate peak enrichment using
local background normalization by running the ‘callpeak’ function by setting the genome
size at 50 Million based on the C. parasitica genome assembly size, the minimum false
discovery rate (FDR) q-value cutoff for peak detection at 0.01 and the fold-enrichment
cutoff value at 3 to greatly eliminate the possibility of calling the false binding peaks of
the CPVIB-1 protein [118]. The command used for MACS2 callpeak is listed here
(macs2 callpeak -t all_biological_replicates.bam -c all_vib1_replicates.bed -g 50000000 n outputfile_cpvib-1 -q 0.01 --fe-cutoff 3.0 -B --nomodel --trackline --verbose 3). Finally,
Hypergeometric Optimization of Motif Enrichment (HOMER) version 4.10, a suite of
tools for motif discovery (findMotifsGenome.pl) and annotation analysis
(annotatePeaks.pl) was used to identify the recognition sequence of the CPVIB-1 protein
and annotate the potential target genes of the CPVIB-1 protein with default parameters
[119]. Both HOMER tools have the advantage to take the custom genome and annotation
files, which can be applied to all non-model organisms rather than the built-in model
organisms.
Results
Validation of functional substitution and expression of the FLAG-tagged CPVIB-1
for CPVIB-1
As discovered by Rong Mu and described in Chapter I, the Dcpvib-1 strain shows
profuse sporulation and reduced aerial hyphal growth compared to its isogenic EP155
strain (Figure 5.1). By contrast, with the FLAG-tagged CPVIB-1 expression vector
transformed into the Dcpvib-1 strain, the phenotype was recovered partially with increase
in aerial hyphal growth and decrease in sporulation (Figure 5.1). We attribute this
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difference to the use of a non-native promoter to drive expression of the FLAG tagged
CPVIB-1.
The vegetative incompatibility assay was designed by culturing fungal mycelium
plugs in close proximity (2~4 mm apart) on BGA Medium. Compatible colonies will fuse
to create a uniform structure that becomes indistinguishable from a single colony grown
alone. In C. parasitica, vegetative incompatibility between incompatible colonies can be
seen by the production of a barrage where the colonies meet on BGA Medium. In the
same study from Rong Mu in the Chapter I, the Dcpvib-1 strain was found to regulate the
vegetative incompatibility of EP155 and EU1, which have different alleles at the vic4
locus, when using this assay (Figure 5.2, A). However, with the deletion of cpvib-1 from
both strains, the absence of barrage in the vegetative incompatibility assay indicated they
were compatible with each other (Figure 5.2, B). Based on this background, the positive
FLAG-tagged CPVIB-1 strain was tested using the vegetative incompatibility assay with
the EU1-Dcpvib-1 strain (Figure 5.2, C). The barrage formation was observed in the
BGA Medium that indicated the proper operation of the FLAG-tagged CPVIB-1 protein
(Figure 5.2, C).
Rong Mu also discovered that the deletion of cpvib-1 caused a large reduction in
virulence of C. parasitica. In this study, the virulence assay of three strains (EP155 wild
type strain, Dcpvib-1 strain and FLAG-tagged CPVIB-1 strain) was performed on the
American chestnut stems with five replicates for each strain. The cankers display of the
virulence assay from these three strains indicated the virulence recovery of the FLAGtagged CPVIB-1 strain (Figure 5.3). By utilizing the one-way ANOVA test to analyze the
statistical differences of canker sizes among the three strains, the results suggested the
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significantly differences of canker size between any two strains with a p-value < 0.01.
The R package ggboxplot was used to display the cankers size numerical data categorized
by strains (Figure 5.4). The virulence assay showed that the canker sizes of the positive
FLAG-tagged CPVIB-1 strain were significantly larger than the Dcpvib-1 strain and close
to the EP155 wild type strain. Both the phenotype assay and virulence assay results
confirmed the functional substitution of FLAG-tagged CPVIB-1 for CPVIB-1 in C.
parasitica.
In the end, western blots were used to confirm the expression and detectability of
the FLAG-tagged CPVIB-1 protein by the anti-FLAG antibody with the expected 72KDa
size band (Figure 5.7, Figure 5.8) An additional band higher than 75KDa protein standard
(Figure 5.6, Figure 5.7, Figure 5.8) was also detected and is further described next
section.

Rapamycin acts through a CPVIB-1-related pathway
Rapamycin induces cell death through CPVIB-1
In EP155 strain, with CPVIB-1 protein present, the viable cell rate in 10 ng/ml
rapamycin group was 27.15 % of the control group from the MTT viable cell
measurement assay. In contrast, in the Dcpvib-1 strain without the presence of CPVIB-1
protein, the viable cell rate was 63.83 % on average under the same rapamycin treatment
(Figure 5.5). The results were statistically significant differences based on a t-test
analysis (p-value < 0.001). Thus, the induced cell death rate of 10 ng/ml rapamycin was
significantly decreased without the presence of protein CPVIB-1.
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Rapamycin increases accumulation of the FLAG-tagged CPVIB-1
The FLAG-tagged CPVIB-1 protein accumulation level was detected by western
blot for cultures grown in both EMM full Medium and 10 ng/ml rapamycin
treatment/EMM full Medium (Lane 1 and 2, Figure 5.6). Rapamycin treatment increased
the FLAG-tagged CPVIB-1 protein accumulation (Lane 1 and 2, Figure 5.6), consistent
with the western blot assay of the positive FLAG-tagged CPVIB-1 strain cultured in PDB
and 10 ng/ml rapamycin treatment PDB (Lane 1 and 2, Figure 5.7). However, the
detectable protein bands were larger than the predicted size (72 KDa) and less abundant
than expected when using 25 µg total protein (Figure 5.6).
CPVIB-1 is ubiquitin decorated
Based on the unexpectedly large detected protein bands from the western blot
assay and the multiple positive ubiquitination sites prediction of the CPVIB-1 protein
sequences using UbiSite (http://csb.cse.yzu.edu.tw/UbiSite/), it was hypothesized that
CPVIB-1 could be ubiquitinated which might lead to its degradation in ubiquitin
proteasome system. It is the principle mechanism for protein catabolism in cytosol and
nucleus including the degradation of the transcriptional regulators like CPVIB-1 [120].
The results of the western blot assay using 80 µg total protein showed two detectable
protein bands by anti-FLAG antibody, one above the 75 KDa marker that was identified
previously in last step, the other below the 75 KDa marker and closer to the predicted
size of 72 KDa (Lane 1 and 2, Figure 5.7). Interestingly, rapamycin treatment increased
the accumulation of FLAG-tagged CPVIB-1 protein, and the upper band with the
rapamycin treated samples was clearly enhanced.
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Using immunoprecipitated FLAG-tagged CPVIB-1 proteins in a western blot
assay with the anti-FLAG and anti-ubiquitin antibody, only the upper band was detected
using anti-ubiquitin antibody, but the two band were still detected using the anti-FLAG
antibody (Figure 5.8).
The connection between CPVIB-1, the nutrient starvation, and rapamycin
treatment
The growth inhibition caused by rapamycin in C. parasitica is related to CPVIB-1 and
the nitrogen starvation response
The growth rate of EP155 strain and its isogenic Dcpvib-1 strain was decreased
most in the low-glucose medium with or without the presence of rapamycin (Table 5.3).
The EP155 strain was found more to be sensitive to the treatment of rapamycin compared
to the Dcpvib-1 strain (Table 5.3). The growth rate differences of two strains between
treatments in EMM full medium condition suggested the growth inhibition caused by
rapamycin was affected by the presence of CPVIB-1 gene (Table 5.3). This rapamycin
growth inhibition affect was enhanced under the nitrogen starvation environment to the
EP155 strain compared to the Dcpvib-1 strain (Table 5.3). However, the same
phenomenon was not found in both glucose and nitrogen starvation environment (Table
5.3).
The glucose starvation environment stimulates accumulation of the FLAG-tagged
CPVIB-1
Western blot assay was used to the detect the FLAG-tagged CPVIB-1 protein
accumulation level from the FLAG-tagged CPVIB-1 transformed strain in both EMM
full Medium and EMM-Low glucose Medium. The results suggested that the
accumulation of the FLAG-tagged CPVIB-1 protein increased under the glucose
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starvation condition (Lane 1 and 3 Figure 5.6). However, the nitrogen starvation
treatment was found not to increase the FLAG-tagged CPVIB-1 protein accumulation
level (Lane 1 and 5, Figure 5.6).
ChIP-sequencing reveals the binding recognition sequence motif and downstream
genes of CPVIB-1
Quality assessment of ChIP-Seq reads
The ChIP DNA libraries were sequenced using the Illumina paired end
sequencing technology, generating 32 to 83 million reads for six samples (Table 5.4) with
the existence of poor quality nucleotides and NEB adapters detected using FastQC
(Figure 5.9 (A)). With the application of Trimmomatic to remove the poor-quality
nucleotides and NEB adapters, there were about 16 to 26 million remaining paired reads
for each sample (Table 5.4). After the alignments and removal of reads that mapped to
multiple locations, the single-locus mapped reads from three biological replicates of one
group were combined together in BAM format to be used to call the peaks that were
bound by FLAG-tagged CPVIB-1 protein.
Quality assessment of DNA fragments distribution, peak calling and regulated genes
identification.
The first step of a general ChIP-Seq bioinformatics analysis is to remove the PCR
duplicates. This is critical because of the low amount input DNA for preparing the library
in this study [121]. However, most tools designed to perform the redundant reads
removal were for sonication fragmentation projects rather than nuclease fragmentation as
used in this work. However, by default MACS2 was designed to serve this goal through
removing redundant reads to retain no more than one read per genomic location [118].
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After this step, there were 2.69 million and 0.823 million reads retained from the FLAGtagged-CPVIB-1 (untreated) and the FLAG-tagged-CPVIB-1-Rapamycin (treated)
samples, respectively (Table 5.4).
The second step was to adjust read position based on fragment size distribution
because the sequenced DNA reads from a ChIP library are often only encompassing the
minimal DNA fragments spanning the protein-DNA interactions [118]. Since the
sequencing technology is likely to sequence the 5’ end of the both strands, the reads
mapped to genome appear to be at the left or right side of the protein-DNA interaction.
Therefore, the reads density around a true binding site should show a bimodal enrichment
pattern, with forward strand tags enriched upstream of the binding site and reverse strand
tags enriched downstream [118]. MACS2 is a model-based analysis tool designed to
capture the reads that represent the ends of the fragments in a ChIP-DNA library and
determine the reads that are responsible for peak calling. Both the FLAG-tagged-CPVIB1 and the FLAG-tagged-CPVIB-1-Rapamycin samples showed the expected bimodal
pattern (Figure 5.10). The d value of 128 and 112 bp for both samples represents the
estimated distribution of DNA fragment size (Figure 5.10), a typical value for
transcription factors and critical to extend the ChIP-Seq reads to accurately represent the
original ChIP protein-DNA binding sites [118].
The third step is to calculate peak enrichment using local background
normalization. As recommend by a comparison report of the tools designed for ChIP-Seq
analysis, MACS2 was selected because it was designed to perform peaks calling step
without the requirement of an input control sample [122]. The strategy is to model the
number of reads from a genomic region using Poisson distribution with dynamic
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parameter that varies along the genome to differentiate the peaks from the genome
background [118]. In this study, the control samples (from strain Dcpvib-1, thus a strain
with no FLAG-tagged protein to recover) failed to generate sufficient DNA input for
sequencing, which makes the MACS2 the best analysis tool for our project. Meanwhile,
the parameters of fold-change and q-value (minimum FDR, false discovery rate) was set
at 3 and 0.01 to reduce the possibility of false positive peaks calling. There were 275 and
358 peaks were called in the FLAG-tagged-CPVIB-1 and the FLAG-tagged-CPVIB-1Rapamycin samples, separately (Table 5.5). One example of the peak that was identified
as a binding site of FLAG-tagged CPVIB-1protein in PDB broth and rapamycin
treatment is shown in Figure 5.11 (A). A second example of a peak only detected as a
binding site of FLAG-tagged CPVIB-1 protein in PDB broth is shown in Figure 5.12 (B).
A peak that was only detected as a binding site of FLAG-tagged CPVIB-1protein in
rapamycin treatment is shown in Figure 5.11 (C).
Recognition sequence analysis
To reveal the FLAG-tagged CPVIB-1protein recognition sequences from the 275
and 358 peaks called in the last step, the HOMER program was used to extract sequences
from the genome corresponding to the peak regions, auto-normalize the sequence bias by
building the background automatically and check the enrichment of known recognition
sequences of genes from its reliable library, as well as find the de novo recognition
sequences of length less than 8 bp [119].
In the FLAG-tagged CPVIB-1 samples, the recognition sequence GAGAGAGA
(Reverse Complementary: TCTCTCTC) was identified as the top candidate with a pvalue of 1e-20 and exists in 68 out of 275 (24.73%) peaks (Figure 5.12(A)). The distance
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between recognition sequence center and all the peak summits was calculated to
determine its specific position within the peaks (Figure 5.12 (B)). A consistent feature for
the transcription factors described in other studies was that the majority of recognition
sequences were located within the summit region of peaks[109; 119] as was the case in
the FLAG-tagged-CPVIB-1 sample data. In addition, by searching the similar recognition
sequences in HOMER library, five well-studied proteins were found to bind similar
recognition sequences with significant low p-values (Table 5.6) and their recognition
sequences are shown in Figure 5.12 (C). The top candidate protein identified to share the
similar GAGAGAGA recognition sequences is BPC6, which was identified as a
transcriptional regulator involved in developmental processes in Arabidopsis thaliana
(Figure 5.12 (C)) [112]. This GAGAGAGA recognition sequences was identified with an
p-value of 1e-30 and exists in 58 out of the 275 (21.09%) peaks in the FLAG-taggedCPVIB-1 samples (Figure 5.12 (C)). Another three known genes are FRS9, a putative
transcription activator involved in regulating light control of development, BPC1, a
transcriptional regulator involved in developmental processes and a GAGA-repeat
binding protein that were also shown to have a highly similar GAGA recognition
sequence (Figure 5.12 (C)) [123-124]. The other known protein, VRN1 is a T-repeats
element binding transcriptional repressor of FLC, a major target of the vernalization
pathway (Figure 5.12 (C) [125].
In the FLAG-tagged-CPVIB-1-Rapamycin samples, the recognition sequence
GG[A]A[C]AGA[G]A[G]G (Reverse Complementary: CT[C]T[C]CTT[G]C[T]C[T])
was identified as the top candidate with a p-value of 1e-7 and exists in 116 out of 357
(32.49%) peaks (Figure 5.13(A)). The distance between recognition sequence center and
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all the peak summits were calculated as well (Figure 5.13 (B)). The majority of this
recognition sequence located within the central region of peaks in the FLAG-taggedCPVIB-1-Rapamycin sample as well but with a diffusion distribution towards the nearby
regions [109; 119]. In addition, scanning the HOMER library identified five well-studied
proteins that were found to bind similar recognition sequence with significant low pvalues (Table 5.7) and their motifs are shown in Figure 5.13 (C). With an p-value of 1e-7,
the top candidate was identified to be KLF10, which is a transcriptional repressor that
acts as an effector of transforming growth factor beta signaling in Homo sapiens (Figure
5.13 (C)) [126]. The same GGGGGT[C]GTGT[G]C[G]C[T] recognition sequence of
KLF10(Zf) exists in 27 out of the 357 (7.56%) peaks in the FLAG-tagged-CPVIB-1Rapamycin samples (Figure 5.13 (C)). Another three known proteins, FRS9, BPC6 and
GAGA-repeat were identified in the FLAG-tagged-CPVIB-1 samples as well (Figure
5.13 (C)) [112; 123]. The other matched protein that was unique in the rapamycin
treatment samples sharing a similar GAGA-repeat recognition sequence, TRL is a
transcriptional activator to promote the open chromatin conformation to allow the access
to other transcription factors (shown in Figure 5.13 (C)) [111].
Functional annotation of FLAG-tagged CPVIB-1 targeted genes
HOMER was used to annotate the location of the peaks in terms of important
genomic features, such as transcription start site (TSS), transcription termination site
(TTS), exon (Coding region), 5’ UTR, 3’ UTR, intronic, and intergenic using the C.
parasitica genome and the most recent 2017-version annotation [119]. For the FLAGtagged CPVIB-1 samples, 264 out of 275 peaks were annotated to be in the genomic
features of the C. parasitica predicted genes (Table 5.5). The GO terms clustering
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program REVIGO was used to visualize the biological processes of the targeted genes of
FLAG-tagged CPVIB-1 protein (Figure 5.14). The highlighted GO term with the highest
peak-score was GO:0000753 Cell morphogenesis, involved in conjugation and cellular
fusion and its related gene is Ep155_U_T00007121. This is similar to the FIG1 gene
from Saccharomyces cerevisiae, responsible for cell-cell communication, cell fusion
(Figure 5.14) [127]. The second group of clustered GO terms we are interested in were
the GO:0006914 autophagy and GO:0042981 regulation of apoptotic process, thus both
involved in the programmed cell death pathways. The other GO term cluster groups were
highlighted to represent the variety of genes involved in different biological processes,
such as meiosis, metabolism, transport, transcription, translation and post-translation
(Figure 5.14).
In order to investigate the expression profile of the FLAG-tagged CPVIB-1
targeted genes, the transcriptome data from Chapter IV that compared the EP155 wild
type and Dcpvib-1 mutant strains were utilized. There were 118 out of the above 264
genes significantly altered in the Dcpvib-1 mutant strain suggested that about half of the
observed targets of FLAG-tagged CPVIB-1 protein had their transcription process
directly modulated. The GO term distribution of these 118 genes were also visualized
using REVIGO [92]. The highly important GO terms mentioned above, such as, cell
morphogenesis involved in conjugation, regulation of apoptosis, meiosis, metabolism,
transport and transcription were found to be significantly altered in transcriptional level
(Figure 5.15). In addition, several GO terms were highlighted to be significantly
regulated in the Dcpvib-1 mutant strain included proteolysis, carbohydrate metabolism
and mRNA processing, which have also been discussed in the Chapter IV (Figure 5.15).
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With rapamycin treatment, 292 out of 358 peaks were annotated to be in the
genomic features (Table 5.5). The majority of their GO terms were similar to the nonrapamycin treated FLAG-tagged CPVIB-1 samples, but the unique ones that were
presenting with the rapamycin treatment are shown in Figure 5.16. most interestingly,
these include GO:0031929 TOR signaling, which was linked to gene
Ep155_U_T00000852 with a function similar to STE20 (target of rapamycin complex2
subunit) in Schizosaccharomyces pombe (Figure 5.16). Also, the GO terms with highest
peak scores were the phosphorylation and phosphorelay signal transduction systems. In
addition, the protein repair, sterol metabolism, exocytosis and cell redox homeostasis
were highlighted after rapamycin but not were not present in the untreated analysis
(Figure 5.16). Of the 292 genes, 121 were significantly regulated at the transcriptional
level by CPVIB-1 from the transcriptome comparison data. In the GO terms cluster
distribution plot, they were all overlapped with the GO terms from the targets the FLAGtagged CPVIB-1 (untreated) samples (Figure 5.17).
In the 264 genes targeted by FLAG-tagged CPVIB-1 and 292 genes targeted by
FLAG-tagged CPVIB-1 with rapamycin treatment, 21 of them were same genes from
them and the others were unique based on the treatment (Table 5.5). All of them are listed
with their UniProt ortholog protein names, the log2 fold change value in the
transcriptional level in the absence of CPVIB-1, and the GO terms and biological
processes they involved in (Table 5.8). Among them, the apoptotic regulation gene
(YBR241C), the glucose metabolism gene (cfp, pyruvate decarboxylase), the oxidationreduction process (mutM), the mRNA degradation process (dom34, RNA surveillance)
and metabolism (SPBC725.05C) are all plausibly related to the phenotype shift observed
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in the mutant Dcpvib-1 strain, such as the reduced hyphal growth, the reduced virulence
and reduced programmed cell death. Moreover, a transcriptional regulator named SIM1 is
a protein involved in the control of the apoptosis-like cell death and telomere length
homeostasis with CDC13 in S. cerevisiae [128].
Discussion
As a preparative step to revealing the targets of CPVIB-1 in this study, the FLAGtagged CPVIB-1 was expressed and shown to functionally complement the C. parasitica
Dcpvib-1 mutant strain, and to be recoverable by immunoprecipitation. During this work,
CPVIB-1 was found to be decorated by ubiquitin which might lead to the degradation of
CPVIB-1 through the ubiquitin-proteasome system (UPS). UPS is a universal regulation
system shown to control the localization, abundance and activity of transcription factors
[129]. As one of the principal mechanism for protein catabolism, the UPS regulates the
abundance of the transcription activators by covalently tagging the proteins with multiple
ubiquitin molecules (Conjugation), and subsequently degrading the tagged proteins via
the proteasome activity (Degradation) [120; 130]. Based on the bands migration
compared to the protein molecular weight standards, we estimated that the mass of
ubiquitin modified FLAG-tagged CPVIB-1 protein to be approximately 22 KDa larger
than the predicted size and much more abundant led to the hypothesis that the CPVIB-1
protein was associated with multiple ubiquitin modifications at one or various sites or
other types of post-translation modification.
CPVIB-1 was found to be induced by rapamycin and carbon starvation treatment.
In the study of vegetative incompatibility system in fungus P. anserina, rapamycin was
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discovered to be able to mimic the incompatibility reaction by targeting the TOR (target
of rapamycin) signaling pathway, which has the TOR protein kinase (conserved from
humans to yeast) to control cell growth in response to nutrient availability [104-105].
Generally, rapamycin inhibits the TOR signaling pathway leading to the autophagy,
expression of starvation-induced genes and inhibition of translation in yeast and other
organisms [102; 105]. Therefore, rapamycin was hypothesized to be a promoter for the
expression of CPVIB-1 to induce programmed cell death. To test this hypothesis, the
viable cell number in the rapamycin treated and untreated were measured using the MTT
assay, the hyphal growth rate in the rapamycin treated, nutrient starvation treated and
untreated were measured, and the accumulation level of FLAG-tagged CPVIB-1 in the
rapamycin treated, nutrient starvation treated and untreated samples was detected.
The viable cell number in rapamycin treated mycelium was significantly reduced
compared to the control indicating the same inhibition mechanism of cell growth through
TOR pathway in C. parasitica as was observed for P. anserina. Second, without the
presence of CPVIB-1, the ability of rapamycin to trigger cell death was reduced,
indicating the relationship between the CPVIB-1 and rapamycin action. Third, the hyphal
growth rate inhibition of the rapamycin treatment was reduced without the presence of
CPVIB-1 compared to EP155 strain. Lastly, the accumulation level of FLAG-tagged
CPVIB-1 protein in the rapamycin treated tissue was clearly increased compared to the
control confirming that CPVIB-1 is induced by rapamycin treatment. Under the nutrient
starvation environment, the TOR signaling pathway was inactivated leading to the similar
outcomes for rapamycin treatment in P. anserina [105]. Therefore, in C. parasitica, the
connections of nutrient starvation, rapamycin and CPVIB-1 was tested using the growth
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rate assay and the western blot assay. The growth rate under the glucose starvation but
not nitrogen starvation was significantly reduced compared to the full defined medium.
Similarly, without the presence of CPVIB-1, the growth rate inhibition of rapamycin
treatment under either of the nutrient starvation was also reduced indicating both
rapamycin and nutrient starvation inactivate the TOR signaling pathway. Furthermore,
while nitrogen starvation did not induce CPVIB-1 expression, the glucose starvation was
found to increase the accumulation of CPVIB-1 similar to the rapamycin treatment. The
related actions of CPVIB-1 and rapamycin present the clear association of regulatory
mechanisms controlling the TOR signaling pathway.
With current technology, ChIP-Seq is the most widely used strategy to explore the
protein-DNA interaction sites, and is suitable for the goal of this study to identify the
targets of a transcriptional factor [131]. In this study, the ChIP DNA library prepared
from the FLAG-tagged CPVIB-1 samples was sequenced for this purpose. Meanwhile,
the FLAG-tagged CPVIB-1 rapamycin treatment samples were prepared to induce the
expression of CPVIB-1 and sequenced as well to explore the possibility of the treatment
leading to differential targets and potentially reveal the regulatory relationship of TOR
and CPVIB-1. Unfortunately, it was impossible to obtain enough background input DNA
for the negative control probably due to the high specificity of the ANTI-FLAG antibody
under the 160 mM sodium salt lysis solution, which is recommended for the high
specificity binding. As for the quality of the sequencing, 16 to 26 million reads were
obtained for each biological replicate after the stringent trimming process (Table 5.4).
ENCODE ChIP-Seq guideline recommended that 20 million reads are suitable for
mammalian studies and 4 million for the Caenorhabditis elegans [131]. Therefore, there
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were ample high-quality DNA reads for our project based on the relatively small genome
size [131]. Because of the absence of the background input negative control, the peakcalling process was set with the extremely harsh parameters to eliminate false discovery.
For both the FLAG-tagged CPVIB1 sample and its rapamycin treated sample, the GArich element was revealed to be the recognition sequence of CPVIB-1 protein. By
searching the similar motif binding genes against the HOMER database, several
transcriptional regulators with the same GA-rich motif binding feature were identified.
They were BPC1, BPC6, FRS9 and VRN1, three GAGA-biding transcriptional regulators
in Arabidopsis plus the TRL and GAGA-repeats factors, two transcriptional regulators in
Drosophila [111-112; 123-125].
Therefore, we conclude that CPVIB-1 is functionally a GAGA-repeats binding
transcriptional regulator (GAF) in C. parasitica that functions in remarkably diverse
range of regulatory contexts, including activation/repression of genes’ transcription,
mitosis maintenance, cell development, and autophagy, cell-cell communication,
virulence, nucleosome assembly, etc. In other systems, GAF transcriptional regulators
were found to be responsible for the activation and silencing of gene expression by
specific binding to the promoter regions of various genes, including homeotic genes
during developmental stages [96]. In this study, CPVIB-1 was found to target 275 genes
distributed in various biological processes and significantly altered about half of them at
the transcription level. These processes included mitosis, biosynthesis, metabolism,
autophagy, cell fusion, and translation, which are consistent with the roles found from
former studies of GAFs in other systems (Figure 5.15) [112; 124; 132-134].
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CPVIB-1 targets at least six important regulators. SIM1 is involved in the control
of the apoptosis-like cell death and telomere length homeostasis [128], which correlates
with the function of CPVIB-1 to maintain pathogenesis that was observed in both
Chapter I and IV. Epithelial mesenchymal transition (EMT) plays roles in altering cells to
a mesenchymal cell phenotype [135]. Proteasome regulator is an essential component of
the ubiquitin-proteasome system [130]. GTPase signaling regulator activates GTPase
signaling pathway and involves in the virulence [136-137]. CRZ1 regulator is essential
for the pathogenicity by regulating the calcium signaling and high-osmolarity glycerol
response (HOG) signaling pathway [109; 138]. In the end, SAP30 regulator was
discovered to be a component of histone deacetylase complex, which involved in
telomere maintenance and the infectious growth of rice blast fungus [139].
Furthermore, GAFs have been found to act as more than a typical transcriptional
factor but also the genome-scale transcriptional regulator by facilitating the formation
and maintenance of nucleosome free regions of the chromatin to expose the promoter
sequences for the access of other transcriptional factors [111]. In this study, the target
genes of CPVIB-1 include the DNA helicase for the mitosis, telomere maintenance and
the decomposition of the chromatin complex and the activators for the transcription of
RNA polymerase II promoter for the promotion of the transcription process [140-142]
(Figure 5.15), all of which would fit with this role. In conclusion, CPVIB-1 is a GAGAmotif biding transcriptional regulator (GAFs) in C. parasitica. This is the first confirmed
GAGA repeats binding regulator identified in fungi that functions in the regulating of
various downstream transcription factors and downstream genes involved in diverse
biological processes including homeotic genes as well as in the regulation of the genome130

wide transcription process by promoting the chromatin decomposition for releasing the
DNA segments for transcription polymerase and other factors.
By mimicking the vegetative incompatibility process using rapamycin, the
recognition sequence of CPVIB-1 was shifted slightly to target genes involved in the
autophagy, phosphorylation, sporulation, cell redox hemostasis, protein glycosylation,
exocytosis, and the TOR signaling pathway. With the treatment by rapamycin, the
FLAG-tagged CPVIB-1 protein targets 357 genes and only 33.9% of them were
significantly altered in the transcriptome profile of the CPVIB-1 deletion strain, but there
were a few new noteworthy targets.
The apoptosis-inducing factor 2 gene encodes an oxidoreductase, which plays a
role in mediating the apoptotic cell death by binding to a sequence-specific DNA site
[143]. The LAE secondary metabolism regulator coordinates response to light in
Aspergillus and regulates T-toxin production, virulence, oxidative stress response and cell
development of maize pathogen Cochliobolus [144]. The cAMP-independent regulator
PAC2 was found to be required for sporulation, regulating the meiotic cell cycle and
negatively regulating cell fusion [145]. Furthermore, the identified C. parasitica version
of cAMP-independent regulator PAC2 was significantly up-regulated in the CPVIB-1lacking strain. Lastly, the aspartic protease PEP1 gene, encodes a secreted aspartic
endopeptidase that contributes to the virulence [146]. In conclusion, there is a remarkable
confluence of the phenotypic characteristics of a strain lacking CPVIB-1 and the specific
gene targets that this procedure has revealed that are involved in programmed cell death,
virulence, meiosis, cell fusion, and sporulation progress.
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Intriguingly, with the treatment of rapamycin, CPVIB-1 was found to target the
TOR2 subunit STE20, one component of the TOR Complex [147]. The TOR signaling
pathway includes two segments, TOR1 and TOR2 [102]. TOR1 is the interaction site for
rapamycin and is responsible for regulating the sensing of stress, growth factors, nutrients
to regulate the protein synthesis, lipid and nucleotide synthesis, and autophagy. TOR2
was found to be insensitive to rapamycin but sensitive to growth factors that regulated
survival and proliferation [102]. Meanwhile, two other genes, the hybrid signal
transduction histidine kinase K and acetate kinase, were targeted by CPVIB-1 during the
rapamycin treatment with the highest peak scores and they are involved in the
phosphorylation and the phosphorelay signal transduction biological processes. With the
discovery that the TOR contained a C-term kinase domain, it was found to play a central
regulator role in an abundant and diverse set of genes which are important for cell growth
by reacting with related kinase family proteins [102]. In conclusion, in the presence of
rapamycin CPVIB-1 targets the TOR2 and other kinases which are involved in the TOR
signaling pathway.
Ultimately, we have shown that both the carbon starvation and rapamycin inhibit
the TOR signaling pathway leading to the autophagy and inhibition of cell growth,
consistent with other systems. However, CPVIB-1 was found to target TOR2 expression
and be induced by rapamycin and carbon starvation treatment. Therefore, we propose a
model such that rapamycin or a nutrient starvation signal targeting TOR1 results in
changes to CPVIB-1 expression. This, in turn, affects TOR2-regulated pathways by
perturbing important members of the complex. Thus, we propose a novel regulatory
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mechanism whereby CPVIB-1 acts as a mediator to link the separate regulatory regimes
of TOR1 and TOR2-dependent pathways.
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Tables and Figures
Table 5.1

Solution recipes used in this chapter.

Solution Name

Components

Osmotic Medium

1.2 M MgSO4;
10 mM NaH2PO4;
adjust pH to 5.8 with 0.5 M Na2HPO4

Digestion Buffer

1 % β-glucuronidase [Sigma G-7770];
0.2 % Lysing enzyme [Sigma L-1412];
0.6 % Bovine Serum Albumin [Fisher BP
1605];
1.5 % VinoflowTM

filter sterilization

Trapping Buffer

0.4 M Sorbitol;
100 mM Tris-HCl pH 7.0

autoclave
sterilization

STC

1 M Sorbitol;
100 mM CaCl2;
100 mM Tris-HCl pH 8.0

autoclave
sterilization

PTC

40 % Polyethylene glycol 4000 MW;
100 mM Tris-HCl pH 8.0;
100 mM CaCl2

autoclave
sterilization

Regeneration
Medium

1 M sucrose;
0.1 % Yeast Extract;
0.1 % Casein Hydrolysate

autoclave
sterilization

BGA Medium

2.4 % PDA;
0.7 % malt extract agar;
0.2 % yeast extract;
0.08 % tannic acid;
0.005 % mg Bromocresol Green;
0.06 % drops Tween 20;
2 % BD BactoTM Agar
50 mM Tris-HCl pH 8.0;
20 mM NaCl;
1 % Triton-X100;
0.1 % CHAPS;
0.1 % NP-40

autoclave
sterilization

25 mM Tris;
192 mM Glycine;

No sterilization

Protein
Extraction Buffer

TGS Running
Buffer

134

Sterilization
protocol
filter sterilization

filter sterilization

0.1 % SDS, pH 8.3
TBST

20 mM Tris;
150 mM NaCl;
0.05 % Tween 20, pH 7.6

No sterilization

Transfer Buffer

25 mM Tris;
192 mM glycin;
20 % Methanol

No sterilization

PB Buffer

75.4 mM Na2HPO4;
24.6 mM NaH2PO4

autoclave
sterilization

MTT Solution

50 mg Thiazolyl Blue Tetrazolium
Bromide; dissolved in 10 ml PB Buffer

filter sterilization

MTT Solvent

4 mM HCl;
0.1 % NP-40;
dissolved in isopropanol

filter sterilization

1X TE Buffer

10 mM Tris-Hcl ph 8.0;
1 mM EDTA

filter sterilization

135

136

Too little to be detected
Too little to be detected
1
Too little to be detected
1.5
2.0
2.7
2.1
2.5
3.4

FLAG-tagged-CPVIB-1- Rapamycin-rep2
FLAG-tagged-CPVIB-1- Rapamycin-rep3

10.5
22.8

Concentration of purified DNA library
(ng/ul)
0.6
1.22
0.4
6.16
12.8
18.1
7.74
280
317

DNA fragments
size
2
Too low
2
Too low
2
Too low
273
272
286
275

2

Too little to be detected indicated the concentration of the DNA samples lower than the lowest threshold of the Qbit Fluorometer.
Too low indicated the concentration of the DNA library was lower than or close to 1 ng/µl that the DNA chip of Agilent 2100
Bioanalyzer® was not able to detect it.

1

1

Dcpvib-1-rep1
Dcpvib-1-rep2
Dcpvib-1-rep3
FLAG-tagged-CPVIB-1-rep1
FLAG-tagged-CPVIB-1-rep2
FLAG-tagged-CPVIB-1-rep3
FLAG-tagged-CPVIB-1-Rapamycin-rep1
1

Mass of Purified DNA (ng)

The mass of DNA extracted from ChIP, the concentration of ChIP libraries, and the DNA fragment size of ChIP
libraries.

Sample name

Table 5.2

137

Medium condition

The growth rate of the EP155 and its Dcpvib-1strain on various media with and without rapamycin treatment.

Growth rate (mm/day)
EP155
Dcpvib-1
EMM
9.27±0.600 8.70±0.263
EMM-Low glucose
7.98±1.135 7.01±0.139
EMM-No Nitrogen
8.82±0.416 8.01±0.482
EMM-Low glucose-No Nitrogen
8.57±0.269 8.40±0.225
EMM-10 ng/ml rapamycin
5.49±0.990 5.71±0.266
EMM-Low glucose-10 ng/ml rapamycin
5.52±0.029 5.26±0.212
EMM-No Nitrogen-10 ng/ml rapamycin
5.70±0.137 6.36±0.322
EMM-Low glucose-No Nitrogen-10 ng/ml rapamycin 5.57±0.284 5.42±0.289
Growth rate (mm/day) was calculated from the growth diameter of fungus each day in solid media with three biological replicates.
The numbers represent the growth rate and the standard deviation within the three biological replicates.

Table 5.3
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Original reads
number (Million)
43
83
43
42
49
32

FLAG-tagged-CPVIB-1-rep1
FLAG-tagged-CPVIB-1-rep2
FLAG-tagged-CPVIB-1-rep3
FLAG-tagged-CPVIB-1-Rapamycin-rep1
FLAG-tagged-CPVIB-1- Rapamycin-rep2
FLAG-tagged-CPVIB-1- Rapamycin-rep3

19
26
20
16
24
16

Remained reads
number (Million)

Sequenced reads numbers from ChIP-Seq library.

Samples

Table 5.4

2.69

0.823

18.0

Non-redundant reads
response to call peaks
(Million)

Total reads uniquelymapped and response to
call peaks
(Million)
15.6
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Peaks Number
Total Annotated to
link to genes
275
264
357
292
Unique in
samples
243
261

The results of called peaks from MACS2.

FLAG-tagged-CPVIB-1
FLAG-tagged-CPVIB-1Rapamycin

Samples

Table 5.5

Present in transcriptome
significantly regulated genes
118
121

Unique in transcriptome
significantly regulated genes
106
109
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Consensus
YTYTCTCTCTCTCTA
RGAGAGAGAAAG
GARGAGAGAGAA
TTTTTTTTTT
CTCTCTCTCY

PC6(BBRBPC)/col-BPC6-DAP-Seq
FRS9(ND)/col-FRS9-DAP-Seq
BPC1(BBRBPC)/colamp-BPC1-DAP-Seq
VRN1(ABI3VP1)/col-VRN1-DAP-Seq
GAGA-repeat/Arabidopsis-Promoters

1.00E-30
1.00E-18
1.00E-11
1.00E-10
1.00E-08

P-value
58
68
68
38
79

# of Target
Sequences
with Motif
(of 275)
21.09%
24.73%
24.73%
13.82%
28.73%

% of
Target
Sequences
with Motif
3.00%
7.43%
10.07%
3.98%
14.75%

% of
Background
Sequences with
Motif

The top five genes that recognize similar sequences with FLAG-tagged-CPVIB-1 protein from HOMER database.

Motif Name

Table 5.6
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Consensus
GGGGGTGTGTCC
RGAGAGAGAAAG
YTYTCTCTCTCTCTA
RGAGAGAG
CTCTCTCTCY

KLF10(Zf)/HEK293-KLF10

FRS9(ND)/col-FRS9-DAP-Seq

BPC6(BBRBPC)/col-BPC6-DAP-Seq

Trl(Zf)/S2-GAGAfactor-ChIP-Seq

GAGA-repeat/Arabidopsis-Promoters

1.00E-03

1.00E-04

1.00E-04

1.00E-05

1.00E-05

P-value

58
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22

42

# of Target
Sequences with
Motif (of 357)
27

16.25%

36.69%

6.16%

11.76%

% of Target
Sequences with
Motif
7.56%

10.18%

27.13%

2.26%

5.71%

% of Background
Sequences with
Motif
2.64%

The top five genes that recognize similar sequences with FLAG-tagged-CPVIB-1 protein with the treatment of
rapamycin from HOMER database.

Motif Name

Table 5.7
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Similar to Slc38a3: Sodium-coupled neutral amino acid transporter 3
(Rattus norvegicus)
Similar to DDB_G0272472: Calponin homology domain-containing
protein DDB_G0272472 (Dictyostelium discoideum)
Similar to SPAC10F6.14c: ABC1 family protein C10F6.14c
(Schizosaccharomyces pombe (strain 972 / ATCC 24843))
Similar to rplV: 50S ribosomal protein L22 (Arcobacter butzleri (strain
RM4018))
Similar to cfp: Pyruvate decarboxylase (Neurospora crassa (strain
ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987))
Similar to blr3397: Nitrilase blr3397 (Bradyrhizobium diazoefficiens
(strain JCM 10833 / IAM 13628 / NBRC 14792 / USDA 110))
Similar to YBR241C: Probable metabolite transport protein YBR241C
(Saccharomyces cerevisiae (strain ATCC 204508 / S288c))

Ep155_U_T00001309_1

Ep155_U_T00004752_1

Ep155_U_T00008921_1

Ep155_U_T00003573_1

Ep155_U_T00002322_1

Ep155_U_T00002163_1

Ep155_U_T00006432_1

Gene name

0.46

0.58

0.70

4.12

-0.47

-0.57

log2
fold
change
0.76

GO:0000287,
GO:0003824,
GO:0016831,
GO:0030976
GO:0006807,
GO:0016810
GO:0005215,
GO:0016020,
GO:0016021,
GO:0022857,
GO:0022891,
GO:0042981,
GO:0055085

GO terms

Nitrogen compound
metabolic process
Regulation apoptotic
process, Transmembrane
transport

Glucose metabolism

Involved biological
processes

The 21 target genes of FLAG-tagged CPVIB-1 protein with and without rapamycin treatment.

Nearest PromoterID

Table 5.8
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Similar to STM1: Suppressor protein STM1 (Saccharomyces cerevisiae
(strain ATCC 204508 / S288c))
Protein of unknown function
Similar to At2g17033: Pentatricopeptide repeat-containing protein
At2g17033 (Arabidopsis thaliana)
Similar to dom34: Protein dom34 (Schizosaccharomyces pombe (strain
972 / ATCC 24843))
Similar to nuf2: Kinetochore protein Nuf2 (Danio rerio)
Similar to SPBC725.05c: Uncharacterized
pyrophosphatase/phosphodiesterase C725.05c (Schizosaccharomyces
pombe (strain 972 / ATCC 24843))
Similar to AF_2170: Kelch domain-containing protein AF_2170
(Archaeoglobus fulgidus (strain ATCC 49558 / VC-16 / DSM 4304 /
JCM 9628 / NBRC 100126))
Similar to tcmP: Tetracenomycin polyketide synthesis Omethyltransferase TcmP (Streptomyces glaucescens)

Ep155_U_T00000385_1

Ep155_U_T00002100_1
Ep155_U_T00002361_1

/

/

/
/

/

/
/

/

/
/

-2.82

1.51

1.12
-0.31

GO:0008168,
GO:0032259

GO:0003824,
GO:0008152

GO:0070481,
GO:0070966,
GO:0071025

GO:0000034,
GO:0006146,
GO:0009168,
GO:0019239

GO:0016491,
GO:0055114

Methylation

Metabolic process

RNA surveillance,
Nuclear-transcribed
mRNA catabolic process,
no-go decay

Purine ribonucleoside
monophosphate
biosynthetic process,
Adenine catabolic process

Oxidation-reduction
process

Nearest promoterID is the predicted gene ID from 2017-version annotation that the peaks located in their gene promoter regions.
Log2 fold change is the transcription level changes in the Dcpvib-1 strain. (‘/’ indicates the transcription level were not significantly
regulated).

Ep155_U_T00001196_1

Ep155_U_T00005230_1

Ep155_U_T00001179_1

Ep155_U_T00009393_1
Ep155_U_T00001837_1

Ep155_U_T00003820_1
Ep155_U_T00005122_1

Ep155_U_T00002128_1

Ep155_U_T00009404_1

Similar to Zan: Zonadhesin (Mus musculus)
Similar to SEC31B: Protein transport protein SEC31 homolog B
(Arabidopsis thaliana)
Similar to mutM: Formamidopyrimidine-DNA glycosylase
(Lactococcus lactis subsp. cremoris)
Similar to GPI19: Phosphatidylinositol Nacetylglucosaminyltransferase subunit GPI19 (Ashbya gossypii (strain
ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056))
Similar to CAH: Cyanamide hydratase (Myrothecium verrucaria)
Similar to AAH1: Adenine deaminase (Gibberella zeae (strain PH-1 /
ATCC MYA-4620 / FGSC 9075 / NRRL 31084))

Ep155_U_T00003188_1
Ep155_U_T00002617_1

Table 5.8 (continued)

Figure 5.1

Phenotype recovery assay from the Dcpvib-1 strain with the FLAG-tagged
CPVIB-1 expression vector.

(A) The representative phenotype of Dcpvib-1 strain with profuse sporulation and
reduced aerial hyphal growth compared to the representative phenotype of its isogenic
EP155 strain (B).
(C) The representative phenotype of the FLAG-tagged CPVIB-1 strain with the
expression vector transformed into the Dcpvib-1 strain (C) was partially recovered
compared to the representative phenotype of its isogenic EP155 strain (B).
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Figure 5.2

Vegetative incompatibility assay of C. parasitica.

(A) EP155 wild type demonstrated incompatibility with EU1. (B) Deletion of cpvib-1
from both EP155 and EU1 converted them to the compatible fusion with each other. (C)
The FALG-tagged CPVIB-1 expression vector transformed in the Dcpvib-1 strain
recovered the incompatibility with EU1-Dcpvib-1 strain.

145

Figure 5.3

Cankers display of the virulence assay with various C. parasitica strains
infecting the American chestnut stems.

The representative cankers on dormant chestnut stems were caused by C. parasitica after
21 days. Canker sizes were highlighted with red lines for each strain.
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Figure 5.4

Cankers size analysis of the virulence assay with various C. parasitica
strains infecting the American chestnut stems.

Boxplot represented the cankers size from virulence assay. Each dot represented the
canker size of one sample, the horizontal line in the middle of the box represented the
mean number of the cankers size in each strain and the vertical line at the bottom of the
box represented of the standard deviation.
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Figure 5.5

The cpvib-1 mutant strain showed less viability reduction when treated
with rapamycin. The proportion of viable cells were measured using the
MTT viability assay with and without 10 ng/ml rapamycin treatment.

The y axis is the absorbance/mg fungal tissue obtained from the spectrophotometer at 570
nm wavelength. The x axis is the rapamycin treatment (Green bars) and PB buffer control
(Red bars) within two strains. The black line at the top of each bar is the standard
deviation among three biological replicates, each with three technical replicates.
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Figure 5.6

The representative image from western blot assay of FLAG-tagged CPVIB1 proteins from the nutrient starvation and rapamycin treatment.

Lane M, 15 µl of Bio-Rad protein ladder,
lane 1, 25 µg total proteins from EMM Medium culture,
lane 2, 25 µg total proteins from EMM Medium culture with 10 ng/ml rapamycin,
lane 3, 25 µg total proteins from EMM-Low glucose culture,
lane 4, 25 µg total proteins from EMM-Low glucose with 10 ng/ml rapamycin,
lane 5, 25 µg total proteins from EMM-No Nitrogen culture,
lane 6, 25 µg total proteins from EMM-No Nitrogen with 10 ng/ml rapamycin.

149

Figure 5.7

The representative image from western blot assay of the FLAG-tagged
CPVIB-1 protein using anti-FLAG antibody.

Lane M, 15 µl of Bio-Rad protein ladder,
lane 1, 80 µg total proteins from the positive FLAG-tagged CPVIB-1 strain treated with
10 ng/ml rapamycin,
lane 2, 80 µg total proteins from the positive FLAG-tagged CPVIB-1 strain (positive
control),
lane 3, 80 µg total proteins from EP155 strain (negative control),
lane 4, 80 µg total proteins from Dcpvib-1 strain (negative control).
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Figure 5.8

The representative image from western blot assay of the
immunoprecipitated FLAG-tagged CPVIB-1 protein.

(A) the western blot image using anti-FLAG primary antibody, (B) the western blot
image using anti-Ub antibody.
Lane M, 15 µl of Bio-Rad protein ladder,
lane 1, the immunoprecipitated FLAG-tagged CPVIB-1 protein from 800 µg total
proteins of the positive FLAG-tagged CPVIB-1 strain (positive control),
lane 2, the immunoprecipitated FLAG-tagged CPVIB-1 protein from 800 µg total
proteins from the positive FLAG-tagged CPVIB-1 strain treated with 10 ng/ml rapamycin
lane 3, the immunoprecipitated FLAG-tagged CPVIB-1 protein from 800 µg total
proteins from EP155 strain (negative control),
lane 4, the immunoprecipitated FLAG-tagged CPVIB-1 protein from 800 µg total
proteins from Dcpvib-1 strain (negative control).
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(A)

(B)
Figure 5.9

Per base sequence quality plot of sample 1 from FastQC.

X axis is the position in reads (150 bp for each read), Y axis is the sequencing quality
score (Above 30 are considered high quality) (A) The plot was from the original reads of
sample 1. (B) The plot was from the reads of sample 1 after trimming process.
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(A)

(B)
Figure 5.10

MACS2 models for peaks in FLAG-tagged-CPVIB-1 samples and the
FLAG-tagged-CPVIB-1-Rapamycin samples.

X axis is the distance to the middle point of the peaks, and Y axis is the distribution
percentage of tags.
(A) The 5’ strand-separated tags from the FLAG-tagged-CPVIB-1 sample were aligned
by the center of their forward and reverse peaks. (B) The 5’ strand-separated tags from
the FLAG-tagged-CPVIB-1-Rapamycin sample were aligned by the center of their
forward and reverse peaks.
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Figure 5.11

Three examples of peaks identified in the promoter regions of annotated
genes.

(A) Two peaks were identified in the promoter of the same gene from both FLAG-tagged
CPVIB-1 samples and its Rapamycin treatment samples (highlighted with black arrows).
(B) The peak was identified in the promoter of the gene from only FLAG-tagged CPVIB1 samples (highlighted with red arrows). (C) The peak was identified in the promoter of
the gene from only FLAG-tagged CPVIB-1-Rapamycin samples (highlighted with green
arrows).
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Figure 5.12 (Continued)

(C)
Figure 5.12

The predicted recognition sequences of FLAG-tagged CPVIB-1 samples.

(A) The GAGAGAGA recognition sequence of FLAG-tagged CPVIB-1 protein. (B) The
distance between the center of predicted recognition sequences and the peaks summit. (C)
The top rank HOMER known genes with similar recognition sequences of FLAG-tagged
CPVIB-1 protein.

156

(A)

0.005

Sites per bp per peak

0.0045
0.004
0.0035
0.003
0.0025
0.002
0.0015
0.001
0.0005
0
-

-

-

-

-

- -80 -60 -40 -20 0

20 40 60 80 100 120 140 160 180 200

200 180 160 140 120 100

Distance from Peak summit

(B)

157

Figure 5.13 (Continued)

(C)
Figure 5.13

The predicted recognition sequences of FLAG-tagged CPVIB-1Rapamycin samples.

(A) The similar (GA)n recognition sequences of FLAG-tagged CPVIB-1-Rapmaycin
samples. (B) The distance between the center of predicted recognition sequence and the
peaks summit. (C) The top rank HOMER known genes with similar recognition
sequences of FLAG-tagged CPVIB-1 protein with the treatment of rapamycin.
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Figure 5.14

The “Scatterplot & Table” view of REVIGO showing the GO clusters of
the direct targeted genes by FLAG-tagged CPVIB-1 protein.

The y axis represents the peak score of each GO term.
The x axis represents the semantic scale of the GO terms.
The bubble color indicates the log2 fold change value from the positive (red, upregulated) to negative (blue, green, and yellow down-regulated). The size of the bubble
indicates the frequency of the GO term in the dataset.
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Figure 5.15

The “Scatterplot & Table” view of REVIGO showing the GO clusters of
the direct targeted genes by FLAG-tagged CPVIB-1 protein and
significantly altered in transcriptional level in the Dcpvib-1 mutant strain.

The y axis represents the log2 fold change of each GO term.
The x axis represents the semantic scale of the GO terms.
The bubble color indicates the log2 fold change value from the positive (red, upregulated) to negative (blue, green, and yellow down-regulated).
The size of the bubble indicates the frequency of the GO term in the dataset.
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Figure 5.16

The “Scatterplot & Table” view of REVIGO showing the GO clusters of
the direct targeted genes by FLAG-tagged CPVIB-1 protein with
rapamycin treatment.

The y axis represents the peak score of each GO term.
The x axis represents the semantic scale of the GO terms.
The bubble color indicates the log2 fold change value from the positive (red, upregulated) to negative (blue, green, and yellow down-regulated).
The size of the bubble indicates the frequency of the GO term in the dataset.
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Figure 5.17

The “Scatterplot & Table” view of REVIGO showing the GO clusters of
the direct targeted genes by FLAG-tagged CPVIB-1 protein with
rapamycin treatment and significantly altered in transcriptional level in the
Dcpvib-1 mutant strain.

The y axis represents the log2 fold change of each GO term.
The x axis represents the semantic scale of the GO terms.
The bubble color indicates the log2 fold change value from the positive (red, upregulated) to negative (blue, green, and yellow down-regulated).
The size of the bubble indicates the frequency of the GO term in the dataset.
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DISCUSSION
Significance of a re-annotated C. parasitica genome
In 2002, Ouzounis defined the term, re-annotation, stating the trend and
requirement for genome re-annotation to discover more gene and protein functions, test
and refine the mistakenly predicted genes, and perform the comparison of existing and
newly developed methods [148]. Next generation sequencing (NGS) technologies create
great opportunities for various genomics, transcriptomics, and proteomics projects of
exotic non-model organisms [80; 149]. Meanwhile, the drive for re-annotation of the
prior existing genomes arises with the up-to-date evidence, such as transcriptomic and
proteomic datasets as well as the newly developed bioinformatics tools. [150]. As the
most significant factor for judging the various versions of annotation, quality assessment
always represents a great challenge and raises a serious issue since then [148]. For
example, the genome of C. parasitica was sequenced, annotated, and released in 2009
using the technology and tools available at that time, but did not contain any quality
assessment step.
In this study, with deep transcriptome sequencing and updated protein evidence,
re-annotation of C. parasitica genome is more accurate and informative compared to the
prior version. Furthermore, since MAKER2 is the first bioinformatics tool to provide a
quality metrics system, the quality assessment provided a means to highlight any
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problematic predicted gene models for further manual curation and also gave a measure
for the comparison of two annotation versions.
This significantly improved genome annotation (2017-version) not only serves the
purpose to provide accurate and informative results for characterizing the roles of
CPVIB-1 using RNA-Seq and ChIP-Seq projects, but also provides a valuable resource
for researchers who are interested in both comparative and functional studies of C.
parasitica. The integrated annotation analysis by applying the MAKER2-two-pass
pipeline has facilitated the improvement of the genome annotation, and this approach can
be applied to other biological systems.
Development and application of PEPA, a prior genome annotation evaluation
pipeline
In 2009, Bakke reported a comparison of three automated genome annotations,
the Joint Genome Institute (JGI), the National Microbial Pathogen Data Resource
(NMPDR) and the J. Craig Venter Institute (JCVI) [151]. Later in 2013, a semiautomated genome annotation comparison scheme was developed to perform the
functional comparison only [75]. In 2011, MAKER2 was developed to attach a quality
assessment system to the automated genome annotation, which providing a means to
compare the annotations in quality aspect besides the structural and functional features
[48].
PEPA is a pipeline designed for the evaluation of any pre-existing genome
annotation with no quality metric system. It is a simple pipeline that was developed to
comprehensively estimate the accuracy of each prior predicted gene model, to provide
updated transcripts and protein evidence using the MAKER2 legacy annotation program,
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and enrich the gene models with a quality metrics system and internal domains (InterPro
ID). It also contained a R script to perform a comparison of the prediction quality of all
gene models from the prior annotation and the newer version. Finally, it included a
python script that was developed to sort each individual gene model from the prior
genome annotation into four categories (Match, Similar, Different, Noexist) based on
their discrepancies with the newer version.
The PEPA evaluation pipeline has a significant benefit for the future work in C.
parasitica by providing reliable insights of each predicted gene model that researchers
are interested in with the new quality metrics system and sorting system. It also has
profound impact to the genome projects of exotic non-model organisms, in which the
structural and functional accuracy of a predicted gene model is extremely important for
characterizing it by developing the knock-out constructs. To the best of our knowledge, a
comprehensive pipeline designed to evaluate a prior genome annotation, regardless of the
format against a newer version, has not been presented yet to illustrate the structural and
functional differences of each gene model and its accuracy.
Structure of CPVIB-1
CPVIB-1 is a NDT80/PhoG-like transcription factor
CPVIB-1 is predicted to be a putative p53-like transcription factor from the
InterPro Protein sequence analysis and classification website (Figure 6.1) [152]. The
NDT80-DNA binding domain (PRU00850) is found in proteins with size ranging from
185-382 amino acids that have transcription factor activity and many are thought to
response to celluar nutritional status (https://prosite.expasy.org/rule/PRU00850). NDT80like genes are found only in the Amorphea (unikont) lineage, which includes animals,
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fungi and Amoebozoa [31]. The number of these genes present in the genome varies in
the fungi, ranging from zero to six in the Ascomycota class [153]. Before this study, the
analysis of NDT80-like genes has only been completed in three fungal species, the
haploid ascomycetes S. cerevisiae, Aspergillus nidulans, and N. crassa, which contain
one, two and three NDT80-like genes, respectively [30; 154]. In C. parasitica, there are
three NDT80-like genes identified in the 2017-version annotation:
Ep155_U_G00001434, similar to transcription factor vib-1; Ep155_U_G00009104,
similar to transcription factor pacG; and, Ep155_U_G00004090, similar to meiosisspecific transcription factor NDT80. All of them were predicted to be transcription
factors and orthologs of VIB-1 gene in N. crassa, pacG gene in A. nidulans, and NDT80
gene in S. cerevisiae, respectively [32; 154-155].
The NDT80-DNA binding domain in yeast is comprised of a b-sandwich core
with seven b-strands and three short a-helices and shows high structural conservation
with similar domains from N. crassa, D. melanogaster, and humans, and is absolutely
conserved in the positions that are identified to interact with DNA [156]. The SWISSMODEL was used to predict the quaternary structure of CPVIB-1 and the same bsandwich core was observed with an additional six b-strands and short a-helices
(https://swissmodel.expasy.org/) (Figure 6.2). In this study, CPVIB-1 is the first NDT80DNA binding transcription factor in C. parasitica to be characterized by its structure and
functions.
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Ubiquitin decoration in CPVIB-1
Transcription factors comprise a relatively small portion of genome,
approximately 7% in humans and 1.1% in C. parasitica (2017-version annotation) and
function as the gatekeepers of cellular functions, integrating signal transformation into
the activation/repression of gene expression that reconfigures the cell physiology in real
time [157]. Post-translational modifications (PTMs) regulate the function, abundance,
and activity of the transcription factors in every aspect [157]. Among all the PTMs, the
more prominently studied are phosphorylation, methylation, glycosylation, acetylation,
sumoylation, and ubiquitination [129; 157-160]. In all the well-studied PTMs, the
ubiquitination modified transcription factors are found to be the least prevalent in
humans[157]. Ubiquitin is a small protein that is covalently linked to the lysine side chain
of substrates by the cognate E3 ligase. This may occur at single or multiple lysine
residues [161]. Generally, poly-ubiquitination of transcription factors marks them for
degradation through the proteasomal system, which is called the ubiquitin-dependent
proteolysis pathway [129; 159].
In this study, the ubiquitin modification of CPVIB-1 was predicted using UbSite
online tool (http://csb.cse.yzu.edu.tw/UbiSite/), where the protein sequence of CPVIB-1
was predicted to have eight ubiquitination sites (Ubi-sites) with relatively high
confidence scores (Figure 6.3). Consistent with the above identification, CPVIB-1 was
found to be covalently attached with at least one ubiquitin proteins from western blot
assay in one or multiple sites, and its ubiquitinated-version comprised the major portion
of total cellular CPVIB-1. It is most likely that the non-ubiquitinated version is the one
with DNA binding activity in genome. Based on the difficulties experienced in extracting
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sufficient DNA bound to CPVIB-1 protein compared to other ChIP-Seq projects, it can
be speculated that the poly-ubiquitination of CPVIB-1 leads to the degradation through
the classic proteolysis pathway, which regulates the level of active CPVIB-1 protein in
cells [99; 109].
Functions of CPVIB-1
NDT80-DNA binding transcription factor CPVIB-1
In budding yeast (S. cerevisiae), the NDT80-like protein is required for the
completion of meiosis [154]. In the pathogenic Candida albicans, the CaNDT80-like
protein is required for antifungal drug resistance, hyphal growth, biofilm formation, and
virulence [162-164]. In the filamentous fungus A. nidulans, NDT80-like XprG is a
regulator of a large number of genes involved in carbon starvation, extracellular protease,
mycotoxin and penicillin production [31; 153; 165]. In N. crassa, VIB-1 is required for
expression of genes that are involved in vegetative incompatibility-induced programmed
cell death and is also a regulator for the genes involved in nutrient starvation [32; 34; 79].
In C. parasitica the ortholog of the above NDT80-like transcription factors, CPVIB-1, is
a regulator of vegetative incompatibility programmed cell death, hyphal growth,
sporulation, and virulence.
This study is the first to attempt characterization of the targets of the NDT80-like
transcription factor CPVIB-1. By using large-scale transcriptome comparison analysis,
the regulating mechanisms behind the above functions can be understood. For example,
the role of CPVIB-1 in carbon metabolism CPVIB-1 has been identified to regulate at
least five various but directly related KEGG carbon pathways that repress glucose
utilization. Besides, the accumulation of CPVIB-1 is increased with the glucose
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starvation treatment using western blot assay that is congruent with the above
transcriptome analysis results. Meanwhile, CPVIB-1 has also been determined to regulate
various genes related to the pathogenesis. Perhaps the regulation of carbon metabolismrelated genes by CPVIB-1 is an important response during the plant host infection
process, which could explain the reduced virulence of the Cpvib-1 deletion strain (Figure
6.4). However, we also found that CPVIB-1 is a universal regulator that is essential for
RNA process, cellular biosynthesis processes, responses to stress, and hundreds of other
genes with diverse functions (Figure 6.4). With the studies from the NDT80-like
transcription factors in the above model fungal species, transcriptomics alone failed to
provide insights to further explain the targets of CPVIB-1. Therefore, we performed the
ChIP-Seq to explore the direct targeted genes of CPVIB-1.
GAGA factor CPVIB-1
In Drosophila, GAGA factor (DmGAF) has an extraordinarily diverse set of
functions that include the activation and silencing of gene expression, nucleosome
organization, remodeling chromosome architecture and mitosis by directly interacting
with a small subset of target genes and indirectly interacting with many others to serve
varied functions [96]. In vertebrates, all GAGA factors (vGAF) contains N-terminal
BTB/POZ domains, four C-terminal zinc finger domains for the (GA)n specific DNA
binding, and multiple PTM sites for phosphorylation, acetylation, and ubiquitination.
Similar to the function of DmGAF in Drosophila, vGAF play roles in gene activation,
repression, enhancer blocking, and cell development and differentiation [166].
In this study, using the ChIP-Seq method, CPVIB-1 has been identified as the first
GAGA factor in the fungal kingdom. CPVIB-1 was found to bind to sequences associated
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with 264 genes that function in remarkably diverse range of regulatory contexts,
including activation/repression of transcription, mitosis maintenance, cell development,
autophagy, cell-cell communication, virulence, nucleosome assembly, and others.
Furthermore, CPVIB-1 was found to bind to sequences thought to control a DNA
helicase for mitosis, telomere maintenance and the decomposition of the chromatin
complex as well as the activators for the transcription of RNA polymerase II promoter for
the promotion of the transcription process. Like the GAGA factors in Drosophila and
human, CPVIB-1 is a multifaceted transcription factor with diverse roles in gene
activation and repression, maintenance of mitosis and cell development (Figure 6.5)
[166].
CPVIB-1 functions in the TOR signaling pathway
Our interest in the role and function of CPVIB-1 stemmed from the observation
that this protein is required for the response to certain vegetative incompatibility
responses. In P. anserina, the idi gene, which is induced during programmed cell death
and triggered by vegetative incompatibility, was also found to be induced upon nitrogen
and carbon starvation [105]. In the same study, a well-known pathway response to
nutrient signals, the TOR kinase pathway, was linked to the vegetative incompatibility
and rapamycin was demonstrated to be capable of inducing the expression of idi gene to
mimic the vegetative incompatibility [105].
In this study, rapamycin and the carbon starvation was found to induce the
accumulation of CPVIB-1 protein. Moreover, CPVIB-1 was found to positively
correlated with the action of rapamycin to inhibit the fungal cell growth. To explore the
mechanisms behind the link of vegetative incompatibility and TOR signaling pathway,
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the ChIP-Seq method was applied to identify the recognition sequence bound by the
CPVIB-1 protein. The recognition sequence of CPVIB-1 upon rapamycin treatment was
found to be slightly shifted to a flexible (GA)n motif and, therefore, the annotated genes
associated with this altered recognition sequence were shifted as well. In particular,
CPSTE20, a TOR2 complex subunit, and CPRGA1, a Rho-type GTPase-activating
protein, were found to be in this adjusted set of CPVIB-1 protein targets.
In yeast Ste20p, also known as the ortholog of Avo3p, is the largest subunit of
TORC2 complex and the C-terminal part of Ste20p, is located close enough to the
rapamycin binding domain of TORC2 to protect it from the binding of rapamycin in yeast
[167-168]. Rga1p plays a crucial role in activating multiple GTPase genes, major
components in the MAPK cascade for the activation of the TOR2 signaling pathway
[169-170] . Both of these genes code for critical proteins involved in the TOR signaling
pathway and the data presented here indicates they are regulated directly by CPVIB-1
upon the treatment of rapamycin.
A new interpretation of the TOR signaling pathway that includes CPVIB-1
In yeast, the macrolide antifungal chemical rapamycin was found to bind to
peptidyl-prolyl cis-trans isomerase, also as known as Fpr1p. [101; 171-173].
Subsequently, from the mutants that conferred resistance to rapamycin, the target of
rapamycin was identified [171; 174]. There were two novel proteins, Tor1p (target of
rapamycin 1) and Tor2p (target of rapamycin 2), that were found to physically interact
with the Fpr1-rapamycin complex in the FRB domain (Fpr1-rapamycin binding domain)
[175-178].
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The domain structure and amino acid sequences of Tor1p and Tor2p are
evolutionarily conserved [175]. In yeast, both of them contain the HEAT repeats, FAT,
FRB, kinase, FIT and FATC (Figure 6.6). Although the primary structure of the Tor1p
and Tor2p are highly similar to each other, their cellular functions are distinct [175; 179].
The kinase activity of TOR complex 1 (TORC1) is found to be essential for cell growth
by promoting anabolism, such as protein biosynthesis, lipid biosynthesis and nucleotide
biosynthesis for the need of new cells by phosphorylating proteins, promoting mRNA
translation initiation process, promote ribosome biosynthesis [102; 113]. TORC1 also
represses catabolism, such as autophagy and ubiquitin-proteasome system [102]. While
TORC1 regulates cell growth and metabolism, the kinase activity of TOR complex 2
(TORC2) controls proliferation and survival process by phosphorylating several
downstream protein kinases and regulating the glucose utilization in humans by
responding to insulin signal [102; 113].
This functional distinction between them is due to the differences in the
composition of the TOR complexes. TORC1 is composed with either Tor1p or Tor2p as
the back-bone protein, and Kog1p, Tco89p, and Lst8p are subunits (Figure 6.5) [180182]. In TORC2, there are Tor2p is always the TOR protein and is assembled with the
subunits of Avo1p, Avo2p, Avo3p, Bit61p, and Lst8p (Figure 6.6) [183-186]. Avo3p is
found to be an essential scaffold protein to assemble TORC2 and interact with FAT and
kinase domains of Tor2p within TORC2 to prevent the accessibility from the FKBP12rapamycin complex [186]. Because of this, TORC1 is sensitive to rapamycin treatment,
since it lacks the Avo3p component, but TORC2 was found to be resistant to rapamycin
treatment [178].
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In C. parasitica, CPVIB-1 was associated with the promoter region of cpste20,
encoding a ortholog protein of Avo3p following the treatment with rapamycin [168]. The
binding recognition motif of CPVIB-1 in this promoter region is GAGAAGAGC
following the treatment with rapamycin, which is slightly shifted from GAGAGAGA
under untreated conditions. Rapamycin is known to target TORC1 to inactivate its
function. We have shown that CPVIB-1 protein accumulated to higher levels following
rapamycin treatment or glucose starvation. Our data from RNA-Seq showed that in the
∆cpvib-1 strain glucose utilization is significantly and consistently upregulated.
Therefore, we propose that a function of CPVIB-1 is to repress this pathway, opposite to
the role of TORC2. Similarly, CPVIB-1 appears to be required for the repression of
protein, lipid, and steroid biosynthesis, and activation of autophagy and proteolysis,
which is opposite to TORC1. Furthermore, our data also shows by ChIP-Seq that CPVIB1 can bind to the promoter regions of cpste20, which encoding protein to protect TORC2
from rapamycin action, but the regulation interplay between TORC1 and TORC2 was
observed but not understood. Based on the results of this study, we proposed a revised
model of TOR signaling that places CPVIB-1 between the TORC1 and TORC2. To be
responsible for inducing the cell death autophagy in vegetative incompatibility, CPVIB-1
is repressed by TORC1 under normal conditions. However, during the nutrient starvation
or rapamycin treatment, TORC1 is initially inactivated, which led to the increased
accumulation of CPVIB-1. In turn, CPVIB-1 bound the promoter of cpste20 repressing
its transcription and, presumably its protein abundance, thereby resulting in less
protection of TORC2 from rapamycin. Ultimately, rapamycin is then able to inactivate
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both TORC2 and TORC1 resulting in more profound effects of inhibition of cell growth,
cell survival and proliferation (Figure 6.7).
Future directions
Because our predicted model of the function of CPVIB-1 in TOR signaling
pathway superseded our earlier transcriptome work, we do not have transcriptome
profiling data of C. parasitica following treatment with rapamycin. Therefore, an
immediate first strategy would be to perform transcription level comparison of cpste20
between C. parasitica EP155 strain and its isogenic Dcpvib-1 strain under the same
conditions of rapamycin treatment as the ChIP-Seq experimental design. Also, it is
necessary to perform the comparison analysis against to the EP155 strain and its isogenic

Dcpvib-1 strain without rapamycin treatment. If rapamycin targets TORC1 leading to the
induction of CPVIB-1, leading to the repression of cpste20, rendering TORC2 vulnerable
to rapamycin, we can predict that the cpste20 will be repressed in transcript level in
EP155 strain in rapamycin treatment with the presence of CPVIB-1 compared to in

Dcpvib-1 strain upon the same condition of rapamycin treatment without the presence of
CPVIB-1 as well as in EP155 strain without the rapamycin treatment.
A second option would be to test the potential for CPSTE20 protein detection
using the commercial anti-STE20 antibody, subdomain VI from yeast (Sigma-Aldrich,
USA). If this was cross-species functional as a detection tool, we could test the
prediction that the accumulation of CPSTE20 protein will be decreased in EP155 strain
following rapamycin treatment in the presence of CPVIB-1 compared to the Dcpvib-1
strain or in the EP155 strain without rapamycin treatment.
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The TOR signaling system is known as one of the signal network systems that has
been evolutionarily conserved among eukaryotes [103; 187; 188]. In higher eukaryotes,
such as in humans, mammalian TORC1 (mTORC1) plays a central role in regulating all
of the downstream factors and therefore controls the balance between anabolism and
catabolism in response to the environmental conditions [113]. Dysfunctions in the TOR
signaling network can closely correlate with pathological conditions including diabetes,
cancer, obesity, and neurodegeneration [187]. However, for the TORC2, because the
knockout of TOR2 gene in yeast is lethal and TORC2 is resistant to rapamycin, the
studies of upstream and downstream factors of TORC2 signaling haven’t been
extensively investigated [113; 189]. Here we present a potential inhibition strategy for
TORC2, rapamycin with the CPVIB-1, in C. parasitica. With this strategy, an immediate
third idea would be to perform the transcriptome sequencing of C. parasitica EP155
strain and its isogenic Dcpvib-1 strain under the same conditions of rapamycin treatment
as the ChIP-Seq experimental design. With the transcriptome data available, it would be
possible to perform the comparison analysis against to the transcriptome EP155 strain
and its isogenic Dcpvib-1 strain as in Chapter III. The transcriptome comparison analysis
can be used to reveal the downstream factors of TORC2 signaling pathway with the
above inhibition strategy. Meanwhile, the genes downstream of TORC1 are responsible
for regulating CPVIB-1 can also be revealed using the same strategy. Furthermore, the
transcriptome comparison analysis of the EP155 strain with and without rapamycin
treatment can be used to understand the mechanism of TORC1 slightly shifting the
recognition sequence of CPVIB-1 as well.
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Tables and Figures

Figure 6.1

InterPro Protein sequence analysis & classification prediction results of
CPVIB-1 protein.
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Figure 6.2

The predicted quaternary structure of CPVIB-1 from SWISS-MODEL.
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Figure 6.3

The Ubiquitination sites identified for CPVIB-1 protein sequences in the
UbiSite web server.
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Figure 6.4

The biological processes regulated by CPVIB-1 from the transcriptome
comparison analysis.
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Figure 6.5

The biological processes regulated by CPVIB-1 from the ChIP-Seq
analysis combined with transcriptome comparison analysis.
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(A)

(B)
Figure 6.6

TOR complexes in C. parasitica modified from S. cerevisiae [113].

(A) represents the components of TORC1 and (B) represents the components of TORC2,
modified from the TORC complexes in yeast [113].
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Figure 6.7

A revised model of TOR signaling that places CPVIB-1 between the TORC1 and TORC2 based on the results of this
study.

REFERENCES
1.

WA., M., A new chestnut disease. Torreya, 1906. 6(9): p. 186-9.

2.

Merkel, H.W., A deadly fungus on the American chestnut. NY Zool. Soc. Annu.
Rep., 1906. 10: p. 97-103.

3.

Anderson, P.J. and W.H. Rankin, Endothia canker of chestnut. Vol. 347. 1914:
Cornell University.

4.

Gryzenhout, M., B.D. Wingfield, and M.J. Wingfield, New taxonomic concepts
for the important forest pathogen Cryphonectria parasitica and related fungi.
FEMS Microbiol Lett, 2006. 258(2): p. 161-72.

5.

Anagnostakis, S.L., Chestnut blight: the classical problem of an introduced
pathogen. Mycologia, 1987. 79(1): p. 23-37.

6.

Anagnostakis, S.L., Chestnut bark tannin assays and growth of chestnut blight
fungus on extracted tannin. Journal of chemical ecology, 1992. 18(8): p. 13651373.

7.

Anagnostakis, S.L. and B. Hillman, Evolution of the chestnut tree and its blight.
Arnoldia, 1992. 52(2): p. 2-10.

8.

Dalgleish, H., et al., Consequences of Shifts in Abundance and Distribution of
American Chestnut for Restoration of a Foundation Forest Tree. Forests, 2015.
7(12): p. 4.

9.

Heiniger, U. and D. Rigling, Biological control of chestnut blight in Europe., in
Annu.Rev.Phytopathol. 1994. p. 581-599.

10.

Grente, J. and S. Sauret, L'hypovirulence exclusive est-elle controllee par des
determinants cytoplasmiques? C.R. Acad. Sci. Paris Ser.D., 1969. 268: p. 31733176.

11.

Eusebio-Cope, A., et al., The chestnut blight fungus for studies on virus/host and
virus/virus interactions: from a natural to a model host. Virology, 2015. 477: p.
164-175.

183

12.

Shapira, R., et al., The contribution of defective RNAs to the complexity of viralencoded double-stranded RNA populations present in hypovirulent strains of the
chestnut blight fungus Cryphonectria parasitica. EMBO J., 1991. 10(4): p. 741746.

13.

Choi, G.H., R. Shapira, and D.L. Nuss, Cotranslational autoproteolysis involved
in gene expression from a double-stranded RNA genetic element associated with
hypovirulence of the chestnut blight fungus. Proc.Natl.Acad.Sci.U.S.A, 1991.
88(4): p. 1167-1171.

14.

Craven, M.G., et al., Papain-like protease p29 as a symptom determinant encoded
by a hypovirulence-associated virus of the chestnut blight fungus. J.Virol., 1993.
67(11): p. 6513-6521.

15.

Shapira, R. and D.L. Nuss, Gene expression by a hypovirulence-associated virus
of the chestnut blight fungus involves two papain-like protease activities.
Essential residues and cleavage site requirements for p48 autoproteolysis.
J.Biol.Chem., 1991. 266(29): p. 19419-19425.

16.

Anagnostakis, S.L. and P.R. Day, Hypovirulence conversion in Endothia
parasitica. Phytopathology, 1979. 69: p. 1226-1229.

17.

Nuss, D.L., Biological control of chestnut blight: an example of virus-mediated
attenuation of fungal pathogenesis. Microbiol.Rev., 1992. 56(4): p. 561-576.

18.

Milgroom, M.G. and P. Cortesi, Biological control of chestnut blight with
hypovirulence: a critical analysis. Annu Rev Phytopathol, 2004. 42: p. 311-38.

19.

Biella, S., et al., Programmed cell death correlates with virus transmission in a
filamentous fungus. Proceedings of the Royal Society of London B, 2002.
269(1506): p. 2269-2276.

20.

Zhang, D.X., et al., Vegetative incompatibility loci with dedicated roles in
allorecognition restrict mycovirus transmission in chestnut blight fungus.
Genetics, 2014. 197(2): p. 701-14.

21.

Paoletti, M. and S.J. Saupe, Fungal incompatibility: evolutionary origin in
pathogen defense? Bioessays, 2009. 31(11): p. 1201-10.

22.

Saupe, S.J. and N.L. Glass, Allelic specificity at the het-c heterokaryon
incompatibility locus of Neurospora crassa is determined by a highly variable
domain. Genetics, 1997. 146(4): p. 1299-309.

23.

Cortesi, P., et al., Genetic control of horizontal virus transmission in the chestnut
blight fungus, Cryphonectria parasitica. Genetics, 2001. 159(1): p. 107-18.

24.

Choi, G.H., et al., Molecular characterization of vegetative incompatibility genes
that restrict hypovirus transmission in the chestnut blight fungus Cryphonectria
parasitica. Genetics, 2012. 190(1): p. 113-27.
184

25.

Espagne, E., et al., HET-E and HET-D belong to a new subfamily of WD40
proteins involved in vegetative incompatibility specificity in the fungus Podospora
anserina. Genetics, 2002. 161(1): p. 71-81.

26.

Kubisiak, T.L. and M.G. Milgroom, Markers linked to vegetative incompatibility
(vic) genes and a region of high heterogeneity and reduced recombination near
the mating type locus (MAT) in Cryphonectria parasitica. Fungal Genet Biol,
2006. 43(6): p. 453-63.

27.

Pinto, I., D.E. Ware, and M. Hampsey, The yeast SUA7 gene encodes a homolog
of human transcription factor TFIIB and is required for normal start site selection
in vivo. Cell, 1992. 68(5): p. 977-88.

28.

Galagan, J.E., et al., The genome sequence of the filamentous fungus Neurospora
crassa. Nature, 2003. 422(6934): p. 859-68.

29.

Staben C, Y.C., Neurospora crassa a mating-type region. . Proceedings of the
National Academy of Sciences, 1990. 87(13): p. 4917-21.

30.

Hutchison, E.A. and N.L. Glass, Interplay Between NDT80 Homologs and the
Protein Kinase IME-2 Regulates Sexual Development, but Not Meiosis, in
Neurospora crassa. Genetics, 2010.

31.

Katz, M.E. and S. Cooper, Extreme Diversity in the Regulation of Ndt80-Like
Transcription Factors in Fungi. G3 (Bethesda), 2015. 5(12): p. 2783-92.

32.

Xiang, Q. and N.L. Glass, Identification of vib-1, a locus involved in vegetative
incompatibility mediated by het-c in Neurospora crassa. Genetics, 2002. 162(1):
p. 89-101.

33.

Xiang, Q. and N.L. Glass, The control of mating type heterokaryon
incompatibility by vib-1, a locus involved in het-c heterokaryon incompatibility in
Neurospora crassa. Fungal Genet Biol, 2004. 41(12): p. 1063-76.

34.

Xiong, Y., J. Sun, and N.L. Glass, VIB1, a link between glucose signaling and
carbon catabolite repression, is essential for plant cell wall degradation by
Neurospora crassa. PLoS Genet, 2014. 10(8): p. e1004500.

35.

Rong, M., Investigation of factors associated with vegetative incompatibility and
virus transmission in cryphonectria parasitica, in Department of Biology. 2011,
New Mexico State University.

36.

Nowrousian, M., Next-generation sequencing techniques for eukaryotic
microorganisms: sequencing-based solutions to biological problems. Eukaryotic
cell, 2010. 9(9): p. 1300-1310.

37.

Eddy, S.R., What is a hidden Markov model? Nature Biotechnology, 2004. 22: p.
1315-1316.
185

38.

Stanke, M., et al., AUGUSTUS: a web server for gene finding in eukaryotes.
Nucleic Acids Res, 2004. 32(Web Server issue): p. W309-12.

39.

Yandell, M. and D. Ence, A beginner's guide to eukaryotic genome annotation.
Nat Rev Genet, 2012. 13(5): p. 329-42.

40.

Feldmesser, E., et al., Improving transcriptome construction in non-model
organisms: integrating manual and automated gene definition in Emiliania
huxleyi. BMC genomics, 2014. 15(1): p. 148.

41.

Benson, D.A., et al., GenBank. Nucleic Acids Res, 2008. 36(Database issue): p.
D25-30.

42.

Trapnell, C., L. Pachter, and S.L. Salzberg, TopHat: discovering splice junctions
with RNA-Seq. Bioinformatics, 2009. 25(9): p. 1105-11.

43.

Wang, J., et al., Identification of Novel Transcribed Regions in Zebrafish (Danio
rerio) Using RNA-Sequencing. PLoS One, 2016. 11(7): p. e0160197.

44.

Trapnell, C., et al., Differential gene and transcript expression analysis of RNAseq experiments with TopHat and Cufflinks. Nature protocols, 2012. 7(3): p. 562.

45.

Holt, C. and M. Yandell, MAKER2: an annotation pipeline and genome-database
management tool for second-generation genome projects. BMC bioinformatics,
2011. 12(1): p. 491.

46.

Korf, I., SNAP: Semi-HMM-based Nucleic Acid Parser. Ian Korf homepage:
http://homepage/. mac. com/iankorf, 2013.

47.

Lomsadze, A., et al., Gene identification in novel eukaryotic genomes by selftraining algorithm. Nucleic acids research, 2005. 33(20): p. 6494-6506.

48.

Yandell, C.H.a.M., MAKER2: an annotation pipeline and genome database
management tool for second generation genome projects. BMC Bioinformatics,
2011. 12: p. 491.

49.

Thrasher, A., et al., Scaling up genome annotation using MAKER and work
queue. International Journal of Bioinformatics Research and Applications 2, 2014.
10(4-5): p. 447-460.

50.

Wang, Z., Y. Chen, and Y. Li, A brief review of computational gene prediction
methods. Genomics, proteomics & bioinformatics, 2004. 2(4): p. 216-221.

51.

Allen, T.D., A.L. Dawe, and D.L. Nuss, Use of cDNA microarrays to monitor
transcriptional responses of the chestnut blight fungus Cryphonetria parasitica to
infection by virulence-attenuating hypoviruses. Eukaryotic Cell, 2003. 2(6): p.
1253-1265.
186

52.

Ghosh, S. and C.-K.K. Chan, Analysis of RNA-Seq data using TopHat and
Cufflinks, in Plant Bioinformatics. 2016, Springer. p. 339-361.

53.

Consortium, U., UniProt: a hub for protein information. Nucleic acids research,
2014. 43(D1): p. D204-D212.

54.

Horton, P., et al., WoLF PSORT: protein localization predictor. Nucleic Acids
Res, 2007. 35(Web Server issue): p. W585-7.

55.

Knowledgebase, U., a hub of integrated protein data Magrane Michele;
Consortium Uniprot Database: the journal of biological databases and curation
(2011), 2011 (), bar009 ISSN. The UniProt Knowledgebase (UniProtKB) acts as a
central hub of protein knowledge by providing a unified view of protein sequence
and functional information. Manual and automatic annotation procedures are used
to add data directly to the database while extensive cross-referencing to more
than. 120.

56.

Lukashin, A.V. and M. Borodovsky, GeneMark. hmm: new solutions for gene
finding. Nucleic acids research, 1998. 26(4): p. 1107-1115.

57.

Stanke, M. and B. Morgenstern, AUGUSTUS: a web server for gene prediction in
eukaryotes that allows user-defined constraints. Nucleic acids research, 2005.
33(suppl_2): p. W465-W467.

58.

Stanke, M. and S. Waack, Gene prediction with a hidden Markov model and a
new intron submodel. Bioinformatics, 2003. 19(suppl_2): p. ii215-ii225.

59.

Campbell, M.S., et al., Genome Annotation and Curation Using MAKER and
MAKER-P. Curr Protoc Bioinformatics, 2014. 48: p. 4 11 1-39.

60.

Apweiler, R., et al., The InterPro database, an integrated documentation resource
for protein families, domains and functional sites. Nucleic acids research, 2001.
29(1): p. 37-40.

61.

Apweiler, R., et al., InterPro—an integrated documentation resource for protein
families, domains and functional sites. Bioinformatics, 2000. 16(12): p. 11451150.

62.

Quevillon, E., et al., InterProScan: protein domains identifier. Nucleic acids
research, 2005. 33(suppl_2): p. W116-W120.

63.

Bell, J.A., et al., Physical and genetic map of the mitochondrial genome of
Cryphonectria parasitica Ep155. Current genetics, 1996. 30(1): p. 34-43.

64.

't Hoen, P.A., et al., Deep sequencing-based expression analysis shows major
advances in robustness, resolution and inter-lab portability over five microarray
platforms. Nucleic acids research, 2008. 36(21): p. e141-e141.
187

65.

Conesa, A., et al., A survey of best practices for RNA-seq data analysis. Genome
biology, 2016. 17(1): p. 13.

66.

Syme, R.A., et al., Comprehensive Annotation of the Parastagonospora nodorum
Reference Genome Using Next-Generation Genomics, Transcriptomics and
Proteogenomics. PLoS One, 2016. 11(2): p. e0147221.

67.

Vleeshouwers, V.G. and R.P. Oliver, Effectors as tools in disease resistance
breeding against biotrophic, hemibiotrophic, and necrotrophic plant pathogens.
Molecular plant-microbe interactions, 2014. 27(3): p. 196-206.

68.

Liu, Y. and B. Schmidt, Long read alignment based on maximal exact match
seeds. Bioinformatics, 2012. 28(18): p. i318-i324.

69.

Stothard, P. and D.S. Wishart, Automated bacterial genome analysis and
annotation. Curr Opin Microbiol, 2006. 9(5): p. 505-10.

70.

Aziz, R.K., et al., The RAST Server: rapid annotations using subsystems
technology. BMC Genomics, 2008. 9: p. 75.

71.

Markowitz, V.M., et al., The integrated microbial genomes (IMG) system in
2007: data content and analysis tool extensions. Nucleic Acids Res, 2008.
36(Database issue): p. D528-33.

72.

Liu, X., X. Jian, and E. Boerwinkle, dbNSFP v2. 0: a database of human nonsynonymous SNVs and their functional predictions and annotations. Human
mutation, 2013. 34(9).

73.

Karen Eilbeck*, S.E.L., Christopher J Mungall†, Mark Yandell†, and R.D.a.M.A.
Lincoln Stein‡, The Sequence Ontology: a tool for the unification of genome
annotations. Genome Biology, 2005. 6: p. R44.

74.

Kalkatawi, M., I. Alam, and V.B. Bajic, BEACON: automated tool for Bacterial
GEnome Annotation ComparisON. BMC Genomics, 2015. 16: p. 616.

75.

Liu Z, M.H., Goryanin I., A semi-automated genome annotation comparison and
integration scheme. BMC Bioinformatics, 2013. 14(1): p. 172.

76.

Allemann, C., et al., Genetic variation of Cryphonectria hypoviruses (CHV1) in
Europe, assessed using restriction fragment length polymorphism (RFLP)
markers. Mol.Ecol., 1999. 8(5): p. 843-854.

77.

Cortesi, P. and M.G. Milgroom, Genetics of vegetative incompatibility in
cryphonectria parasitica. Appl Environ Microbiol, 1998. 64(8): p. 2988-94.

78.

Colot, H.V., et al., A high-throughput gene knockout procedure for Neurospora
reveals functions for multiple transcription factors. Proc. Natl. Acad. Sci. USA,
2006. 103(27): p. 10352-10357.
188

79.

Dementhon, K., G. Iyer, and N.L. Glass, VIB-1 is required for expression of genes
necessary for programmed cell death in Neurospora crassa. Eukaryot Cell, 2006.
5(12): p. 2161-73.

80.

Nowrousian, M., Next-generation sequencing techniques for eukaryotic
microorganisms: sequencing-based solutions to biological problems. Eukaryot
Cell, 2010. 9(9): p. 1300-10.

81.

Trapnell, C., et al., Transcript assembly and quantification by RNA-Seq reveals
unannotated transcripts and isoform switching during cell differentiation. Nat
Biotechnol, 2010. 28(5): p. 511-5.

82.

Andrews, S., FastQC: a quality control tool for high throughput sequence data.
2010.

83.

Bolger, A.M., M. Lohse, and B. Usadel, Trimmomatic: a flexible trimmer for
Illumina sequence data. Bioinformatics, 2014. 30(15): p. 2114-20.

84.

Langmead, B. and S.L. Salzberg, Fast gapped-read alignment with Bowtie 2. Nat
Methods, 2012. 9(4): p. 357-9.

85.

Langmead, B., et al., Ultrafast and memory-efficient alignment of short DNA
sequences to the human genome. Genome Biol, 2009. 10(3): p. R25.

86.

Li, H., et al., The Sequence Alignment/Map format and SAMtools. Bioinformatics,
2009. 25(16): p. 2078-9.

87.

Anders, S., P.T. Pyl, and W. Huber, HTSeq--a Python framework to work with
high-throughput sequencing data. Bioinformatics, 2015. 31(2): p. 166-9.

88.

Love, M.I., W. Huber, and S. Anders, Moderated estimation of fold change and
dispersion for RNA-seq data with DESeq2. Genome Biol, 2014. 15(12): p. 550.

89.

Luo, W., et al., GAGE: generally applicable gene set enrichment for pathway
analysis. BMC Bioinformatics, 2009. 10: p. 161.

90.

Luo, W. and C. Brouwer, Pathview: an R/Bioconductor package for pathwaybased data integration and visualization. Bioinformatics, 2013. 29(14): p. 1830-1.

91.

JH, Z., Pedigree-drawing with R and graphviz. Bioinformatics, 2006. 22(8): p.
1013-4.

92.

Supek, F., et al., REVIGO summarizes and visualizes long lists of gene ontology
terms. PLoS One, 2011. 6(7): p. e21800.

93.

Williams, C.R., et al., Trimming of sequence reads alters RNA-Seq gene
expression estimates. BMC Bioinformatics, 2016. 17: p. 103.
189

94.

Lushchak, V.I., Adaptive response to oxidative stress: Bacteria, fungi, plants and
animals. Comp Biochem Physiol C Toxicol Pharmacol, 2011. 153(2): p. 175-90.

95.

Smith, M.L., C.C. Gibbs, and M.G. Milgroom, Heterokaryon incompatibility
function of barrage-associated vegetative incompatibility genes (vic) in
Cryphonectria parasitica. Mycologia, 2006. 98(1): p. 43-50.

96.

Lomaev, D., et al., The GAGA factor regulatory network: Identification of GAGA
factor associated proteins. PLoS One, 2017. 12(3): p. e0173602.

97.

Zhang, H., et al., MgCRZ1, a transcription factor of Magnaporthe grisea, controls
growth, development and is involved in full virulence. FEMS Microbiol Lett,
2009. 293(2): p. 160-9.

98.

Schmidt, D., et al., ChIP-seq: using high-throughput sequencing to discover
protein-DNA interactions. Methods, 2009. 48(3): p. 240-8.

99.

Robertson, G., et al., Genome-wide profiles of STAT1 DNA association using
chromatin immunoprecipitation and massively parallel sequencing. Nat Methods,
2007. 4(8): p. 651-7.

100.

Mundade, R., et al., Role of ChIP-seq in the discovery of transcription factor
binding sites, differential gene regulation mechanism, epigenetic marks and
beyond. Cell Cycle, 2014. 13(18): p. 2847-52.

101.

Desai, B., B. Myers, and S. Schreiber, FKBP12-rapamycin-associated protein
associates with mitochondria and senses osmotic stress via mitochondrial
dysfunction. Proc Natl Acad Sci, 2002. 99(7): p. 4319-24.

102.

Saxton, R.A. and D.M. Sabatini, mTOR Signaling in Growth, Metabolism, and
Disease. Cell, 2017. 168(6): p. 960-976.

103.

Loewith, R. and M.N. Hall, Target of rapamycin (TOR) in nutrient signaling and
growth control. Genetics, 2011. 189(4): p. 1177-201.

104.

Rohde, J., J. Heitman, and M.E. Cardenas, The TOR kinases link nutrient sensing
to cell growth. J Biol Chem, 2001. 276(13): p. 9583-6.

105.

Dementhon, K., et al., Rapamycin mimics the incompatibility reaction in the
fungus Podospora anserina. Eukaryot Cell, 2003. 2(2): p. 238-46.

106.

Schafer K, B.T., Monoclonal anti-FLAG antibodies react with a new isoform of
rat Mg2+ dependent protein phosphatase β. . Biochemical and biophysical
research communications., 1995. 207(2): p. 708-14.

107.

Bhowmick R, H.U., Chattopadhyay S, Nayak MK, Chawla-Sarkar M., Rotavirusencoded nonstructural protein 1 modulates cellular apoptotic machinery by
targeting tumor suppressor protein p53. Journal of virology, 2013. 87(12): p.
6840-50.
190

108.

Chambers AE, S.P., Randeva H, Banerjee S. , Microvesicle-mediated release of
soluble LH/hCG receptor (LHCGR) from transfected cells and placenta explants.
. Reproductive Biology and Endocrinology., 2011. 9(1): p. 64.

109.

de Castro, P.A., et al., ChIP-seq reveals a role for CrzA in the Aspergillus
fumigatus high-osmolarity glycerol response (HOG) signalling pathway. Mol
Microbiol, 2014. 94(3): p. 655-74.

110.

<gaga factor.pdf>.

111.

Bejarano, F. and A. Busturia, Function of the Trithorax-like gene during
Drosophila development. Dev Biol, 2004. 268(2): p. 327-41.

112.

Hecker, A., et al., The Arabidopsis GAGA-Binding Factor BASIC
PENTACYSTEINE6 Recruits the POLYCOMB-REPRESSIVE COMPLEX1
Component LIKE HETEROCHROMATIN PROTEIN1 to GAGA DNA Motifs.
Plant Physiol, 2015. 168(3): p. 1013-24.

113.

Inoue, Y. and W. Nomura, TOR Signaling in Budding Yeast, in The Yeast Role in
Medical Applications. 2018, InTech.

114.

Churchill, A.C.L., et al., Transformation of the fungal pathogen Cryphonectria
parasitica with a variety of heterologous plasmids. Curr Genet, 1990. 17: p. 2531.

115.

McLean, T.C., P.A. Hoskisson, and R.F. Seipke, Coordinate Regulation of
Antimycin and Candicidin Biosynthesis. mSphere, 2016. 1(6).

116.

Anagnostakis, S.L., et al., Hypovirus transmission to ascospore progeny by fieldreleased transgenic hypovirulent strains of Cryphonectria parasitica.
Phytopathology, 1998. 88(7): p. 598-604.

117.

Patel, N., et al., Use of the tetrazolium salt MTT to measure cell viability effects of
the bacterial antagonist Lysobacter enzymogenes on the filamentous fungus
Cryphonectria parasitica. Antonie Van Leeuwenhoek, 2013. 103(6): p. 1271-80.

118.

Feng, J., et al., Identifying ChIP-seq enrichment using MACS. Nat Protoc, 2012.
7(9): p. 1728-40.

119.

Heinz, S., et al., Simple combinations of lineage-determining transcription factors
prime cis-regulatory elements required for macrophage and B cell identities. Mol
Cell, 2010. 38(4): p. 576-89.

120.

Muratani, M. and W.P. Tansey, How the ubiquitin-proteasome system controls
transcription. Nat Rev Mol Cell Biol, 2003. 4(3): p. 192-201.

121.

Loh, Y.E., et al., Bioinformatic Analysis for Profiling Drug-induced Chromatin
Modification Landscapes in Mouse Brain Using ChlP-seq Data. Bio Protoc,
2017. 7(3).
191

122.

Steinhauser, S., et al., A comprehensive comparison of tools for differential ChIPseq analysis. Brief Bioinform, 2016. 17(6): p. 953-966.

123.

Lin, R. and H. Wang, Arabidopsis FHY3/FAR1 gene family and distinct roles of
its members in light control of Arabidopsis development. Plant Physiol, 2004.
136(4): p. 4010-22.

124.

Kooiker, M., et al., BASIC PENTACYSTEINE1, a GA binding protein that
induces conformational changes in the regulatory region of the homeotic
Arabidopsis gene SEEDSTICK. Plant Cell, 2005. 17(3): p. 722-9.

125.

King, G.J., et al., The Arabidopsis B3 domain protein VERNALIZATION1 (VRN1)
is involved in processes essential for development, with structural and mutational
studies revealing its DNA-binding surface. J Biol Chem, 2013. 288(5): p. 3198207.

126.

Chang, V.H., et al., Kruppel-like factor 10 expression as a prognostic indicator
for pancreatic adenocarcinoma. Am J Pathol, 2012. 181(2): p. 423-30.

127.

Erdman S, L.L., Malczynski M, Snyder M., Pheromone-regulated genes required
for yeast mating differentiation. . The Journal of cell biology, 1998. 140(3): p.
461-83.

128.

Van Dyke, M.W., et al., Stm1p, a G4 quadruplex and purine motif triplex nucleic
acid-binding protein, interacts with ribosomes and subtelomeric Y' DNA in
Saccharomyces cerevisiae. J Biol Chem, 2004. 279(23): p. 24323-33.

129.

Ee, G. and N. Lehming, How the ubiquitin proteasome system regulates the
regulators of transcription. Transcription, 2012. 3(5): p. 235-9.

130.

Heinemeyer, W., P.C. Ramos, and R.J. Dohmen, The ultimate nanoscale mincer:
assembly, structure and active sites of the 20S proteasome core. Cell Mol Life
Sci, 2004. 61(13): p. 1562-78.

131.

Bailey, T., et al., Practical guidelines for the comprehensive analysis of ChIP-seq
data. PLoS Comput Biol, 2013. 9(11): p. e1003326.

132.

Biggin MD, T.R., Transcription factors that activate the Ultrabithorax promoter
in developmentally staged extracts. . Cell, 1988. 53(5): p. 699-711.

133.

Durmowicz, M.C. and R.J. Maier, Roles of HoxX and HoxA in biosynthesis of
hydrogenase in Bradyrhizobium japonicum. J Bacteriol, 1997. 179(11): p. 367682.

134.

Kim, S., et al., Homeobox transcription factors are required for conidiation and
appressorium development in the rice blast fungus Magnaporthe oryzae. PLoS
Genet, 2009. 5(12): p. e1000757.
192

135.

Lekva, T., et al., Epithelial splicing regulator protein 1 and alternative splicing in
somatotroph adenomas. Endocrinology, 2013. 154(9): p. 3331-43.

136.

Li, Y., et al., MoRic8 Is a novel component of G-protein signaling during plant
infection by the rice blast fungus Magnaporthe oryzae. Mol Plant Microbe
Interact, 2010. 23(3): p. 317-31.

137.

Nagata Y, O.M., Nakata H, Shozaki Y, Kozasa T, Todokoro K., A novel regulator
of G-protein signaling bearing GAP activity for Gαi and Gαq in megakaryocytes.
Blood, 2001. 97(10): p. 3051-60.

138.

Kim, S., et al., Combining ChIP-chip and expression profiling to model the
MoCRZ1 mediated circuit for Ca/calcineurin signaling in the rice blast fungus.
PLoS Pathog, 2010. 6(5): p. e1000909.

139.

Ding, S.L., et al., The tig1 histone deacetylase complex regulates infectious
growth in the rice blast fungus Magnaporthe oryzae. Plant Cell, 2010. 22(7): p.
2495-508.

140.

Lahaye A, S.H., Thines-Sempoux D, Foury F. , PIF1: a DNA helicase in yeast
mitochondria. The EMBO Journal, 1991. 10(4): p. 997-1007.

141.

Rehmeyer, C.J., et al., The telomere-linked helicase (TLH) gene family in
Magnaporthe oryzae: revised gene structure reveals a novel TLH-specific protein
motif. Curr Genet, 2009. 55(3): p. 253-62.

142.

Sbia, M., et al., Regulation of the yeast Ace2 transcription factor during the cell
cycle. J Biol Chem, 2008. 283(17): p. 11135-45.

143.

Marshall, K.R., et al., The human apoptosis-inducing protein AMID is an
oxidoreductase with a modified flavin cofactor and DNA binding activity. J Biol
Chem, 2005. 280(35): p. 30735-40.

144.

Wu, D., et al., ChLae1 and ChVel1 regulate T-toxin production, virulence,
oxidative stress response, and development of the maize pathogen Cochliobolus
heterostrophus. PLoS Pathog, 2012. 8(2): p. e1002542.

145.

Ramanujam, R. and N.I. Naqvi, PdeH, a high-affinity cAMP phosphodiesterase,
is a key regulator of asexual and pathogenic differentiation in Magnaporthe
oryzae. PLoS Pathog, 2010. 6(5): p. e1000897.

146.

Monod, M. and Z.M. Borg-von, Secreted aspartic proteases as virulence factors
of Candida species. Biol Chem, 2002. 383(7-8): p. 1087-93.

147.

Hayashi, T., et al., Rapamycin sensitivity of the Schizosaccharomyces pombe tor2
mutant and organization of two highly phosphorylated TOR complexes by specific
and common subunits. Genes Cells, 2007. 12(12): p. 1357-70.
193

148.

Ouzounis CA, K.P., The past, present and future of genome-wide re-annotation.
Genome Biology, 2002. 3(2): p. comment200-1.

149.

Dalman, K., et al., A genome-wide association study identifies genomic regions
for virulence in the non-model organism Heterobasidion annosum s.s. PLoS One,
2013. 8(1): p. e53525.

150.

Ren, Z., et al., Improvements to the rice genome annotation through large-scale
analysis of RNA-Seq and proteomics datasets. . bioRxiv, 2018: p. 300426.

151.

Bakke, P., et al., Evaluation of three automated genome annotations for
Halorhabdus utahensis. PLoS One, 2009. 4(7): p. e6291.

152.

Wang, P., et al., p53 domains: structure, oligomerization, and transformation.
Mol Cell Biol, 1994. 14(8): p. 5182-91.

153.

Katz ME, B.K., Yi G, Cooper S, Nonhebel HM, Gondro C., A p53-like
transcription factor similar to Ndt80 controls the response to nutrient stress in the
filamentous fungus, Aspergillus nidulans. F1000Research, 2013. 2.

154.

Chu S, D.J., Eisen M, Mulholland J, Botstein D, Brown PO, Herskowitz I., The
transcriptional program of sporulation in budding yeast. Science, 1998.
282(5389): p. 699-705.

155.

MacRae WD, B.F., Sibley S, Garven S, Gwynne DI, Arst HN, Davies RW.,
Characterization of an Aspergillus nidulans genomic DNA fragment conferring
phosphate-non-repressible acid-phosphatase activity. Gene, 1993. 130(2): p. 24751.

156.

Montano SP, C.M., Fingerman I, Pierce M, Vershon AK, Georgiadis MM.,
Crystal structure of the DNA-binding domain from Ndt80, a transcriptional
activator required for meiosis in yeast. . Proceedings of the National Academy of
Sciences, 2002. 99(22): p. 14041-6.

157.

Filtz, T.M., W.K. Vogel, and M. Leid, Regulation of transcription factor activity
by interconnected post-translational modifications. Trends Pharmacol Sci, 2014.
35(2): p. 76-85.

158.

Bannister AJ, M.E., Regulation of gene expression by transcription factor
acetylation. Cellular and Molecular Life Sciences CMLS, 2000. 57(8-9): p. 118492.

159.

Conaway RC, B.C., Conaway JW., Emerging roles of ubiquitin in transcription
regulation. Science, 2002. 296(5571): p. 1254-8.

160.

Whitmarsh AJ, D.R., Regulation of transcription factor function by
phosphorylation. Cellular and Molecular Life Sciences CMLS, 2000. 57(8-9): p.
1172-83.
194

161.

Jadhav, T. and M.W. Wooten, Defining an Embedded Code for Protein
Ubiquitination. J Proteomics Bioinform, 2009. 2: p. 316.

162.

Chen, C.G., et al., CaNdt80 is involved in drug resistance in Candida albicans by
regulating CDR1. Antimicrob Agents Chemother, 2004. 48(12): p. 4505-12.

163.

Nobile, C.J., et al., A recently evolved transcriptional network controls biofilm
development in Candida albicans. Cell, 2012. 148(1-2): p. 126-38.

164.

Sellam, A., et al., Role of transcription factor CaNdt80p in cell separation, hyphal
growth, and virulence in Candida albicans. Eukaryot Cell, 2010. 9(4): p. 634-44.

165.

Katz, M.E., K.A. Gray, and B.F. Cheetham, The Aspergillus nidulans xprG
(phoG) gene encodes a putative transcriptional activator involved in the response
to nutrient limitation. Fungal Genet Biol, 2006. 43(3): p. 190-9.

166.

Srivastava, A., A.S. Kumar, and R.K. Mishra, Vertebrate GAF/ThPOK: emerging
functions in chromatin architecture and transcriptional regulation. Cell Mol Life
Sci, 2018. 75(4): p. 623-633.

167.

Alvarez, B. and S. Moreno, Fission yeast Tor2 promotes cell growth and
represses cell differentiation. J Cell Sci, 2006. 119(Pt 21): p. 4475-85.

168.

Matsuo, T., et al., Loss of the TOR kinase Tor2 mimics nitrogen starvation and
activates the sexual development pathway in fission yeast. Mol Cell Biol, 2007.
27(8): p. 3154-64.

169.

Nonaka H, T.K., Hirano H, Fujiwara T, Kohno H, Umikawa M, Mino A, Takai Y.
, A downstream target of RHO1 small GTP-binding protein is PKC1, a homolog
of protein kinase C, which leads to activation of the MAP kinase cascade in
Saccharomyces cerevisiae. . The EMBO journal, 1995. 14(23): p. 5931-8.

170.

Schmitz HP, L.A., Heinisch JJ., Regulation of yeast protein kinase C activity by
interaction with the small GTPase Rho1p through its amino-terminal HR1
domain. Molecular microbiology, 2002. 44(3): p. 829-40.

171.

Heitman, J., et al., FK 506-binding protein proline rotamase is a target for the
immunosuppressive agent FK 506 in Saccharomyces cerevisiae. Proceedings of
the National Academy of Sciences, 1991. 88(5): p. 1948-1952.

172.

Koltin, Y., et al., Rapamycin sensitivity in Saccharomyces cerevisiae is mediated
by a peptidyl-prolyl cis-trans isomerase related to human FK506-binding protein.
Molecular and Cellular Biology, 1991. 11(3): p. 1718-1723.

173.

Martel, R., J. Klicius, and S. Galet, Inhibition of the immune response by
rapamycin, a new antifungal antibiotic. Canadian journal of physiology and
pharmacology, 1977. 55(1): p. 48-51.
195

174.

Heitman, J., N.R. Movva, and M.N. Hall, Targets for cell cycle arrest by the
immunosuppressant rapamycin in yeast. Science, 1991. 253(5022): p. 905-909.

175.

Kunz, J., et al., Target of rapamycin in yeast, TOR2, is an essential
phosphatidylinositol kinase homolog required for G1 progression. Cell, 1993.
73(3): p. 585-596.

176.

Lorenz, M.C. and J. Heitman, TOR mutations confer rapamycin resistance by
preventing interaction with FKBP12-rapamycin. Journal of Biological Chemistry,
1995. 270(46): p. 27531-27537.

177.

Stan, R., et al., Interaction between FKBP12-rapamycin and TOR involves a
conserved serine residue. Journal of Biological Chemistry, 1994. 269(51): p.
32027-32030.

178.

Zheng, X.-F., et al., TOR kinase domains are required for two distinct functions,
only one of which is inhibited by rapamycin. Cell, 1995. 82(1): p. 121-130.

179.

Helliwell, S.B., et al., TOR1 and TOR2 are structurally and functionally similar
but not identical phosphatidylinositol kinase homologues in yeast. Molecular
biology of the cell, 1994. 5(1): p. 105-118.

180.

Loewith, R., et al., Two TOR complexes, only one of which is rapamycin sensitive,
have distinct roles in cell growth control. Molecular cell, 2002. 10(3): p. 457-468.

181.

Reinke, A., et al., TOR complex 1 includes a novel component, Tco89p
(YPL180w), and cooperates with Ssd1p to maintain cellular integrity in
Saccharomyces cerevisiae. Journal of Biological Chemistry, 2004. 279(15): p.
14752-14762.

182.

Wedaman, K.P., et al., Tor kinases are in distinct membrane-associated protein
complexes in Saccharomyces cerevisiae. Molecular biology of the cell, 2003.
14(3): p. 1204-1220.

183.

Cameron, A.J., et al., mTORC2 targets AGC kinases through Sin1-dependent
recruitment. Biochemical Journal, 2011. 439(2): p. 287-297.

184.

Gatherar, I., et al., Identification of a novel gene hbrB required for polarised
growth in Aspergillus nidulans. Fungal Genetics and Biology, 2004. 41(4): p.
463-471.

185.

Liao, H.-C. and M.-Y. Chen, Target of rapamycin complex 2 signals to
downstream effector yeast protein kinase 2 (Ypk2) through adheres-voraciouslyto-target-of-rapamycin-2 protein 1 (Avo1) in Saccharomyces cerevisiae. Journal
of Biological Chemistry, 2012. 287(9): p. 6089-6099.

186.

Wullschleger, S., et al., Molecular organization of target of rapamycin complex 2.
Journal of Biological Chemistry, 2005. 280(35): p. 30697-30704.
196

187.

Laplante, M. and D.M. Sabatini, mTOR signaling in growth control and disease.
Cell, 2012. 149(2): p. 274-293.

188.

Sabatini, D.M., Twenty-five years of mTOR: Uncovering the link from nutrients to
growth. Proceedings of the National Academy of Sciences, 2017: p. 201716173.

189.

Menand, B., et al., Expression and disruption of the Arabidopsis TOR (target of
rapamycin) gene. Proceedings of the National Academy of Sciences, 2002. 99(9):
p. 6422-6427.

197

ADDITIONAL TABLES AND FIGURES

198

199

258862
Ep155_U_T00006215_1
356517
Ep155_U_T00006216_1
255909
Ep155_U_T00004868_1
231803
Ep155_U_T00004505_1
355955
Ep155_U_T00004864_1
263897
Ep155_U_T00008600_1
58876
Ep155_U_T00000186_1

2017

2009

2017

2009

2017

2009

2017

2009

2017

2009

2017

2009

2017

Gene ID

2009

Annotation

GGTGGCAACGCAAGAAC

CCATCGTCATCGCCTTCA

/

GAGATTCGGCAGATCAGTGG

/

CGGAAGAACAGAAGCAACAAG

/

GCTCTACCAGCCTTAAGGAATC

/

GGACCAGCTTACCACACTTATG

CAGCATTGTGAAGTCCGTCTA

/

CGAGCTGCTCATGCCTAAT

Forward Primer
(5’-3’)
CTGGATTAGCGACTGCATAGAG

CAGCTACAGTCCTCGCA

/

AATACGATGCTTCTCGCTCTC

/

GTACCACGCTCAACCAGTAA

/

GTGATCCGGCAGAAACCA

/

GATTCGAGGTGATCCTGCTATATT

GATTCGAGGTGATCCTGCTATATT

CAGTTTGTCGAAGGCTTTGT

/

GAGGTGACCTTCTCGAATGATG

Reverse Primer
(5’-3’)
CGGAACGATCGTCACTGTT

Primers used for validation of the prediction of 27 predicted genes (2009-version and 2017-version).

SIMILAR

Category

Table A.1

Additional Tables and Figures.
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Different

356706
Ep155_U_T00006769_1
98319
Ep155_U_T00006769_1
231853
Ep155_U_T00007748_1
102253
Ep155_U_T00007119_1
357202
Ep155_U_T00007829_1
261603
Ep155_U_T00007774_1
346358
Ep155_U_T00005807_1
245160
Ep155_U_T00000872_1
357444
Ep155_U_T00008473_1
222652
Ep155_U_T00007540_1
346810
Ep155_U_T00006866_1

2009

2017

2009

2017

2009

2017

2009

2017

2009

2017

2009

2017

2009

2017

2009

2017

2009

2017

2009

2017

2009

2017

Table A.1 (continued)

TCTCTATTCCTGACTCGTCTCC

TCTCTATTCCTGACTCGTCTCC

TGTTATCGCGAAGGGCTATC

TCTTGATACAGGCGTTGATCTG

CTTCTTCTTCCCTCTCCATCAC

/

ATGTCGCAGGGCTTGTC

/

GGTCGACCCTCACTTCAC

GCTGTTTGTGGTCTCGTTATTC

GATGCGGAGATGTGCATTG

AAGGGCAAGAAGAGCAGAAG

GCAGAGGACTACGACTATGAAG

/

GCAATGTGGCTCAGTTTCTTTC

GTCTTGAACTGGAAGGACGAG

/

GGTCTTCACCTGAAGCTTGT

TGATCGTCTTCGACTCAAACTG

ATGAGGTCTCCATCCATCCT

ATGTCTGCCCGCGATTATT

/

CCGCTTGATCCTTCCTCTTTAT

CCAGGCTTGTCTCGATCAAA

GCGAGTATGAGCACCTCTTT

CTCTGGGCACAGTTGTGTAA

CATCTGGTCCTCGTCAAACA

/

GACAGATCCTGTTCCTCCTTC

/

CAGGAAAGACTCCGGTATGTAG

GGTCGACCCTCACTTCAC

GCATCGATCTACCAGCATGA

GCATCGATCTACCAGCATGA

GCCTTATTCCCACCCATGA

/

CTTCGTTTGGGCGCATTTC

GCCGAGATATGCGTCGAAA

/

CAAGACGGCCCTTGGTATT

GCTCTCCATAGCCACTGTTC

CTTACCCTCAAAGTCGGAGAAG

GAGACCAGACTTTCCACCATAG

/

201

334967
71384
68001

2009

2009

2009

Ep155_U_T00001901_1

2017

75444

231988

2009

2009

Ep155_U_T00005405_1

2017

241925

322230

2009

2009

Ep155_U_T00007212_1

2017

65946

94097

2009

2009

Ep155_U_T00006108_1

2017

ATGGTGGGCAGCCTTTG

GCCTTGTATCTTCTTACGGATCTT

ACTATTTGCCTTGCAGGTCTT

TGATCCTGTTAGCCTTGCTATT

GAGCGTCGTGGTGTCATT AT

TGCAGTCTAACCTATCAGCAATC

GGACAGGCAGAAGACATCAA

/

ATGAACACGACCTTACTACGAG

/

AGGAGGTGGAGCGTCTT

AGGAGGTGGAGCGTCTT

TCACTGGTTTGGGTGTTAGG

GGTCGCGCAAGGTTAAATG

GTCAATGAATATGGTGCAGAGGA

ATGCTCATGCTTCTGTGCTAT

GCAGTGCATTGGCCTCT

CCAATGGGTTGGTAGTGTATCT

GAA CCA TCA GAG CAG AGAAGAG

GAACTCCCTGCGGATACTTG

GGGTTATTCAGAGCCCATCTAC

/

GTGCCAACCGATCATGTAGA

/

AGCACATTCGCCTTGTCT

AGCACATTCGCCTTGTCT

CTACAGATGAACGAGGTATGGG

CTACAGATGAACGAGGTATGGG

“/” represents that it is not necessary to design primer for this version to be able using diagnostic PCR to validate the accuracy of
the gene from both versions.

Noexist

260426

2009

Table A.1 (continued)

Figure A.1

Figure 1 of agarose gel pictures for validation of 27 predicted gene models (2009version and 2017-version) using PCR.

(1KB) M is 1Kb size ladder, and lane 1, 4, 7, 9, 11 and 14 are the genomic DNA product of
gene1, gene4, gene8 (2017-version), gene8 (2009-version), gene10 and gene17, separately. The
other lanes’ information is listed in the Table 3.3.
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Figure A.2

Figure 2 of agarose gel pictures for validation of 27 predicted gene models (2009version and 2017-version) using PCR.

lane 1, 3, 5 and 8 are the genomic DNA product of gene3(2009-version), gene3(2017-version),
gene5 and gene7, separately, and M (100bp) is 100bp size ladder. The other lanes’ information is
listed in the Table 3.3.
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Figure A.3

Figure 3 of agarose gel pictures for validation of 27 predicted gene models (2009version and 2017-version) using PCR.

(100 bp) M is 1Kb size ladder, and lane 1, 4, 7, 10, 13 and 16 are the genomic DNA product of
gene2, gene9, gene11, gene12, gene13 and gene14, separately. The other lanes’ information is
listed in the Table 3.3.
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Figure A.4

Figure 4 of agarose gel pictures for validation of 27 predicted gene models (2009version and 2017-version) using PCR.

(1KB) M is 1Kb size ladder, and lane 1, 4, 6, 8, 10, 12 and 14 are the genomic DNA product of
gene 21, gene 23, gene24, gene25, gene26, gene27 and gene22, separately, and in the end
M(100bp) is 100bp size ladder. The other lanes’ information is listed in the Table 3.3.
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Figure A.5

Figure 5 of agarose gel pictures for validation of 27 predicted gene models (2009version and 2017-version) using PCR.

(100bp) M is 100bp size ladder, and lane 1, 4, 7, 10, 13 and 16 are the genomic DNA product of
gene6, gene15, gene16, gene18, gene19 and gene20, separately. The other lanes’ information is
listed in the Table 3.3.
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